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Introduction 
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Intermedíate filaments: regulation of gene expression 
Introduction 
The cytoskeleton of eukaryotic cells consists of three major fibrillar networks: 
microfilaments (25 nm), intermediate filaments (10 nm) and microtubules (5 nm) which 
can be distinguished on the basis of ultrastructural and immunological properties. 
Microfilaments and microtubules are involved in a number of vital processes such as cell 
division, protoplasmic streaming, locomotion, anchorage and cellular polarity. The 
function of intermediate filaments (IFs), however, is not fully understood yet. Only 
recently has progress been reported on the elucidation of some functional aspects of IF. 
Determinations of the gene structure and sequence of various IF genes has suggested a 
common ancestral origin for all IF types (Bloemendal and Pieper, 1989; Blumenberg, 
1989; Steinert and Roop, 1989; Dodemont et al., 1990; Döring and Stick, 1990). 
Sequence similarity has revealed that IF can be subdivided into six different classes which, 
in the adult organism are expressed in a tissue-specific manner (Table 1). Recently two 
new lens-specific intermediate filaments have been described, which are believed to form 
a special new class (Gounari et al., 1993; Merdes et al., 1993). Furthermore, in the eyes 
of goldfish two novel neurofilament proteins are identified, plasticin and gefiltin. These 
two proteins are unique to the goldfish visual pathway, which has special capacities of 
regeneration, unlike higher vertebrates (Glasgow et al., 1992; Glasgow et al., 1994). On 
the other hand there is some evidence that IF expression is not always absolutely restricted 
to specific cell-types (Bader et al., 1988; Parysek et al., 1988; Rungger-Bràndle et al., 
1989; Thompson and Ziff, 1989; Vitadello et al., 1990; Markl, 1991). 
Several highly informative overviews dealing with assembly, interaction with other cell 
structures and putative functions of IF have been published previously. Rather few reviews 
deal with the regulation of cytoplasmic IF expression and here we restrict ourselves 
largely to this topic. 
Abbreviations: 
AP-1, activator protein 1; AP2, transcription factor AP2; CNS, central nervous system; GFAP, glial 
fibrillary acidic protein; HSV-1, human sarcoma virus 1; LTK, TK mouse L cells; MCF-7, mammary 
carcinoma cell line MCF-7; NF, neurofilament; NF1, transcription factor NF1, NGF, nerve growth factor; 
PC12, rat pheochromocytoma cell line PC12; PNS, peripheral nervous system; SV40, simian virus 40; TK, 
thymidine kinase deficient; TPA, 12-0-tetradecanoylphorboI-13-acelate, VP16, HSV-1 viral transactivator 
protein VP16. 
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IF protein structure 
A common structural model of IF subunits 
emerged from the analyses of a large number 
of different IF protein sequences (Aebi et 
al., 1988; Steinert and Roop, 1988; Bloemen­
dal and Pieper, 1989; Stewart, 1990; Parry 
and Steinert, 1992). This model consists of a 
central rod domain of conserved size, secon­
dary structure and sequence, whose most 
characteristic feature is its helical confor­
mation, only interrupted in the cytoplasmic 
IF by short non-helical linkers (Fig. 1). 
Amino-acid residues in the helical regions 
follow the so-called heptad rule, which im­
plies hydrophobic residues at positions a and 
d of the amino acid sequence. Besides con­
servation of alternating positive and negative 
areas in the helical regions, both ends of the 
rod domain are highly conserved, suggesting 
a crucial role, presumably in the aggregation 
process of IF subunits. The central rod is 
flanked by non-helical end domains of varia­
ble size, sequence and chemical characteris­
tics. However, within a particular class of 
intermediate filaments the end domains may 
display considerable similarity (Conway and 
Parry, 1988). Sequence analysis of the cyto­
plasmic IF end domains showed that they can 
be divided into three subdomains (Steinert 
and Roop, 1988; Zhou et al., 1988), namely 
highly similar regions, variable regions (only 
in type I, II, and IV IF) and highly charged, 
(basic) termini. The secondary and higher-
order structure of the IF end domains are 
still poorly understood. Solid-state NMR 
analyses of epidermal keratin filaments sho­
wed that the glycine-rich end domain sequen­
ces have little order, and may form O-loop-
like folds. 
Table 1. Survey of various IF subunits anil their 
cellular origin CNS, central nervous system; 
PNS, peripheral nervous system 
CELL TYPE 
epithelia 
mesenchymal 
and most 
cultured cells 
muscle cells 
PNS and some 
CNS neuronal 
cells 
glia cells and 
astrocytes 
CNS and PNS 
neuronal cells 
most CNS 
neuronal cells 
nucleated cells 
neuroepithelial 
slem cells 
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IF PROTEIN 
acidic keratins 
basic keratins 
vimentm 
desmin 
penpherin 
GFAP (glial 
fibnllary 
acidic protein) 
neurofilament 
proteins (NF-L, 
NF-M, NF-H) 
a-intemexin 
lanuns (lamín A, 
В, C) 
nestm 
H«jti г 
1 1 
иг 12 
m • 
TYPE 
I 
II 
III 
III 
III 
III 
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Fig. 1. General schematic representaron of the 
domain structure of an IF protein subunit. The a-
hehcal rod domain is flanked by a non-helical N-
terminal head and a non-helical C-terminal tail The 
two helix domains 1 and 2 are separated by linker 
L12. The linkers LI and L2 connect the helices 1A, 
IB and 2A, 2B, respectively The helical domains 
possess heptad sequences which favor Ihe formation 
of a coiled-coil structure Approximately in the 
middle of domain 2B this coiled-coil is interrupted 
leading to Ihe helix "slutter'/reversal (see also 
Steinert & Roop, 1988). 
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IF assembly 
The basic building blocks of intermediate filaments are monomeric protein subunits. 
The first step in the assembly process is the formation of a two-chained coiled-coil mole­
cule, which is stabilized largely by hydrophobic interaction between residues at heptad 
positions a and d. The two monomeric chains are aligned in parallel and in axial register, 
the only way to maximize coiled-coil conformation between the conserved α-helices of the 
two subunits (Steinen and Roop, 1988; Dessev et al., 1990; Heitlinger et al., 1991). 
Keratins are obligate heteropolymers. At least one type I and one type II chain are 
required for assembly (Hatzfeld and Franke, 1985). Heteropolymers are necessary already 
at the level of the dimer formation (Coulombe and Fuchs, 1990; Hatzfeld and Weber, 
1990; Steinert, 1990). Under certain conditions homodimers have also been described 
(Hatzfeld and Weber, 1990; Steinert, 1990). Like keratins neurofilament protein NF-M or 
NF-Η chains are unable to form homopolymeric filaments. Only together with NF-L 
copolymerization leads to heteropolymeric IF (Liem, 1990; Tokutake, 1990; Lee et al., 
1993). Also the newly described lens-specific IF proteins phakinin and filensin copolyme-
rize (Merdes et al., 1993). In vitro purified lamins can form homopolymeric structures 
(Ward and Kirschner, 1990; Gieffers and Krohne, 1991; Moir et al., 1991) and when the 
different lamins are mixed they copolymerize (Steinert and Roop, 1988). Type III subunits 
and a-internexin subunits can form homopolymeric structures too. Type III as well as the 
three NF subunits and probably also α-internexin (Kaplan, et al., 1990) subunits are able 
to copolymerize with homopolymeric IF to form heteropolymers (Monteiro and Cleveland, 
1989; Vitadello et al., 1990; Chin et al., 1991). In contrast, coexpression of peripherin 
and NFs does not result in co-localization of the two structures in vivo (Parysek et al., 
1988). Keratins cannot copolymerize with type III IF (Kreis et al., 1983; Giudice and 
Fuchs, 1987; Rungger-Brändle et al., 1989; Raats et al., 1990; 1991; 1992). The reason 
for this may be that, for instance, keratin and vimentin molecules are of different axial 
lengths and therefore axial alignments of two neighboring molecules cannot take place 
(Steinert et al., 1993). 
The mechanism underlying the molecular sorting that occurs during filament formation 
both in vivo and in vitro is not yet fully understood. For instance the heterotypic recogni-
tion ability and complex formation of keratins is not restricted to one specific signal 
sequence, but resides in at least two different domains distributed over the rod domain 
(Magin et al., 1987; Hatzfeld and Weber, 1990). The use of hybrid IF subunits composed 
of keratin I and vimentin in in vitro and in vivo assembly studies showed that the 
recognition sites for K14 and vimentin are situated in helices IB and 2B (McCormick et 
al., 1991). 
The second step in the assembly process of cytoplasmic IF is the formation of a four 
chain complex. This tetramer is the smallest stable polymer that can exist in solution 
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(Geisler and Weber, 1982; Quinlan et al., 
1984; lp et al., 1985; Quinlan et al., 1985; 
Dodemont et al., 1990;). The structure of the 
tetramer determines the arrangement of mole­
cules within an IF. In several reports desiniti 
or vimentin tetramere with lengths which 
might reflect unstaggered arrangement of the 
dimers have been described (Milam and 
Erikson, 1984; Ip et al., 1985; lp, 1988). 
Whether the observed structures represent 
truly unstaggered tetramers or merely stagge­
red tetramere with back-folded extensions or 
even dimers is not completely clear yet. 
However, convincing evidence has been 
provided for antiparallel packing of desmin 
and glial fibrillary acidic protein (GFAP) 
dimers (Quinlan et al., 1989; Stewart et al., 
1989; Potschka et al., 1990). 
The antiparallel, staggered arrangement of 
the tetramer sustains the idea that the non-
helical N-terminal domain may be involved 
in establishing the stagger through lateral 
interactions during assembly (Sauk et al., 
1984; Traub et al., 1992; Shoeman and 
Traub; 1993). Unfortunately, the exact way 
in which tetramers assemble into higher-order 
structures is still obscure. Nevertheless, a 
model for filament assembly has been propo­
sed in which the assembly of tetramers into 
higher order structures is mediated by two 
different kinds of interaction sites (Lu and 
Lane, 1990; Stewart et al., 1989) (Fig. 2). 
The rod domains are supposed to be invol­
ved in lateral interactions, whereas particular 
sites within both N- and C-terminal non-
helical domains might be involved in longitu-
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Fig. 2. Model for cytoplasmic IF assembly into 
filaments essentially as described by Stewart et al. 
(1989) and by Lu and Lane (1990). Large arrows 
indicate the major steps in the assembly process 
which may take place subsequently and/or simul­
taneously. Small arrows indicate the two types of 
binding sites involved in the assembly process; 
interaction between the helical domains and the 
terminal domains respectively. 
Basal -> Spinous -»Granular -> Cornified 
Fig. 3. Structure of the mammalian epidermis. 
The different cells represent successive steps in 
the differentiation proces from basal cells to fully 
differentiated cornified cells (after Calvin et al., 
1989, with permission). 
dinal head-to-tail interactions. This model has 
been sustained by recent transfection and in vitro assembly studies with different cytoplas­
mic IF (Bader et al., 1991; Papamarcaki et al., 1991; Eckelt et al., 1992; Hatzfeld et al., 
1992; Hatzfeld and Weber, 1992; Hermann et al., 1992; Hofmann and Herrmann, 1992; 
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Letai et al., 1992; Raats et al., 1992; Rorke et al., 1992; Traub et al., 1992; Wilson et 
al., 1992; Heins et al., 1993; reviewed by Raats and Bloemendal, 1992). The nonhelical 
end domains are thought to protrude from the filament backbone where they specify the 
functions of the different IF (Steinen et al., 1985). Furthermore it has been suggested that 
linear polymers of tetramers (protofilaments) associate, eventually through the formation 
of protofibrils (linear polymers of octamers), into cytoplasmic IF (Aebi et al., 1988). For 
the lateral protofilament-protofilament interactions, the tail domain of type III IF proteins 
is reported to contain important structural information (Kouklis et al., 1993). The model 
in which the IF structure is organized by different hierarchical levels of subfilaments is 
consistent with the observation of polymorphic IF structures in electron microscopic 
studies with type I-III IF (Steinen and Roop, 1988; Steinen, 199la,b). Assembly studies 
with nuclear lamin B2 showed a mechanism differing from the one suggested for cyto-
plasmic IF. As in the case of cytoplasmic IF, parallel unstaggered dimers are formed that, 
at the second level of organization, associate longitudinally to form polar head-to-tail 
polymers. At the third level the latter polymers further associate laterally, in a approxima-
te half-staggered fashion, to form filamentous structures which consist of antiparallel head-
to-tail apolar polymers (Heitlinger et al., 1991). The whole process of network formation 
has recently been reviewed (Georgatos, 1993; Heins and Aebi 1994). 
IF expression regulation 
Keratins 
Keratins, the epithelia-specific IF proteins, are among the earliest differentially 
expressed IF gene products. The mouse homologues of the human keratins K8 and K18 
can be detected just prior to blastocyst formation (Brûlet et al., 1980; Oshima et al., 
1983; Duprey et al., 1985). Since keratin filaments are composed of two types of keratins, 
every acidic-type keratin is always expressed together with its basic partner. In the adult 
organism, keratins K8 and K18 are coexpressed primarily in a variety of simple epithelial 
tissues (Moll et al., 1982). Sequence analysis indicates that K8 and K18 represent the first 
keratins from which more specialized keratins have been derived (Blumenberg, 1988). The 
structure and organization of several keratin genes have been reported and the list is still 
growing (Glass and Fuchs, 1988; Leube et al., 1988; Oshima et al., 1988; Ouellet et al., 
1988; Wilson et al., 1988; Krauss and Franke, 1990; Waseem et al., 1990; Collins et al., 
1992; Troyanovsky et al., 1992). 
Epithelia can be subdivided into simple and stratified epithelia. The latter are composed 
of several different layers (Fig. 3) and can have specialized functions, corresponding to 
their location. The cells in the different layers represent successive steps in the differentia-
tion process. The cell layer closest to the basal lamina, contains most undifferentiated 
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keratinocytes which express the keratin pair K5 and K14 (Nelson and Sun, 1983). Under 
proliferative conditions additional keratins can be expressed, like for instance the keratin 
pair K6 and K16 (Mansbridge and Knapp, 1987; Stoler et al., 1988). The suprabasal cells 
of the specialized stratified epithelia all express different keratin pairs. The suprabasal 
cells of the mucosal epithelium of the esophagus express the keratin pair K4 and К13 
(Steinen et al., 1985), whereas in cornea КЗ and K12 are found. Keratinizing epidermis is 
characterized by Kl, К10, K2 and KU (Fuchs and Green, 1980; Kopan et al., 1987) and 
fully differentiated cells of this type of epidermis form the uppermost layer, the stratum 
corneum. Keratinocytes in this cell layer are almost entirely composed of keratins and all 
organelles including the nuclei vanish. In hair follicles two different groups of keratins are 
found. The 'soft' hair keratins K5, K6, K14, K16 and K17 are expressed, as well as the 
epidermis-specific Kl and K10 pair (Bowden et al. 1987; Stark et al., 1990). Moreover, 
the 'hard' hair keratins (α-keratins) are also expressed in nails, the filiform papillae of the 
tongue and the thymic reticulum (Heid et al., 1986, 1988a,b; Lynch et al., 1986; Bowden 
et al., 1987; Stark et al., 1987). An exception to the tissue-specific and pairwise expressi­
on of the keratins is К19, which has no basic partner. Induction of expression of this 
protein occurs in response to unbalanced overexpression of any basic keratin. Several 
aspects of keratin expression have also been reviewed by Galvin et al. (1989), Epstein 
(1992) and Oshima (1992). 
Since technology advanced it is becoming clear that retinole acid, one of the metabolic 
derivatives of vitamin A, plays an important role in the regulation of the process of 
epidermal differentiation. In tissue culture retinole acid promotes an undifferentiated 
phenotype: keratinocytes do not show stratification and do not synthesize cornified envelo­
pes (Yuspa and Harris, 1974). Moreover, depletion of retinoic acid from the culture 
medium leads to reverse effects, for instance increased stratification (Eckert, 1989). In 
certain cell lines, the expression of the keratins K8, K18, K7 and K19, characteristic for 
simple epithelia is enhanced, upon addition of retinoic acid (Kim et al., 1987; Glass and 
Fuchs, 1988, Crowe, 1993). Another keratin which is also induced by this vitamin A 
derivative is the mucosa-specific keratin K13 (Kopan et al., 1987), whereas the differenti­
ation- and proliferation-specific markers Kl, K10, K5, K14, K6 and K16 are suppressed 
(Fuchs and Green, 1981; Eckert and Green, 1984; Tomic et al., 1990). Retinoic acid 
affects the differentiation and proliferation of many types of cells. It exerts its action by 
binding to and activating a specific set of nuclear receptors. The transcription of specific 
genes can be directly controlled by binding of nuclear receptors to their ligand and to a 
specific DNA recognition element. The repressing effect of retinoic acid on the expression 
of the genes for K5, K6, K14 and K16 can already be detected 6 h after retinoic acid 
treatment (Stellmach et al., 1991). This very rapid transcriptional change is in sharp 
contrast with the relatively late retinoic acid-mediated positive response of the simple 
keratins K8 and К18. If the retinoic acid receptor accounts for the increase in expression 
by binding to a specific promoter element one would expect a fast induction mechanism. 
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A direct interaction of the retinoic acid receptor with a specific keratin promoter region 
has not yet been demonstrated. Potential retinoic- acid-responsive elements are present in, 
for instance, the K10 and K14 promoters (Blumenberg et al., 1992), but direct binding to 
these sites still has to be proven. 
Transfection studies of keratin genes have revealed a promiscuous as well as a tissue-
specific expression in cultured cells (Lersch et al., 1989; Jiang et al., 1991). In a transient 
assay using cat constructs, correct expression has been observed for a 605-bp promoter 
fragment of the bovine keratin gene IV, which is comparable with the human K10. For 
the human K18 gene no tissue-specific expression has been detected in transient transfecti-
on assays (Kulesh and Oshima, 1988). A similar gene construct, however, has shown an 
appropriate expression in transgenic mice (Abe and Oshima, 1990; Neznanov and Oshima, 
1993). Furthermore, the transcription regulation of the human Kl gene has been studied in 
transgenic mice. A 12-kb genomic fragment is sufficient for activation of the Kl gene by 
elevated Ca2+ levels in primary epidermal cell cultures derived from newborn transgenic 
mice (Rosenthal et al., 1991). Recently, it has been reported that the calcium response of 
the human Kl gene is mediated by AP-1 factors and steroid hormone receptors (Lu et al., 
1994). The induction of for example keratin Kl and keratin K10 by specific Ca2+ concen-
trations in cultured keratinocytes has been suggested earlier (Huff et al., 1993) and 
probably represents an explanation for the existence of a Ca2+ gradient in vivo in these 
cells (Yuspa et al., 1989). Experiments in transgenic mice with several other keratin gene 
constructs also have shown correct tissue-specific expression of the transgene (Vassar et 
al., 1989, 1991; Bader and Franke, 1990; Bailleul et al., 1990; Rosenthal et al., 1991; 
Fuchs et al., 1992). 
Attempts to resolve the precise mechanism controlling keratinocyte-specific gene 
expression have led to some candidate regulatory elements with their corresponding trans-
acting factors. Using a mouse teratocarcinoma cell line, a differentiation-specific enhancer 
has been found in the downstream region of the mouse endoA gene, corresponding to the 
human keratin 8 (Takemoto et al., 1991). This enhancer also acts on the heterologous 
SV40 promoter. Other cell-type-specific enhancers have been described for the upstream 
regions of the bovine K6 gene, and the human K14 gene, both expressed in stratified 
epithelia (Blessing et al., 1989; Jiang et al., 1990). Moreover, the human K6 upstream 
region contains sequences which can be specifically induced by epidermal growth factor 
(Jiang et al., 1993). Also the possible involvement of AP-1 transcription factor in keratin 
expression regulation has been suggested, in view of the activation of K18 reporter 
constructs by c-fos and c-jun expression vectors (Oshima et al., 1990). After in vitro 
mutagenesis, it has been shown that the activation protein 1 (AP-1) element, responsible 
for this trans-activation, is located within the first intron. More information concerning 
this intron enhancer has been provided by a study describing the activation of keratin 18 
expression via ras signal transduction pathways (Pankov et al., 1994). Also for keratin 19 
AP-1 has been identified as an important regulatory factor. Here the enhancer site is 
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located in the З'-flanking region (Hu and Gudas, 1994). Another known transcription 
factor, important for regulation of the human keratin 14 gene, has been identified since. 
This factor, named KER1 (Leask et al., 1990), which binds to a 10-bp palindromic 
sequence, has later been identified as transcription factor AP2 (Leask et al., 1991). The 
identified DNA element binding AP2 and a distal element act sinergistically in driving the 
expression of the human K14 gene in epidermal cells in vitro and in transgenic mice in 
vivo (Leask et al., 1990). A related transcription factor has also been found in Xenopus. 
This factor, named KTF1, is abundant in embryonic nuclear extracts and binds to a 
similar palindromic sequence (Snape et al., 1991). In the human keratin 5 gene, in 
addition to a potential AP2 binding site, several other DNA elements have been analyzed 
by in vitro DNA interaction studies (Byrne and Fuchs, 1993). Among these potential 
regulating factors are also the recognition sites for the retinole acid receptor and the 
thyroid hormone receptor (Ohtsuki et al. 1992). 
Vimentin 
Vimentin is the intermediate filament protein of mesenchymal cells. It is the only IF 
protein, which deviates from the tissue-specific and developmentally regulated pattern of 
expression. Besides its typical expression in most cultured cells, vimentin is also expres­
sed together with several other IF proteins during immature stages of development (Franke 
et al., 1978). Examples of this phenomenon are, the transient coexpression of neurofila­
ments and vimentin in the developing peripheral nervous system (Cochard and Paulin, 
1984), expression of vimentin and GFAP during astrocyte differentiation (Dahl et al., 
1981; Schnitzer et al., 1981) and coexpression of vimentin and desmin during muscle cell 
differentiation (Lazarides et al., 1982). In very early development in Xenopus, vimentin is 
reported to be expressed in oocytes, eggs and early embryos (Tang et al., 1988; Torpey et 
al., 1990). Furthermore, expression of vimentin in early mouse embryogenesis is 
detectable just until day 8 after gestation (Jackson et al., 1981; Lane et al., 1983). As 
differentiation proceeds, vimentin is exchanged for the tissue-specific intermediate filament 
type. One of the exceptions to this general rule, is the epithelium-derived eye lens, in 
which a high vimentin expression persists into adulthood (Dodemont et al., 1982). 
Vimentin is encoded by a single copy gene in several species (Quax et al., 1983; Quax-
Jeuken et al., 1983; Zehner and Paterson, 1983; Capetanaki et al., 1983; Ferrari et al., 
1986; Perreau et al. 1988; Hennekes et al., 1990). In the chicken, this single copy gene 
encodes two mRNAs (Zehner and Paterson, 1983; Capetanaki et al., 1983) and in Xeno­
pus even several forms of vimentin proteins have been described (Herrmann et al., 1989). 
In the course of time, the tissue-specific expression of vimentin has often been studied 
using mesenchymal cells like fibroblasts, lymphocytes and other hematopoietic cell types 
(Lilienbaum et al., 1986; Sax et al., 1988; Riltling et al., 1989; Tsuro et al., 1990; Po-
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doun and Prystowsky, 1991). As shown for 
several other IF genes, the regulation of 
vimentin expression takes place at the trans-
criptional level. The hamster upstream regu-
latory region of approximately 3.1 kb directs 
tissue-specific expression in transgenic mice 
(Krimpenfort et al., 1988; Pieper et al., 
1989a). In tissue culture this type III protein 
is expressed in most cells, irrespective of 
their embryonic origin (Fig. 4). Vimentin 
mRNA has been reported to be inducible by 
certain peptide growth factors in a variety of Fig. 4. Immunofluorescence study. HeLa cells 
cell types (Ferrari et al., 1986; Alldridge et ^ j , c u b a , e d wi 'h a polyclonal anii-vi» ien,in 
al., 1989). In addition to growth factors, the 
phorbol ester TPA (12-C4etradecanoylphorbol-13-acetate) also exerts a strong positive 
effect on vimentin expression (Laszlo and Bissel, 1983; Siebert and Fukuda, 1985; 
Giese and Traub, 1986; Dellagi et al., 1983). In specifically synchronized MPC-11 mouse 
plasmacytoma cells, TPA has been been able to activate a cell-cycle-dependent pattern of 
vimentin expression (Giese et al., 1992). 
Furthermore TPA and growth factor induction has been reported to be mediated by a 
double AP-1 consensus element in the human vimentin promoter (Rittling et al., 1989). 
The double AP-1 consensus element functions as a strong enhancer in several cell types 
and is conserved in location and function between hamster, mouse and man (Rittling et 
al., 1989; van de Klundert et al., 1992; Pieper et al., 1992). This element seems not to be 
conserved in the chicken vimentin promoter and the cis-acting sequences responsible for 
TPA induction still need to be identified (Stover and Zehner, 1992). Possibly there is 
some divergence, also considering the differences in expression of chicken and hamster 
vimentin gene constructs upon transfection and subsequent differentiation of erytro-
leukemia cells (Ngai et al., 1987). The overall pattern of vimentin expression regulation 
correlates well with the behavior of a growth-regulated gene, or a primary response gene 
(Connell and Rheinwald, 1983; Rittling and Baserga, 1987). The function of the vimentin 
gene in this context is still unclear. Moreover, vimentin is often found in neoplasms, 
where it is expressed together with the cell-type-specific IF protein (Coggi et al., 1989). 
The interesting aspect of vimentin down-regulation upon muscle differentiation has 
been studied by several groups. For instance, in the hamster vimentin gene, a proximal 
promoter region of approximately 175 bp is still able to control down-regulation of 
vimentin expression upon transfection of reporter constructs in the mouse skeletal muscle 
cell line C2C12 (Pieper et al., 1989b). In the chicken vimentin promoter these down-
regulatory elements are contained within a proximal enhancer element between -321 and -
161 bp (Sax et al., 1989). Elsewhere in this promoter, a negative regulatory element or 
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silencer has also been described (Farrell et al., 1990). The protein binding to this element 
has been shown to have a higher binding activity during gizzard muscle development in 
ovo. Moreover, besides this silencer element a 75-bp antisilencer element has been identi-
fied as well as two other silencer elements (Stover and Zehner, 1992; Garzón and Zehner, 
1994). The antisilencer element does not function as a classical enhancer, but is able to 
override the effect of negative regulatory elements in the chicken vimentin promoter only. 
In the human vimenlin promoter two putative negative regulatory regions have been found 
(Rittling et al., 1989; Lilienbaum et al.. 1990; Salvetli et al., 1993). One of these two 
silencer elements is affected by the T-cell leukemia virus type I Tax protein. Two silencer 
elements have also been identified in the hamster vimentin promoter region. They flank 
the AP-1 enhancer element and exhibit strong silencer functions in the vimentin-negative 
mammary carcinoma cell line MCF-7 (van de Klundert et al., 1992). At least one of these 
silencer proteins shows homology with one of the human negative regulatory regions. 
Furthermore, the proximal promoter region also contains cis-acting sequences important 
for at least a basal level of transcription (Rittling et al., 1989; Sax et al., 1990; Pieper et 
al., 1992). In the proximal promoter region of the human vimentin gene a 30-bp sequence 
has been identified, which has proved to be sufficient for inducibility of vimentin 
expression by the Tax protein in hematopoietic cells (Lilienbaum et al., 1990; Lilienbaum 
and Paulin, 1993). This viral protein plays a role in the lymphoproliferative process 
associated with human T-cell leukemia viral type I infection. The involvement of the AP-1 
enhancer (perhaps in conjunction with the negative elements and still unidentified 
sequences) in the tissue-specific regulation of the viinentin gene, is still elusive. This will 
probably only be clarified upon performance of experiments in transgenic mice where no 
tissue-culture-like induction of vimenlin is feasible. 
Desmin 
Desmin exhibits a high degree of tissue specificity, its expression is predominantly 
confined to muscle. The regulation of desmin expression is characterized by a develop-
mental pattern. In mouse development the protein is first expressed in the heart rudiment 
at day 8. Furthermore, at day 9 post-coitum cross-striation of desmin in heart muscle is 
visible and the protein is also detectable in myotomes (Schaart et al., 1989). In the human 
fetus, desmin cross-striation is seen at 10 weeks of development (Carter et al., 1989). 
Cross-striation of desmin protein in mature skeletal muscle tissue is caused by a rearran-
gement of desmin filaments in a sarcomeric fashion around myofibrils at the Z-disc level. 
This differentiation step is associated with an increase in desmin mRNA and protein. Vi-
mentin, which is highly homologous to desmin, is expressed in skeletal myoblast before 
differentiation. According to some authors, vimentin and its mRNA disappear shortly after 
myoblast fusion and formation of myotubes (Dennett et al., 1979; Tokuyasu et al. 1984, 
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myoblasts myotubes 
Fig. 5. Immunofluorescence study of C2C12 cells 
incubated with a polyclonal anti-desmin antibody. 
Myoblasts and differentiated multinucleated myo-
tubes are shown. 
1985; Lilienbaum et al., 1988). Other wor- C2C12 
kers claim that vimentin is still expressed in 
muscle fibers in culture and even in the adult 
animal (Gard and Lazarides, 1980; Capet-
anakietal., 1983). 
The expression pattern of desmin in smo-
oth muscle is much more heterogeneous 
(Gabbiani et al., 1981; Quinlan and Franke, 
1982; Schmid et al., 1982; Fujimoto et al., 
1987). The majority of smooth muscle cells 
in muscular arteries express both vimentin 
and desmin, while those in the elastic arteries 
have only vimentin. This heterogeneity is 
also reflected along the length of blood ves-
sels, whereas desmin-expressing cells in the 
aorta smooth muscle layer increase from the aorta arch to the more distal parts (Osborn et 
al., 1981). Smooth muscle cells of digestive respiratory and urogenital tract express des-
min as their major intermediate filament protein (Gabbiani et al., 1981). The hamster, 
chicken and human desmin genes have been cloned by Quax et al. (1985), Capetanaki et 
al. (1984) and Li et al. (1989), respectively. In all species, desmin is encoded by a single 
copy gene and one single mRNA is produced. Analysis of mRNA and protein levels has 
revealed for desmin as well as for most other IF proteins that mRNA patterns correlated 
with protein patterns. This implies that expression is mainly regulated at the transcriptio-
nal level. 
For characterization of the desmin promoter region in tissue culture the mouse skeletal 
muscle cell line C2 (Yaffe and Saxel, 1977) or derivatives of this myogenic cell line like 
C2C12 (Blau et al., 1983) are often used. Both cell lines are able to differentiate into 
myotubes rapidly and extensively (Fig. 5), while desmin expression is upregulated several-
fold upon differentiation. It has been reported previously, that high-level tissue- and stage-
specific expression could be obtained with a small hamster desmin promoter fragment 
extending from -89 to +25 bp (Pieper et al., 1989b). Furthermore, we and others have 
provided evidence for an enhancer element in the more distal upstream region as well (Li 
and Paulin, 1991; Li and Capetanaki, 1993; Li and Paulin, 1993; van de Klundert et al., 
1994). This region, located approximately 700 bp upstream from the transcription start 
site, functions as an enhancer in myoblasts and myotubes is highly conserved between 
hamster and man and contains several consensus sequences for known muscle-specific 
trans-acting factors. 
Prominent examples of these enhancer binding proteins are the members of the MyoD 
family, MyoD, myogenin, Myf5 and Myf6 (also called MRF4). These myogenic deter-
mination factors contribute to the regulation of the expression of several muscle-specific 
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genes via interaction with one or more Ε-box sequences (Buskin and Hauschka, 1989; 
Pielte et al., 1990; Sartorelli et al., 1990; Wentworth et al., 1991). Forced expression of 
MyoD in fibroblasts and retinal pigmented epithelial cells, has resulted in an increased 
expression of desmin (Choi et al., 1990). in vivo, however, myogenin RNA is detected in 
early myotomes at day 8.5 in mouse development, when desmin also starts to accumulate 
and before MyoD RNA expression, which can be found only 2 days later (Sassoon et 
al., 1989). In cell lines MyoD and myogenin have been reported to activate their own 
expression and cross-activate one another's expression (Braun et al., 1989). Other possible 
candidates for the regulation of desmin expression can be found in a heterogeneous group 
of factors, among which is a factor called MEF-2, all binding to an A+T-rich element 
(Gossett et al., 1989, Pollock and Treismann, 1992). The muscle-specific form of MEF-2 
is able to transactivate muscle-specific genes separately, or in combination with one or 
more Ε-box binding factors (Edmondson et al., 1992) and the factor itself can be induced 
by MyoD and myogenin (Cserjesi and Olson, 1991). Besides several Ε-boxes, the desmin 
upstream enhancer region also contains a putative MEF-2 binding site (Li and Paulin, 
1991). Recently, it has been shown that this MEF-2 site, in conjunction with a nearby E-
box, is necessary for full enhancer activity. Mutagenesis of only one of these two 
elements moderately affects the enhancer function (Li and Capetanaki, 1994; van de 
Klundert, unpublished). The cooperation of Ε-box factors and the MEF-2 binding protein 
fit in a model, which explains the regulation of desmin expression to a certain extent, at 
least in cultured muscle cells. In heart, however no MyoD homologues have been found 
so far. Moreover, the expression of LacZ fusion constructs in transgenic mice has shown 
that regulatory proteins must bind in a region upstream from -1 Kb, because a construct 
which lacks this region is not expressed in the heart and smooth muscle tissue (Marchand 
et al., 1993). 
Glial fibrillary acidic protein 
The glial fibrillary acidic protein (GFAP) was initially isolated from multiple sclerosis 
plaques (Eng et al., 1971). As demonstrated by immunohistochemical studies, GFAP is 
selectively located in astrocytes (Bignami et al., 1972) and represents the major constitu­
ent of astrocytic intermediate filaments. The GFAP genes have been cloned and analyzed 
in mice and men (Balcarek and Cowan, 1985; Reeves et al., 1989). GFAP expression 
levels are highly variable during development of the central nervous system. As differenti­
ation proceeds, neurons are generated at the ventricular surface and then migrate along 
astrocytic processes toward their ultimate destination, whereas astrocytes provide the 
scaffolding and trophic support required for neuronal positioning (Rakic, 1981). Astrocy­
tes, and oligodendrocytes (glia) together make up half the cell content in the human brain. 
Oligodendrocytes, which ensheath nerve fibres, initally express vimentin in an immature 
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stale, but later in development all IF expression vanishes. The expression of vimentin by 
immature astrocytes (glioblasts), is exchanged for GFAP upon maturation (Eng, 1985). 
Depending on the species, the switch from vimentin to GFAP in the developing organism 
may occur prenatally (e.g. in humans) or postnatally (e.g. in mice) (Lewis and Cowan, 
1985a; Mokuno et al., 1989; Landry et al., 1990; Sarthy et al., 1991). In adults, GFAP 
levels increase as a result of the proliferation of astrocytes (reactive gliosis) that occurs in 
a response to a variety of physical, chemical and etiological insults, including Alzheimer's 
disease, epilepsy and multiple sclerosis (reviewed by Eng, 1980). Cultured astrocytes 
modulate their synthesis of GFAP in response to cell density (Goldman and Chiù, 1984; 
Bologa et al., 1988), composition of growth media (Morrison et al., 1985) and both 
glucocorticoid hormones and hormones that stimulate cAMP production (Morrison et al., 
1985; Shafit-Zagardo et al., 1988). 
In the peripheral nervous system GFAP is expressed by Schwann cells. Upon differen-
tiation, myelin-forming Schwann cells down-regulate GFAP, whereas in non-myelin-
forming Schwann cells GFAP persists into adulthood (Jessen et al., 1984). Apart from 
nonmyelinating Schwann cells, GFAP can also be detected by immunocytochemistry in 
peripheral glia, including enteric glia (Jessen and Mirsky, 1980, 1983; Björklund et al., 
1984). GFAP-related antigens have also been detected in non-neuronal tissues, for 
example, lens epithelium (Hatfield et al., 1985). It has been reported that the GFAP 
mRNA, isolated from a rat Schwann cell library, differed in length from the known brain 
GFAP mRNA (Feinstein et al., 1992). At the protein level, a major fragment has been 
identified by tryptic peptide mapping, which is present in the central nervous system 
(CNS) GFAP and absent from the peripheral nervous system (PNS) GFAP. 
The developmental and tissue-specific expression of GFAP points to a complex 
transcriptional and posttranscriptional regulation model. This is reflected in the apparent 
discrepancy which has been found in the transcription rate and mRNA levels during 
different stages of postnatal mouse brain development (Riol et al., 1992). The transcripti-
on rate is maximal 3 days after birth and decreases gradually. Messenger RNA levels, 
however, are low at this time and high at day 15. The reason for this unexpected 
observation is not known. Two studies concerning the transcriptional regulation of the 
GFAP gene have been performed in cultured astrocytes or astrocytoma cells (Miura et al., 
1990; Sarkar and Cowan, 1991). The most important differences between both experi-
mental approaches are the use of the entire GFAP gene by the latter authors and the use 
of GFAP-reporter constructs by Miura et al. (1990). The ш-acting elements required for 
astrocyte-specific expression seem to be located within 256 bp from the transcriptional 
start site. Three trans-acting, factor binding sites have been detected in this region (Miura 
et al., 1990). The most important consensus binding sequences comprise the cAMP 
response element and transcription factors NF1 and AP2 binding site motifs. Mutational 
analysis has revealed (in this case), that the NF1 is a positive regulator and the cAMP and 
AP2 homology regions are negative regulators of GFAP expression. Also, a distal positive 
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enhancer region at approximately 1500 bp upstream has been detected, in addition to a 
proximal enhancer region (Sarkar and Cowan, 1991). When both positive elements are 
present, expression in HeLa and U251 (human astrocytoma) is obtained. Tissue-specific 
expression, however, is observed only when sequences from the first intron are contained 
within the construct. This implies a negative regulatory mechanism to be important for 
astrocyte-specific expression. Sequences downstream from the transcription start also seem 
to play a role in the transcriptional regulation of the human GFAP gene (Besnard et al., 
1991). In addition to the TATA box a downstream initiation site is also important for 
efficient transcription in cultured cells (Nakatani et al., 1990). In the human GFAP 
promoter region a distal positive enhancer element has also been detected at -1500 bp, as 
well as a proximal enhancer region near the basal promoter. The authors claim that both 
regions act in a cell-specific manner, in combination with the GFAP promoter or the 
heterologous SV40 promoter. Differences in cell densities during the experiments may 
have contributed to the reported discrepancies (Besnard et al., 1991). The latter authors 
used nearly confluent cell cultures and, as mentioned earlier, in cultured astrocytes 
synthesis of GFAP is affected by cell density (Goldman and Chiù, 1984). Experiments in 
transgenic mice may contribute to the elucidation of the transciptional regulation model for 
the GFAP gene. 
Neuronal intermediate filaments 
Neurofilaments 
Like most other IF proteins, the expression of the different neuronal IF proteins is both 
tissue-specific and developmentally regulated. While peripherin is found mainly in the 
peripheral nervous system and a-internexin in the central nervous system, the NF triplet 
proteins occur in both the central and the peripheral nervous system. During development 
nestin is the first IF protein to be expressed in neuroepithelial stem cells (Lendahl et al., 
1990). tt-Internexin precedes NF-L and NF-M in the developing central nervous system 
(Kaplan et al., 1990), whereas NF-Η is the last neuronal IF to be expressed during 
mammalian development (reviewed by Liem, 1990). All three NF proteins can be detected 
by immunohistochemical methods at day 9 or 10 after gestation in the mouse embryo 
(Cochard and Paulin, 1984). The cDNAs encoding the entire protein sequences for NF-L, 
NF-M and NF-Η have been published (Lewis and Cowan, 1985b; Julien et al., 1986, 
1988; Napolitano et al., 1987; Lees et al., 1988; Sharpe, 1988; Lieberburg et al., 1989). 
A closer look at NF-Η expression shows that the protein is abundant in spinal cord, 
cerebellum, pons and medulla. These are predominantly brain regions giving rise to long-
axon neurons. NF-Η mRNA levels are highest in neurons that produce long thick axons 
(Hoffman et al., 1987). Additional evidence for the direct correlation between a high NF 
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expression and axonal caliber can be found in two other reports (Muma et al., 1991; Eyer 
and Peterson, 1994). The results of Monteiro et al. (1990), on the other hand, are in sharp 
contrast to the hypothesis that NF expression is involved in the control of axonal caliber. 
The authors demonstrate that an increased expression of NF-L in myelinated nerve fibers 
of transgenic mice is reflected in an increased density of axonal filaments, but not in an 
increased axonal caliber. Future experiments, in which the expression of the other NF 
proteins is changed as well, may provide new clues. 
Although IF proteins of the neurofilament type are normally restricted to neurons, there 
are some reports on expression in non-neuronal cells as well (Granger and Lazarides, 
1983). An interesting aspect of non-neuronal expression has been found in heart conducti-
on myocytes where NF proteins are expressed together with desmin (Vitadello et al., 
1990). Another example is the intermediate filament protein of neuroepithelial stem cells, 
nestin (Lendahl et al., 1990). Its mRNA is detectable transiently during skeletal muscle 
development (Sejersen and Lendahl, 1993). In this light, interesting speculations can be 
made about the transcription factors responsible for this type of non-neuronal expression. 
Myelinating Schwann cells, which normally express vimentin and during an earlier stage 
GFAP, have also been reported to contain an NF protein (Kelly et al., 1992). The authors 
further claim a necessity of axonal contact by the differentiated Schwann cells in order to 
express NF-M. Besides the expression of NF-M in myelinating Schwann cells, an even 
stranger phenomenon appeared on the investigation of the goldfish visual pathway. Glial 
cells in this organism express a keratin protein equivalent to the mammalian keratin K8 
(Giordano et al., 1989). Moreover, a novel type III filament protein of neuronal cells, 
called plasticin, has been described for this organism, which is dissimilar to any of the 
known mammalian type III proteins (Glasgow et al., 1992). 
Several authors have shown the rather promiscuous expression of neurofilament 
promoters in transient expression assays. The human NF-L gene, the mouse NF-L gene 
and the human NF-M gene, driven by their own promoters, are expressed equally well 
when transfected in non-neuronal and neuronal cells (Julien et al., 1990; Monteiro and 
Cleveland, 1989; Pleasure et al. 1990). An additional report has shown that the neuron-
specific expression of the mouse NF-L gene is regulated at the level of transcription 
initation, but a 1.6-kb NF-L promoter linked to the reporter cat gene does not exhibit 
tissue specificity in transient transfection systems (Nakahira et al., 1990). Gene transfer 
into mice seems to be a more appropriate means to detect tissue-specific DNA elements in 
the type IV genes, than transient transfection in cultured cells. This has for, example, 
been shown for the human NF-L and NF-M gene, where tissue-specific expression can be 
obtained in transgenic mice (Julien et al., 1990; Lee et al., 1992; Reeben et al., 1993; 
Yazdanbakhsh et al., 1993). Another study also shows that a 1.5-kb mouse NF-L gene 
promoter is capable of functioning in a neuronal tissue-specific manner in transgenic mice 
bearing the NF-L promoter-VP16 (HSV-1 transactivator) chimeric gene (Byrne and 
Ruddle, 1989). Not only a full transcription unit, but also a chimeric cat construct with a 
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2.3-kb 5'-flanking sequence of the human NF-L gene linked to the cat gene is capable of 
directing tissue-specific expression in transgenic mice (Julien et al., 1990). 
The 1.7-kb mouse NF-L 5'-upstream region has been investigated for the presence of 
hypersensitive regions (Ivanov and Brown 1992). Nuclear extracts prepared from brain 
and liver nuclei have been used for the mapping of hypersensitive regions. In vitro DNase 
I footprinting of one of the brain-specific hypersensitive sites has revealed only minor 
differences between brain and liver nuclear extracts. Recently, it has been found that AP-1 
and Krox24, two immediate early gene products, are able to activate the NF-L promoter 
in P19 embryonal carcinoma cells (Pospelov et al., 1994). The upstream region of the 
human NF-M gene has also been used for in vitro interaction studies (Elder et al., 1992). 
Neuronal-specific regulator elements have not been found, but certain enhancer sequences, 
able to stimulate expression several fold, have been identified. Since transfection experi­
ments suggest that the neurofilament promoter sequences can function in various cell lines, 
mechanisms may exist that repress gene transcription in non-neuronal cells in vivo. 
Indications for this type of regulation can be found in a report describing negatively acting 
regions upstream of all three mouse neurofilament genes (Shneidman et al., 1992). The 
negative regions of NF-Η and NF-L suppress transcription when placed in either orientati­
on in front of a heterologous and homologous promoter. The role of the negative elements 
in regulating NF expression remains unclear, because negative elements reduce transcripti­
on in both neuronal and non-neuronal cells. 
a-Internexin 
The a-internexin gene has been cloned by Ching and Liem (1991) using low-stringency 
hybridization conditions and an NF-M cDNA probe. The gene consists of three exons and 
two introns and has been classified as a type IV intermediate filament gene. a-Internexin 
initially has been identified as a 66-kDa protein that copurified with IF from rat spinal 
cord and optic nerve (Pachter and Liem, 1985). The protein appears to be more abundant 
in development where it is found in most, if not all, neurons of the central nervous 
system. Its expression precedes that of NF-L in most neurons of the developing brain 
(Kaplan et al., 1990). Furthermore, Northern blot analysis shows that the level of rat 
brain α-internexin mRNA reaches a maximum at embryonic day 16 and decreases thereaf­
ter (Fliegner et al., 1990). In the adult rat, expression can be found predominantly in thin 
caliber parallel fibers, whereas neurofilament proteins are highly expressed in large 
neurons (Fliegneretal., 1994). 
Like several other IF protein species, expression of α-internexin is subject to both 
developmental and tissue-specific control. By using 5.0 kb of upstream regulatory 
sequences no tissue-specific α-internexin expression could be detected (Ching and Liem, 
1991). Promoter constructs are equally active in a neuroblastoma cell line as in mouse 
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LTK" cells. This lack of tissue specificity has also been shown for other type IV IF genes 
in transient transfection assays (Julien et al., 1987; Monteiro and Cleveland, 1989; 
Pleasure et al., 1990; Nakahira et al., 1990). The possibility of regulatory sequences in, 
for instance, the 6.2-kb first intron and the very long З'-untranslated region still needs to 
be proved (Ching and Liem, 1991). Furthermore, several candidate consensus sequences 
for transcription factors have been found in the more upstream promoter region. 
Peripherin 
Peripherin is the neuronal intermediate filament protein most closely related to the type 
III proteins vimentin, desmin and GFAP (Leonard et al., 1988). Peripherin was first 
identified in cultures of normal mouse neuronal cells, in differentiating neuroblastoma 
cells and in PC 12 cells (Portier et al., 1984a; Parysek and Goldman, 1987). The cDNA 
sequences and genes of rat and mouse have been cloned and analyzed (Leonard et al., 
1988; Landon et al., 1989; Thompson and Ziff, 1989). Studies in vivo using in situ 
hybridization and immunohistochemical methods have shown that peripherin is found 
abundantly in peripheral nervous system neurons, most cranial nerves, ventral horn motor 
neurons and a few other nuclei in the central nervous system, localized in the hindbrain 
and midbrain (Portier et al., 1984b; Leonard et al., 1988; Parysek and Goldman, 1988). 
During mouse development peripherin is induced after the NF-L protein and is first 
detected in the myelencephalon, at embryonic day 9. As differentiation proceeds, 
peripherin-positive cells are first localized at the outer border of the spinal cord and 
migrate towards the center. Peripherin expressing-cells remain only in the ventral horn of 
the spinal cord and in motor neurons (Troy et al., 1990; Gorham et al., 1990; Escurat et 
al., 1990). PC12 cells, in which synthesis rate has been induced by admission of nerve 
growth factor (NGF), have often been used to study peripherin production. There are 
indications, however, that peripherin expression probably precedes NGF responsiveness of 
neurons in vivo, because the protein is already induced when axons are first being 
generated. At least the NGF receptor is detectable during a later stage in axon formation 
(Gorham et al., 1990). 
The transcriptional regulation of the peripherin gene has been studied by several 
workers, using PC 12 cells with or without NGF stimulation. The first 98 bp preceding the 
transcription start (proximal positive region) linked to a reporter gene are sufficient to 
confer cell-type specific expression (Desmarais et al., 1992). In this region three different 
protein interaction points have been identified by DNase I footprinting. One of these three 
regions surrounds the TATA box and is involved in cell-type-specific expression. The 
other two determine the level of promoter activity. Furthermore, similar experiments have 
been performed using rat peripherin gene constructs, which have been transfected into 
PC12 cells upon admission of NGF (Thompson et al., 1992). As may be expected, the 
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results are comparable with the experiments described above. According to the authors 
the proximal enhancer region contains a positive neuron-specific element in the mouse 
gene and in the rat gene this enhancer region has been identified as a constitutive element. 
In the latter report also a negative regulatory element is described, possibly involved, in 
combination with a distal positive element, in restricting peripherin expression to neuronal 
cells (Thompson et al., 1992). Using transgenic mice other important intragenic sequen-
ces, involved in peripherin cell type specific and injury-induced expression, have been 
defined (Belecky-Adams et al., 1993). 
Nestin 
The last of the neuronal-specific intermediate filament proteins to be discovered is 
nestin, whose expression is restricted to neuroepithelial stem cells. The nestin cDNA has 
been cloned upon screening of a rat expression library with a monoclonal antibody 
specifically binding to a very large proportion of cells in the embryonic brain (Lendahl et 
al., 1990). Nestin is present in the immediate precursors to neurons and neither neurons 
nor glia in the adult brain express the protein. During development neuroepithelial stem 
cells are distinguished from more differentiated cell merely by the expression of nestin 
(Frederiksen and McKay, 1988). Although neurogenesis in the mammalian central nervous 
system is believed to end in the period just after birth, nestin expression has been detected 
in cultured cells derived from the striatum of the adult mouse brain (Reynolds and Weiss, 
1992). When these cells are induced to differentiate upon admission of epidermal growth 
factor, initially nestin is expressed. The controlling elements involved in directing nestin 
expression to neural stem cells or muscle precursors have recently been identified 
(Zimmerman et al., 1994). 
IF functional aspects 
Finally, we want to deal with a few functional aspects of IF which have emerged 
recently. Despite the vast amount of information about IF architectural aspects, their 
actual function still remains elusive. So far, much effort has been invested in the analysis 
of IF network disruption. These studies mainly concentrated on the use of mutant IF gene 
constructs for transfection in cultured cells or expression in transgenic mice. Several 
groups reported overexpression of various IF protein genes in transgenic mice resulting in 
specific aberrations such as cataract formation or hair breakage (Capetanaki et al., 1989; 
Dunia et al., 1990; Monteiro et al., 1990; Powell and Rogers, 1990; Bloemendal, 1991). 
More recently, the aim of some workers has been to provoke the abolishment of IF 
expression. In one of these studies both alleles of the simple keratin K8 were disrupted via 
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homologous recombination (Baribault and Oshima, 1991). The resulting embryonic stem 
cells are able to differentiate into yolk sac embryoid bodies and there are no detectable 
abnormalities in the development of simple epithelia. In transgenic mice, however, the 
targeted disruption of keratin 8 leads to mid-gestational lethality with only a few mice 
surviving into adulthood. According to the authors K8/K18 filaments are important for the 
integrity of the fetal liver (Baribault et al., 1993). 
In another study GFAP expression has been suppressed by stable transfection of an 
astrocytoma cell line with an antisense gene construct (Weinstein et al., 1991). These cells 
still contain vimentin but are deficient in GFAP IF and are not able to respond correctly 
to the presence of neurons in cell culture. Two other studies have been published, 
providing evidence for IF function. In Xenopus, monoclonal antibodies against keratins 
and antisense oligodeoxynucleotides corresponding to keratin coding regions are able to 
cause a defective gastrulation upon injection of oocytes (Klymkowsky et al., 1992; Тогреу 
et al., 1992). In the latter study the oocyte's store of type II cytokeratin mRNA is deple­
ted, which results in a loss of cytokeratin filaments in the cortical cells of the developing 
embryo. Gastrulation fails completely in some of the embryos described in the former 
study, which does not deal with an inhibited expression but rather with an impaired 
filament network. 
Important progress has also been achieved during the last few years of research upon 
mutant keratin filaments. Patients with the skin blistering disease epidermolysis bullosa 
suffer from mutations in their basal keratin genes. The symptoms of the gene defect 
resemble the effects caused by expression of a truncated K14 gene in transgenic mice 
(Vassar et al., 1991). So far, several examples of such genetic defects have been publis­
hed, involving keratins K14 and K5 (Bonifas et al, 1991; Coulombe et al., 1991a,b; 
Ishida-Yamamoto et al., 1991; Lane et al., 1992). A second skin disease, named epider-
molylic hyperkeratosis, also characterized by skin blistering has been described, which is 
also associated with affected keratins (Cheng et al., 1992; Chipev et al., 1992; Rothnagel 
et al., 1992). In contrast to epidermolysis bullosa, this disease exhibits defects in the 
suprabasal cells of the epidermis and in some cases mutations in the specialized keratin 
type K10. Furthermore, expression of a mutated keratin 10 in transgenic mice also leads 
to symptoms resembling epidermolysis hyperkeratosis (Fuchs, 1991; Fuchs et al., 1992; 
Fuchs and Coulombe, 1992). More recently again two disorders involving affected keratin 
genes have been characterized. In epidermolylic palmoplantar keratoderma (Eppk), gene 
mutations in keratin K9 have been found (Reis et al., 1994) and in patients with ichtyosis 
bullosa of Siemens keratin K2 is affected (Rothnagel et al., 1994). All keratin mutations 
involved in skin diseases have recently been reviewed (Fuchs, 1994). 
Also for neurofilament proteins aberrations that point at an association with inherited 
diseases have been described. Transgenic mice that overexpress wild-type NFs or produce 
mutant NFs exhibit abnormalities that resemble amyotrophic lateral sclerosis and motor 
neuron disease (Cote et al., 1993; Xu et al., 1993). All of these findings implicate a step 
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forward in the elucidation of the function of at least some specialized IFs. The functions 
of the other representatives of the IF gene family have to be solved in the future. 
Outline of this thesis 
When this study began, both the hamster vimentin and desmin genes had been cloned. The 
desmin and vimentin gene constructs containing 3.2 kb and 3.4 kb of 5' sequences, 
respectively, had shown correct tissue-specific expression in transgenic mice. Also the 
desmin 5' upstream region had proved to be sufficient for up-regulation of expression 
when cultured skeletal muscle cells differentiate from myoblasts into multinucleated 
myotubes. By that time the family of transcription factors playing an important role in 
muscle cell differentiation became known. In chapters 5 and 6 the involvement of these 
transcription factors in the regulation of desmin expression is described. 
The vimentin gene exhibits a complex pattern of expression. Moreover, the vimentin 
gene is switched on when cells from various origins are brought into tissue culture. We 
undertook the task to investigate the mechanism responsible for this phenomenon. In 
chapters 2 and 3 is described which regulatory elements in the promoter region rule 
vimentin transcription, using cell lines with and without vimentin. Furthermore, in chapter 
4 some aspects of the regulation of vimenlin expression during development are delinea-
ted. 
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Regulation of vimentin expression in cultured cells 
Most cell types start expressing vimentin when brought into tissue culture. Using both 
vimentin-expressing (HeLa) and vimentin-negative (MCF-7) epithelial cell lines, we have identified 
the cii-regulatory DNA elements involved in this process. Sequences located 1.1-0.6 kb upstream 
of the vimentin transcription-initiation site strongly enhance expression in HeLa cells, but are 
silenced in MCF-7 cells. Other regulatory elements in the vimentin promoter (an enhancer 3.2-2.6 
kb ustream and a minimal promoter region including the CAAT-box) are potentially active in both 
cell types, but are silenced by the 0.5-kb fragment in MCF-7 cells. Deletion of this fragment 
restores transcriptional activity of a transfected vimentin promoter. Our data indicate that a double 
AP 1/jun-binding site present in the 0.5-kb fragment mediates the induction of vimentin expression 
in cultured epithelial cells, while silencing sequences located within the same fragment are 
responsible for the absence of vimentin expression MCF-7 cells. 
In contrast to MCF-7 cells, a transfected vimentin promoter and gene are transcriptionally 
active in the vimentin-negative epithelial cell line T24. Transfection studies show that type-III-
intermediate-filament expression is not impaired at any level in these cells. 
Upon transfection and expression of a desmin construct in T24 cells not only desmin, but also 
vimentin was detected. Both proteins assembled into intermediate filaments. This induction of 
vimentin expression appeared to be regulated at the post-transcriptional level. 
INTRODUCTION 
Intermediate filaments (IF) represent a group of cytoskeletal structures of approxima-
tely 10 nm in diameter which, along with microtubules and microfilaments, occur in the 
cytoplasm of virtually all mammalian cells. The IF proteins are encoded by a large 
multigene family and can be divided into six different types on the basis of gene structure 
and homology [1-4]. 
Apart from the lamins, the different types of IF subunits are expressed in a develop-
mentally regulated and tissue-specific fashion. This highly conserved specificity of 
expression suggests that each type or combination of subunits plays an important role in 
cellular differentiation [1-6]. 
Abbreviations: 
IF, intermediate filaments: AP-1, activator protein 1: CAT, chloramphenicol acetyltransferase: TK, 
thymidine kinase: HSV, Herpes simplex vims. 
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The vimentin-expression pattern is more complex than that of the other IF subunits. 
In adult tissues, vimentin is mainly expressed in cells of mesenchymal origin. Moreover, 
during differentiation of a variety of cell types vimentin expression is both positively and 
negatively regulated [1-3,6]. Depending on cell type, vimentin expression can precede the 
expression of the IF subunit specific for a particular tissue, it can be transiently coexpres-
sed during development, or it can remain present in the fully differentiated state [2, 3, 
7]. Coexpression of vimentin (a type-III-IF protein) and other type-III-IF proteins (desmin, 
glial fibrillary acidic protein and peripherin) or type-IV-IF proteins (neurofilaments) 
results in coassembly of these different types of IF subunits into the same filaments. 
Coexpression of vimentin and cytokeratins (type-I and type-II-IF), however, results in the 
formation of separate IF networks [1-3]. 
In the present study we focus on the regulation of a particularly intriguing aspect of 
vimentin expression, i.e. the induction of vimentin-gene expression and subsequent IF 
formation in cultured cells. 
Regardless of their embryonic origin, most eukaryotic cells start synthesizing vimentin 
upon culturing. This can be accompanied by the continued coexpression of the tissue-
specific IF protein, but in other cases only vimentin expression remains [3,7-9]. 
The function of vimentin filaments of cultured cells, and of cells in vivo, has remained 
obscure. Vimentin expression is not essential for the cultured cell since some cell lines 
lack this type of IF or even all types of IF [3, 6]. It has been suggested that vimentin 
expression in vitro is a sign of dedifferentiation [10, 11] and, similarly, that its expression 
in neoplasms might be taken as evidence of reversion towards an embryonic phenotype 
[12]. In many cell, vimentin expression is growth-regulated. Vimentin transcription can be 
induced by serum, a variety of mitogens and also by certain inhibitors of cell proliferati-
on, such as phorbol esters [13, 14]. This complex regulation of expression takes place at 
the transcriptional level an is mediated by various positive and negative elements in the 
ustream region of the vimentin gene [13-18]. 
We have demonstrated previously that 3.2 kb of the vimentin-gene 5' flanking region 
not only directs tissue-specific expression in transgenic mice but also mediates tissue-
culture-induced vimentin expression [19]. The regulatory elements in this region specifi-
cally involved in cell-type specificity of expression and/or induction of vimentin expressi-
on in cultured cells have not yet been identified. Studies concerning the regulation of 
vimentin expression, including deletion analysis of the vimentin promoter in transfection 
assays, have been performed on cultured, vimentin-producing cells, making it impossible 
to distinguish between tissue-specific and tissue-culture induced vimentin expression [13-
18]. 
Here we address this issue by using both vimentin-producing and vimentin-negative 
cell lines. We identify elements which are specifically involved in the regulation of tissue-
culture induced vimentin expression as well as more general control elements. In the 
vimentin-negative cell line MCF-7 [20-23] these elements appear to be silenced. The 
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human bladder carcinoma cell line T24 [22, 24] also lacks vimentin IF, but transfection 
with vimentin-gene and vimentin-derived gene constructs showed that silencing of 
vimentin-gene expression does not occur in this cell line. The effects of type-II-IF 
expression of T24 cells are described. 
MATERIALS AND METHODS 
Plasmid construction and isolation 
In general, plasmid construction and isolation procedures were as described by 
Sambrook et al. [59]. 
Deletion constructs 
Construction of З.І ітСАТ, 599VimCAT and 176VimCAT has been described [15]. 
These constructs are based on the vector pSuperCAT, a derivative of pSVOCAT [60] into 
which the pUC18/19 polylinker has been inserted directly 5' of the chloramphenicol 
acetyltransferase (CAT) marker gene. The constructs 2.6VimCAT, 2.1VimCAT, 1.9Vim-
CAT, 1.4VimCAT and l.lVimCAT were generated from З.І ітСАТ by using the 
Hindlll, Pvull, Pstl, Xhol and EcoRI sites, respectively in the vimentin-promoter region 
and the Hind/// (for 2.6VimCAT) or Pstl site (all other constructs) at 101 bp downstream 
of the transcription-initiation site [15]. Constructs 148VimCAT, 119VimCAT, 97Vim-
CAT, 80VimCAT, 50VimCAT, 22VimCAT and +2VimCAT were generated from 
176VimCAT using the exonuclease Ba/31 under appropriate conditions [59]. Briefly, 
176VimCAT was linearized at the 5' end of the vimentin promoter with Sad, treated for 
different lengths of time with /to/31, subsequently blunt ended with T4 polymerase and 
digested with Bgñl, which cuts in the CAT sequence. The resulting fragments of 
approximately 2.8 kb were ligated to the 1.4-kb Bglll-Smal fragment from pSuperCAT, 
thereby regenerating the pSuperCAT vector. 
The exact length of the Ba/31-deletion constructs was determined by sequence analysis 
using double-stranded DNA following standard procedures [61, 62]. 
The only difference between the 15 CAT deletion constructs described above is the length 
of the vimentin-promoter region and the restriction site at the extreme 5' end. All 
fragments end at position +101. 
The construct 2.5VimCAT was generated by isolating the 2.5-kb BaniHl-Smal 
fragment from З.І ітСАТ and subcloning it in 5' to 3' orientation in pSuperCAT. 
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Enhancer-test constructs 
Plasmid З.І ітСАТге was generated by isolating the 2.5-kb ВатШ-Smal fragment 
as a Smal fragment, using the Smal polylinker site directly 5' of the BamHl site, and 
recloning this fragment in the reversed orientation in the Smal cut З.І ітСАТ vector. 
The vector pBLCAT2 [63] contains the herpes-simplex-virus (HSV) thymidine-kinase 
(TK) promoter fused to the CAT merker gene. Both directly upstream of the TK promoter 
and downstream of the CAT gene lies a polylinker, containing unique restriction sites. 
The plasmid pBLCAT3 is identical to this plasmid but does not contain the TK promoter. 
The plasmids 2.5TKCAT5' and 2.5TKCAT5'rev were generated via isolation of the 
2.5-kb ВатШ-Smál fragment as a BamHl fragment. This was done by subcloning the 
Smal fragment mentioned above (see construction of З.І ітСАТге ) in a Smal-cul 
pUC19 vector 5' of the BamHl site and reisolating the 2.5-kb fragment as a BamHl 
fragment. This was inserted into the BamHl site of the 5' polylinker of pBLCAT2 in both 
orientations. This BamHl fragment was also inserted 5' of the CAT gene in pBLCAT3, 
yielding 2.5CAT5'. The plasmids 2.5TKCAT3' and 2.5TKCAT3'rev were generated by 
isolating the 2.5-kb BamHl-Smal fragment as a Smal fragment (see above) and inserting it 
in the 3' polylinker of pBLCAT2 in both orientations. 
The plasmid 2.0TKCAT5' was generated from 2.5TKCAT5' by removing the 5' 0.5-
kb Я/ndIII fragment by partial Hinálll digestion followed by religations. 
The plasmid 0.8 TKCAT5' was generated from 2.5TK-CAT5' by deleting the most 5' 
1.8kb of the vimentin promoter while leaving 0.8 kb from Xhol at 1.4 kb to Smal at 0.6 
kb. This was done by SaRIXhol digestion followed by religation. The San site is located 
in the polylinker 5' of the vimentin promoter. 
The plasmid 0.5TKCAT3'rev contains the 0.5-kb EcoRl-Smal fragment inserted in 
the 3' polylinker of pBLCAT2 in the reversed orientation. As a vector, a partial Eco-
RI/Smal digested pBLCAT2 plasmid was prepared, since an ÊcoRI site is also present in 
the CAT gene. 
The plasmid AP-1TKCAT3' contains a 30-bp DNA fragment, comprising the double 
activator-protein 1 (AP-l)/jun binding site located in the vimentin at -0.7kb. To obtain this 
sequence, the following oligomers were synthesized: 5'-AATTCCGTGAATCATCAC-
CACTGACTCAGC-3 ' (the 3 nucleotides at the 5' end of this 30-residue oligonucleotide 
were introduced to generate an EcoRl site); 5'-GCTGAGTCAGTGGTGATGATT-
C_AC_GG-3'. The double AP-1-consensus sequence is underlined. These oligomers were 
annealed and inserted into the EcoRl and Smal sites of the 3' polylinker of pBLCAT2 in 
the normal orientation. The plasmid AP-1TKCAT2 contains two of these fragments. The 
plasmids 0.5TKCAT5' and 0.5TKCAT5'rev were generated by isolating from 3.1 Vim-
CAT the most 5' part of the vimentin promoter region, running from 3.1 kb to 2.6 kb, as 
a 0.5-kb partial ffmdIII fragment and inserting this fragment in two orientations in the 5' 
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polylinker of pBLCAT2. 
The plasmids 2.5SV40CAT5' and 2.5SV40CAT5'rev were generated by inserting the 
2.5-kb BarriHl fragment into the Bgtll site located 5' of the CAT gene of pAlOCAT, a 
derivative of pSV2CAT containing the simian-virus 40 early promoter but not the 
enhancer [60]. The plasmids 2.5SV40CAT3' and 2.5SV40CAT3' and 2.5SV40CAT3*rev 
were generated by inserting the 2.5-kb ВатШ fragment into the BamHl site 3' of the 
CAT gene in both orientations. 
Isolation and structure of the hamster vimentin gene used in this study has been 
described previously [27]. Generation of the hybrid vimentin/desmin-gene constructs 
pVVim2 [28] and pVDes [19] has also been described previously. 
The plasmids were transformed into bacterial strains Escherichia coli HB101 or JM109. 
All DNA preparations to be used in transfection assays were purified on two successive 
CsCl gradients. 
Cell culture and DNA transections 
HeLa cells, T24 cells, MCF-7 cells, C2C12 cells and hamster lens cells were cultured 
under standard conditions as described previously [15, 21, 22]. 
Cells were transfected either transiently (CAT constructs) or stably (vimentin/desmin-
gene constructs) using the calcium-phosphate precipitation method, essentially as described 
previously [15, 21]. For each cell type, a glycerol shock was applied. 
CAT activity was measured as described [15, 60] and, in most cases, normalized to 
the activity of a cotransfected RSVlacZ plasmid which served as a control to monitor 
transfection efficiency [64]. To each 100-mm2 culture dish 2 μg control plasmid (RSV­
lacZ) and 10 /tg CAT plasmid were added as a coprecipilate. For most transfections, one 
precipitate for each construct was simultaneously divided over the different culture dishes 
containing the different cell types. Experiments were performed at least four times with 
each construct, in most cases using two different preparations of plasmid DNA. 
Cell labeling and quantitative two-dimensional analysis of cell extmcts 
MCF-7, HeLa and T24 cell-labeling with [35S] methionine was performed as described 
previously [21], except that 500 ¿tCi [35S]methionine (>1000 Ci/mmol specific activity; 
Amersham Nederland B.V.) and 100-mm2 culture dishes were used. 
Protein samples were prepared after the methods of Garrels [65, 66] as described in 
Guide to Sample Labeling and Sample Preparation (Protein Databased Inc., New York). 
Briefly, proteins were harvested in sample buffer (0.3% SDS, 5% 2-mercaptoethanol, and 
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20 mM Tris, pH 8.0) and placed at 100 °C for 2 min. Cytotoskeletal fractions were 
isolated as described [21, 67]. 
The samples were cooled on ice and treated with DNase and RNase to reduce 
viscosity. Samples (both total cell extract and IF fractions) were shipped to Protein 
Databases Inc. on dry ice, for further processing. The samples were then analysed for 
radioactivity and assayed by the Lowry method to determine specific activity and protein 
concentration, respectively. The samples were dissolved in isoelectric-focusing buffer (9.5 
M urea, 2% Nonidet P40, 100 mM dithiothreitol and 2% basic ampholines) at 37 °C for 
30 min. 
The two dimensional gel electrophoresis was performed after the mehods of Garrels 
[65, 66], and to achieve reproducible, standardized high resolution gels all procedures and 
operations were computer-controlled and computer-monitored. Approximately 10-20 μ\ 
sample containing approximately 400 000 cpm and 20-30 μ% protein were loaded onto the 
focusing tube which contained 2% pH5-7 ampholines. The second dimension gel was 24 
cm χ 24 cm χ 1 mm and contained 12.5% acrylamide. After electrophoresis at 60 W, the 
gels were processed for fluorography and multiple autoradiographic exposures were made 
[65, 66, 68]. 
Gel films were scanned and computer analyzed as described [66, 68]. The threshold 
of detection and quantification for individual spots (cut-off value) was 3 cpm. 
Antibodies, Western blotting and indirect immunofluorescence assay 
The following polyclonal and monoclonal antibodies were used in this study; a 
polyclonal rabbit antibody (poly-des) to chicken-gizzard muscle desmin [69], an affinity-
purified polyclonal antibody (poly-vim) to bovine lens vimentin [70], the monoclonal 
antibody RD301 to chicken desmin [71], the monoclonal antibody RV202 to bovine lens 
vimentin [72], the affinity-purified polyclonal antibody (poly-ker) to human skin keratins 
[70] and the monoclonal antibodies RCK106 [72] and RCK103 [73] to human keratins. 
Western blotting was performed as reported earlier [21, 74] using the monoclonal 
antibodies RV202 and RD301. Protein bands were visualized using 125I-labeled goat anti-
mouse serum and autoradiography. 
Single-label and double-label indirect immunofluorescence staining of cultured cells 
was performed as described previously [15, 29]. 
Northern blot and run-on analysis 
RNA isolation, Northern blotting and hybridization were performed as described 
previously [15,19]. 
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As a vimentin probe (E49), we used a 520-bp hamster vimentin ЛшЗА fragment 
ranging from -150 bp to +370 bp relative to the transcription-initiation site [15, 19, 29] 
or the 1.25-kb hamster vimentin cDNA pVim-2 [75]. As a desmin probe (X54) a 350-bp 
hamster-desmin Sau3A fragment was used, covering the region from 25 bp of exon 8 to 
120 bp into the 3' untranslated region [15, 19, 71]. As an actin probe, we used a 1.25-kb 
hamster-actin-cDNA fragment [19, 76]. 
Transcriptional run-on assays were performed as described by Knapp et al. [77] 
except that nuclei were isolated from two 100-mm2 culture dishes containing exponentially 
growing HeLa, T24 or MCF-7 cells. Incubation was carried out with 200 μ\ nuclear 
suspension, containing 2-8 χ IO7 nuclei. Labeled RNA was extracted from the reaction 
mixture after 30 min and hybridized to nitrocellulose filters containing hamster vimentin 
cDNA, hamster actin cDNA and pBR322 DNA, at 42 °C for 24 h. Hybridization 
conditions were as in Northern blot analysis. For binding to nitrocellulose, 5 μ% plasmid 
DNA was linearized using appropriate restriction enzymes, denatured in 0.2 M NaOH for 
30 min at room temperature, neutralized with 10 vol. 6 χ NaCl/Cit. (NaCI/Cit., 1 M 
NaCl, 0.33 M citrate [59] and applied to the nitrocellulose using slot-blot equipment 
(Schleicher and Schuell). After hybridization, filters were RNase treated and washed, 
essentially as described [77]. 
RESULTS 
Cell lines lacking vimentin expression 
Most cell-types initiate vimentin expression when brought into tissue-culture [3, 8, 
19]. However, the human bladder carcinoma cell line RT4 and the human breast-adeno-
carcinoma cell line MCF-7 are completely devoid of vimentin, both at the mRNA and 
protein level [21-23]. Cells of the human bladder carcinoma cell line T24 also do not 
contain vimentin-filament networks, but a small subpopulation ( < 1 %) contains short 
fibrillary structures which can be visualized in an immunofluorescence assay using 
antibodies directed against vimentin [22] (and Figla). In addition, trace amounts of 
vimentin mRNA can be detected in T24 cells ([22] and Fig. 7). Comparison of cytoskele-
tal and total-cell extracts of [35S]methionine-labeled HeLa, MCF-7 and T24 cells confir­
med that no significant amounts of vimentin are present in the latter two cell types 
(Fig. lb). 
While vimentin expression is growth regulated and can be stimulated by some growth 
factors [13, 14], we were unable to manipulate the number of vimentin-expressing T24 
cells by changing growth conditions (such as composition of the culture medium; cell 
density; monolayer or suspension culture). To select for vimentin-positive and vimentin-
negative T24 cells, maximal dilution subcloning was applied. Even after several rounds of 
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Fig. 1. Vimentin expression in T24, HeLa and MCF-7 cells. (A) Indirect immunofluorescence staining of 
T24 cells using poly-vim. Only a small subset of cells (here focused on) contains positively staining, short, 
fibrillary structures. Bar indicates 10 μπι. (В) Autoradiographs of two-dimensional gel electrophoresis of 
total (TOT; 1, 3, 5) and cytoskeletal cell extracts (CS; 2, 4, 6) of HeLa (1, 2). MCF-7 (3. 4) and T24 cells 
(5, 6) prepared after metabolic labeling with [35S]methionine. Arrow indicates vimentin position. Note the 
absence of detectable vimentin in T24 and MCF-7 cells. Total cpm loaded were identical for each sample. 
Exposure times were for 4 and 6,5 days; others, 2 days. (C) Nuclear run-on assays showing hybridization of 
nascent transcripts synthesized in isolated nuclei from HeLa, T24 and MCF-7 cells to vimentin cDNA (vim), 
control plasmid DNA (pUC) and actin cDNA (act). Note that vimentin transcription in T24 cells is very low 
relative to actin transcription. For T24 cells, 7 χ IO7 nuclei were used, for HeLa and MCF-7 cells this was 2 
χ 10' and 4 χ 10', respectively. (D) CAT expression mediated by the hamster-vimentin promoter in HeLa, 
T24 and MCF-7 cells. Plasmids used for transfection were pSV2CAT ( + ), pSVOCAT (-) and З.І ітСАТ 
(vim), CM, chloramphenicol; Ac, acetylated forms. 
subcloning, the number of vimentin-expressing cells did not change, indicating that the 
vimentin-containing cells do not represent a subpopulation. 
To examine the regulatory events underlying the different vi men tin-expression 
patterns in these cultured epithelial cells, the rate of transcription of the vimentin gene in 
T24 cells compared to vimentin-expressing (HeLa cells) and non-expressing cells (MCF-7) 
was determined by nuclear run-on analyses. Only low rates of vimentin transcription could 
be detected in T24 cells (Fig.lc). Transfecting MCF-7 cells with constructs containing the 
vimentin promoter linked to a marker gene did not result in significant expression. In 
contrast, this promoter is highly active in T34 cells and in HeLa cells (Fig. Id). 
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Transcriptional regulation of vimenlin expression in cultured epithelial cells 
We demonstrated previously that 3.2 kb of the vimentin promoter region is sufficient 
to mediate tissue-culture-induced vimentin expression [19]. To more precisely identify the 
regulatory elements involved in this process, a series of plasmids was constructed in 
which decreasing lengths of 5' flanking region were transfected in parallel into HeLa and 
MCF-7 cells. In HeLa (Fig.2b) and T24 cells (data not shown), three different regions 
appeared to be involved in modulating the transcriptional activity of the vimentin pro-
moter. Deletion of a 0.6-kb region at the 5' end resulted in a twofold reduction of CAT 
expression. 
Deletion of the region between -1.1 kb and -0.6-kb relative to the transcription-
initiation site decreased CAT expression 5-10-fold. The region from -2.6 kb to -1.1 kb 
could be deleted without affecting CAT-expression levels. Deletions extending beyond the 
CAAT-box at -90 bp completely abolished CAT expression (Fig.2b). Identical results 
were obtained when primary cultures (i.e. human hepatocytes) instead of epithelial cell 
lines were used. These cells initiated vimentin expression after 1-2 days in culture [8, 19] 
and were transfected after 3 days (data not shown). 
Deletion of 5' flanking sequences up to -1.1 kb had no effect on vimentin promoter 
activity in MCF-7 cells (Fig. 2c). However, deletion of the region between -1.1 kb and -
0.6 kb resulted in increased CAT expression, indicating that this sequence has a negative 
effect on vimentin promoter activity in MCF-7 cells. The same series of constructs was 
also transfected into transformed hamster lens cells (fig.2d) and C2C12 cells (data not 
shown). These cell-types express vimentin instead of cytokeratins, not as a result of 
culturing but because they express vimentin in their tissue of origin [25, 26]. Deletion of 
the -1.1 kb to -0.6 kb region did not influence the high vimentin promoter activity in these 
cells (Fig.2d). The effects of deleting the -3.1 kb to -2.6 kb and CAAT-box regions were 
similar as observed for HeLa cells. These data indicate that the region from -1.1 kb kb to 
-0.6 kb in the 5' flanking region of the vimentin gene is involved in activation of the 
vimentin promoter under tissue-culture conditions in epithelial cells, while in cells which 
already express vimentin before being cultured, this region is not needed for high-level 
promoter activity. Reversing the orientation of the -3.1 kb to -0.6 kb vimentin promoter 
fragment resulted in decrease of promoter activity in HeLa cells of 65% (Fig.3) while 
deletion of this region caused a 5-10-fold decrease in activity (Fig.2b). This indicated that 
the fragment has enhancing properties. When the -3.1 kb to -0.6 kb fragment was tested 
in the promoterless plasmids pSuperCAT (2.5VimCAT; see legend to Fig.2) or pBLCAT3 
(Fig.3, 2.5CAT5'), no CAT activity was detected. 
To further characterize the nature of the various regulatory elements, different 
portions of the vimentin promoter were tested for enhancer activity by incorporating them 
into the plasmid pBLCAT2, which contains the HSV TK promoter fused to the CAT gene. 
Some DNA fragments were tested upstream and downstream of the CAT gene in pBL-
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Fig. 2. Functional assay of the hamster-vimentin-promoter region by deletion analysis. (A) Schematic 
representation of the vimentin-promoter deletion constructs, containing varying lengths of the vimentin 5' 
flanking region fused to the CAT marker gene. Arrows indicate 5' ends of each construct. Positions are 
indicated relative to the transcription-initiation site at + 1 in kb (upper part) or in bp (lower part). Constructs 
are designated XVimCAT, where X (in kb or bp) is the position of 5' end of the promoter region. The 
promoteriess construct 2.5VimCAT (not shown) contains the 5' BamHl-Smal fragment fused to the CAT 
gene. CAAT-box (at -90), TATA-box and potential Spl-box (at -122) are underlined. В, BamHl restriction 
«ite; Η, //indili; Pv, Pvuï; Ρ«. fttf; Χ. Xhoì, Ε, EcoW; S, Smal; M, Mboì. The transcription-initiation site 
is located at + 1 . (B-D) Relative CAT activity of deletion constructs depicted in Fig. 2a after transient 
transfection into HeLa cells (B), MCF-7 cells (C) and hamster-lens (HaLe) cells (D). Activity of 3.1 
VimCAT is arbitrarily set al 100% for HeLa and HaLe cells, for MCF-7 cells pSV2CAT activity is taken as 
100%. Values are corrected for variations in transfection efficiency by normalizing against the activity of a 
cotranfected pRSVlacZ plasmid. For each construct, the diagram shows the mean value and standard 
deviation calculated from at least 4 independent experiments. 
CAT2 both in normal and inverted orientation (Fig.3). The region from -3.1 kb to -
0.6 kb displayed strong enhancing activity in HeLa cells (Fig.3). In contrast, this fragment 
did not function as an enhancer in MCF-7 cells. 
Deletion of the 5' 0.5 kb or 1.8 kb from this fragment had no effect on activity 
(Fig.3). The -3.1 kb to -2.6 kb fragment stimulated CAT expression in both cell types 
(Fig. 3.), but the -1.1 kb to -0.6 kb fragment yielded similar results as the entire -3.1 kb 
to -2.6 kb fragment in MCF-7 cells, i.e. not significant CAT activity was detected 
(Fig.3). This indicates that the -1.1 kb to -0.6 kb fragment can function as an enhancer in 
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Fig. 3. Assay for enhancer activity in the 5' flan­
king region of the vimentin gene. A schematic 
representation of the enhancer-test constructs is 
given. TK, HSV-TK promoter; SV40, simian-
virus 40 early promoter; API, AP-1/jun-binding-
site consensus sequence (see Materials and Me­
thods). The black line represents vimentin 5' 
flanking region. Note that plasmids З.І ітСАТ 
and З.І ітСАТге contain the full vimentin 
promoter. Arrow-heads indicate the orientation of 
the promoter fragments relative to the CAT gene. 
CAT activities of the enhancer-test constructs 
after transient tranfection into HeLa cells and 
MCF-7 cells are given relative to pSV2CAT 
activity, which was set at 100% and normalized to 
the activity of pRSVLacZ. At least 4 transfections 
with each construct were performed and average 
values are shown. Background activity of pBL-
CAT2 and pSuperCAT in MCF-7 cells varied be­
tween 2% and 5%. For pAlOCAT (SV40CAT, 
not shown) and pBLCAT3 (not shown) back­
ground activity was on the threshold of detection. 
B, BamUl; H, Hindlli; X, Xhoi; E, EcoKV, S, 
Smal. 
HeLa cells but not in MCF-7 cells. In additi­
on, it inhibits the enhancing capabilities of 
more 5' sequences of the vimentin promoter 
in these cells. 
The -1.1 kb to -0.6 kb vimentin promo­
ter fragment contains a double AP-l/jun-
binding-site consensus sequence at -0.7 kb 
(Fig.4). This sequence was synthesized, 
incorporated into pBLCAT2 and tested in 
HeLa and MCF-7 cells. In both cell types, 
the sequence displayed strong enhancing 
activity (Fig.3), indicating that other sequen­
ces in the -l.lkb to -0.6kb fragment cause 
the silencing effect as observed in MCF-7 
cells. In HeLa cells, the enhancer activity of 
the AP-1 element was similar to that of the 
0.5-kb ЕсоШ-Smal fragment in which this 
element is located, suggesting that the enhan­
cing capacities of this fragment are mediated 
by the double AP-1-consensus sequence at 
-0.7 kb. 
When instead of the HSV-TK promoter, 
the simian-virus 40 early promoter was used 
to test for enhancing capacity of the -3.1 kb 
to -0.6 kb fragment, no CAT activity was 
detected (Fig.3), demonstrating that not all 
heterologous promoters can be stimulated by 
this DNA fragment. 
5'-GTGAATCATCACCACTGACTCAGC-3' 
AP-l/jun consensus: ^TGA^TCA 
С С 
Fig. 4. Sequence located from -708 bp to -685 bp 
upstream of the transcription-initiation site in the 
hamster-vimentin promoter. AP-1/jun-binding 
sites are underlined. The AP-l/jun consensus se­
quence is shown. Note the perfect match of both 
binding sites. 
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Fig. 5. Schematic representation of the IF-gene 
constructs stably transfected into T24 cells. Vi-
mentin, hamster vimentin gene containing 3.2 kb 
of 5' and 2.6kb of 3' flanking sequences. pV-
Vim2, hybrid vimentin-desmin gene construct, in 
which part of the vimentin gene (including exons 
7-9) has been replaced with the corresponding 
region from the hamster-desmin gene. This allows 
detection of the pVVim2-encoded protein with the 
monoclonal antibody RD301. pVDes, hamster-
desmin-gene construct containing the coding 
region of the desmin gene fused to the vimentin 
promoter, vimentin exons (open squares), desmin 
exons (closed squares). E49, vimentin probe; the 
3' part of this probe (indicated by gray region) 
does not hybridize to pVDes. X54, desmin probe. 
L, fusion site between desmin-derived and vimen-
tin-derived sequences. 
Fig. 6. Cytoskeletal fractions of clones of T24 
cells stably transfected with the constructs depic­
ted in Fig. 5, analyzed by one-dimensional SDS-
/PAGE and immunoblotting. (A) Coomassie Bril­
liant Blue (CBB) staining of SDS/polyacrylamide 
gel. (-») vimentin position. (B) Immunoblots, 
incubated with the monoclonal antibody to vimen-
tin (RV202, mVim) and subsequently with the 
monoclonal antibody to desmin (RD301), mDes). 
C, untransfected T24 cells; vimDl, T24 cell clone 
Dl, transfected with the vimentin gene; vimE4, 
clone E4, transfected with the vimentin gene; neo, 
control clone, transfected with pSV2neo only; 
des, tranfected with pVDes; vvim2, transfected 
with pVVim2. 
Expression of type-III-JF-gene constructs in T24 cells 
Contrary to MCF-7 cells, the low rate of transcription of the endogenous vimentin 
gene of T24 cells is not reflected in the promoter activity of vimentin promoter/CAT 
constructs transfected into these cells (Fig. Id). 
To examine possible dominant negative regulatory effects of elements located within 
or downstream of the vimentin gene, transfections with the hamster vimentin gene [27] 
were performed. In addition, the vimentin/desmin hybrid genes pVVim2 [28, 29] and 
pVDes [19] were used (Fig.5). We have previously demonstrated that in transgenic mice 
these constructs can be expressed with endogenous vimentin in a tissue-specific fashion, 
while the pVVim2-derived and pVDes-derived transcripts, proteins and IF can be readily 
discerned from their endogenous counterpart [19, 29]. Since the immunofluorescence and 
CAT assays might indicate that a deviant vimentin incapable of de novo IF formation is 
synthesized in T24 cells, expression of these IF constructs could rescue the endogenous 
vimentin by allowing the mutant vimentin to incorporate into a preformed type-III-IF 
network. 
Cytoskeletal extracts from stably transfected clones were analyzed by SDS/PAGE and 
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Western blotting (Fig.6). T24 cells trans-
fected with the intact vimentin gene expres­
sed correctly sized vimentin at high levels. 
The pVVim2 protein was also expressed and 
was detected with a polyclonal antibody 
against desmin (data not shown). 
Surprisingly T24 cells transfected with 
pVDes not only expressed desmin, but also 
correctly sized vimentin (Fig.6b). Southern-
blot analysis of chromosomal DNA showed 
that these cells only contained the pVDes 
construct and not pVVim2 or the hamster 
vimentin gene (data not shown). 
Northern-blot analysis demonstrated that 
the transfected vimentin gene, pVVim2 and 
pVDes were all expressed at high levels. 
Vimentin expression levels even exceeded 
those of transformed hamster-lens cells which 
express vimentin at high levels (Fig.7). Both 
untransfected T24 cells and T24 cells only 
transfected with the neomycin plasmid, con­
tained trace amounts of vimentin mRNA 
(Fig. 7b). The pVDes-expressing clones did 
not display elevated vimentin transcript le­
vels, indicating that the increase in vimentin 
protein expression observed in these cells is 
not caused by induction or derepression at 
the transcriptional level. 
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Fig. 7. Northern-blot analysis of 10 pg total RNA 
from exponentially growing stably tranfected T24 
cell clones. For each tranfectant, RNA was isola­
ted from two independently cultured clones to 
allow detection of fluctuations in expression levels 
caused by differences in growth conditions. Blots 
were first hybridized to vimentin probe E49 (a), 
subsequently to a vimentin cDNA probe (b) and 
an actin probe (c). Lanes des" were also hybridi­
zed to a desmin probe (X54), HeLa, RNA from 
HeLa cells (2 ¿ig); HaLe, hamster lens cells (10 
ftg); C, untranfected T24 cells; neo, pSV2neo-
transfected cells; vvim2, pVVim2-transfected T24 
cells; vimE4, vimentin-gene transfected T24 cells; 
des and des", pVDes-transfected T24 cells. Note 
more sensitive detection of human vimentin trans-
cripts with the hamster-cDNA probe than with 
vimentin probe E49, allowing detection of low 
levels of human vimentin RNA. This is caused by 
differences in sequence similarity and probe 
length (similarity between E49 and the corres-
ponding human vimentin region is 78%). 
Influence of desmin expression on levels of 
other proteins 
For a more detailed and quantitative analysis of the newly synthesized vimentin in 
pVDes-expressing cells, cytoskeletal and total [35S]methionine-labeled cell fractions of 
pSV2neo-transfected and pVDes-transfected cells were compared by automated, high-
resolution two-dimensional gel electrophoresis. Representative autoradiographs are shown 
in Fig.8. 
For quantification, multiple exposures were subjected to computer-assisted analysis. 
Desmin was detected at the expected position in pVDes-transfected T24 cells, but not in 
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T24 cells transfected with pSV2neo only 
(Fig.8). Desmin comprised 0.3% of total 
cellular protein and 0.8% of cytoskeletal 
proteins. Vimentin was detected at the cor­
rect position in the pVDes cell line. In these 
cells the rate of vimentin synthesis was 200-
200-fold lower than desmin synthesis. 
In the pSV2neo-transfected control cell 
line, vimentin was detected at least once 
(Fig.8). While the amount of vimentin was 
too low for quantification by computer or for 
detection in Western blotting, it was at least 
20-fold lower than in pVDes cells, since 
otherwise it would have been above the 
threshold of detection (see Materials and Me­
thods). Computer-assisted analysis of the 
quantitative similarities between identical pro­
teins from pVDes-transfected and pNeo-transfected cells showed that of 838 proteins 
matched in total cell extracts, 79% displayed no change in expression level. The same 
value was found for the cytoskeletal fraction (out of 264 proteins matched). Desmin 
expression had no detectable impact on cell growth or morphology. 
Type-III-IF formation in T24 cells 
To examine whether in T24 cells type-III-IF expression is impaired at the level of IF 
assembly, indirect immunofluorescence assays using both polyclonal and monoclonal 
antibodies directed against vimentin, desmin and cylokeratin were performed on stable 
transfectants expressing vimentin, desmin or the pVVim2 hybrid protein. 
Normal type-III-IF networks were observed in each of these cell lines (Fig. 9). 
Staining of desmin-expressing cells with antibodies against vimentin revealed that the 
endogenous vimentin did participate in IF formation (Fig.9e). These IF networks appeared 
more extensive when poly-vim was used in the assay, while using a monoclonal antibody 
against vimentin resulted in very weak staining, indicating that only small amounts of vi-
mentin were present in these filaments. 
Double-label indirect immunofluorescence assays with polyclonal antibodies against 
vimentin or desmin and a monoclonal antibody against cytokeratin 18 showed that the 
type-III-IF networks colocalized to a large extent with the cytokeratin network (Fig.9). In 
cells of the T24 clone Dl, which expressed vimentin at very high levels (Fig.6), vimentin 
not only assembled into IF but also accumulated in strongly fluorescent clumps. 
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Fig. 8. Autoradiographs of two-dimensional gel 
electrophoresis of total (TOT; 1,3) and cytoskele­
tal cell extracts (CS; 2,4) of T24 cell clones 
stably transfected with pVDes (Des; 1,2) or pSV-
2neo (neo; 3,4) prepared after metabolic labeling 
with [55S]me(hionine. Arrow pointed downwards 
indicates vimentin position (2), upward arrows 
indicate desmin positions (1,2). Total cpm loaded 
were identical for each sample. Exposure times 
for 1 and 3, 5 days; 2 and 4, 10 days. 
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Similar clumps were observed upon 
single staining of these cells with a mono­
clonal antibody against keratin (Fig.9,i-k), 
indicating that the cytokeratin network was 
affected by vimentin overexpression. Effects 
on cell viability or morphology were not 
detected. 
DISCUSSION 
Transcriptional regulation of vimentin ex­
pression 
Fig. 9. Double-label and single-label immunofluo­
rescence staining of T24 cell clones stably trans-
fected with pVDes (a,b,e), pVVim2(c,d) the vi-
mentin gene (g,h,i-k) or pSV2neo (f). (a,b), 
pVDes-transfected cells incubated with poly-des (a) 
and mono-ker (b). (c,d), pVVim2-transfected cells 
incubated with poly-des (c) and mono-ker (d). 
Identical results were obtained when poly-vim was 
used instead of poly-des (not shown). Note (parti­
al) colocalization of desmin and pVVim2 filaments 
with keratin IF. (e) pVDes transfected cells incu­
bated with poly-vim. Note vimentin IF staining in 
these cells transfected with pVDes. (f), pSV2 neo-
transfected cells incubated with poly-vim. Note 
absence of vimentin and keratin IF. (i), Vimentin-
gene transfected cells (clone Dl) incubated with 
mono-vim. (j), As in k, incubated with mono-ker. 
(k), As in i, at higher magnification. Cells from 
clone DI expressed hamster vimentin at very high 
levels (Fig. 6). In these cells, most of the vimentin 
appeared to be present in clumps instead of IF (i). 
This vimentin overexpression led to disturbance of 
the keratin IF network (j,k). Bar indicated 10 μη\. 
Induction of vimentin expression in 
cultured cells is regulated at the level of 
transcription and can be mediated by 3.2 kb 
of the hamster vimentin promoter [19]. Here 
we show that at least three different regions 
in this promoter are involved in the regulati­
on of vimentin expression in cultured cells. 
An enhancer which is active both in vimen-
tin-expressing and in vimentin-negative cells 
is located between -3.2 kb and -2.6 kb relati­
ve to the transcription initiation site. A 
CAAT-box sequence at -90 bp is required for 
expression. The region from -1.1 kb to -0.6 
kb functions as a strong enhancer in vimen-
tin-expressing cultured epithelial cells but has 
the opposite effect in vimentin-negative 
MCF-7 cells. In cultured cells which are 
derived from vimentin-expressing cells which 
do not express cytokeratins, this region is not 
needed for high-level vimentin expression. 
The properties of this region seem to be 
related to the double AP-1/jun-binding site 
present in this fragment. The AP-1-binding 
site is a highly conserved enhancer-like ele­
ment present in many viral and cellular genes 
that is recognized by the Fos and Jun family 
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of oncoproteins [30-40]. Enhancer activity of the AP-1 site is dependent on cellular and 
promoter context ([36] and references therein). We show here that the AP-1/jun-binding 
site can function as a strong enhancer in both HeLa and MCF-7 cells. However, in MCF-
7 cells DNA elements in the -1.1 kb to -0.6 kb promoter fragment are capable of silencing 
not only this AP-1 site but also of the entire -3.2 kb to -0.6 kb region, including the en-
hancer located between -3.2 kb and -2.6 kb. 
These date indicate that the -1.1 kb to -0.6 kb region and the double AP-1-binding 
site located within it, are instrumental in inducing vimentin expression in cultured 
epithelial cells, while the silencing activity of this fragment explains the absence of 
vimentin expression in MCF-7 cells. The exact position and silencing characteristics of 
two negative regulatory elements within the -1.1 kb to -0.6 kb region will be described 
elsewhere [32]. 
Both in HeLa and in T24 cells the simian-virus 40 early promoter failed to be 
stimulated by the -3.2 kb to -0.6 kb fragment, whereas vimentin-promoter and HSV-TK-
promoter activities were strongly enhanced by this fragment. This may be related to the 
fact that both the vimentin and TK promoter contain a CAAT-box, while the simian-virus 
40 (SV40) early promoter does not. The human vimentin promoter contains a double AP-
1/jun-binding site located at exactly the same position as in the hamster promoter. This se-
quence is involved in the increase of vimentin expression that occurs when serum is added 
to quiescent cells [14]. The AP-1 transcriptional complex is composed of serum-inducible 
proteins such as c-Fos and c-Jun [31-35]. Hormones and growth factors present in serum 
have been shown to increase nuclear AP-1 binding activity via several signaling pathways 
[37]. 
Taken together, the data indicate that serum inducibility of vimentin expression via 
enhanced activity of the AP-1 transcriptional complex is, at least in part, responsible for 
the induction of vimentin 
expression in cultured cells. Since serum-starved cells do express vimentin, albeit at lower 
levels [13, 14], and since a construct containing 241 bp of the proximal human vimentin 
promoter but not the AP-1-binding site remained serum inducible [13], the possibility 
remains that additional regulatory elements are involved in the induction of vimentin 
expression in tissue culture. 
In contrast to MCF-7 cells, vimentin-negative T24 cells transcribed a tranfected 
vimentin promoter construct and intact vimentin gene at high rates, while endogenous 
vimentin transcription and steady-state mRNA levels were low. This indicates that 
transcriptional factors needed for vimentin expression are present but do not activate the 
endogenous gene. Mutation or methylation of endogenous promoter sequences might cause 
this effect. 
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Post-transcriptional regulation of vimentin expression 
Transfections of T24 cells with IF-gene constructs demonstrated that type-Ill IF 
proteins can be expressed at high levels and assembled into IF. Surprisingly, expression of 
hamster desmin resulted in induction of endogenous vimentin expression at the post-
transcriptional level. This protein appeared to be correctly sized as judged by Western 
blotting and high-resolution two-dimensional gel elctrophoresis. In addition, the human 
vimentin was incorporated into the desmin IF. Even at the low expression levels observed 
in T24 cells, networks which were readily detectable in indirect immunofluorescence 
assays using a polyclonal antibody directed against vimentin. Quantitative analysis 
revealed that vimentin levels in desmin-expressing cells were 100-200-fold lower than 
desmin levels. More importantly, in control T24 cells, vimentin expression was mostly 
undetectable. 
Our results show that T24 cells normally express very low levels of vimentin, which 
are insufficient for de novo IF assembly. The minimal stable polymer for IF appears to 
be the tetramer (for reviews see [38-40]). Newly synthesized vimentin is found in a 
soluble pool of tetramers, from which it assembles into IF [40-42]. It has been demonstra-
ted that IF are dynamic structures into which newly sythesized subunits are readily incor-
porated, even when expressed at relatively low levels [40,43-50]. When coexpressed, 
desmin and vimentin subunits form heterodimers which subsequently take part in IF 
formation [51]. IF subunits which cannot take part in IF formation, e.g. because they 
contain a mutation or, in the case of keratins, because only type-I or type-II subunits are 
expressed, are subject to rapid degradation [50, 52, 53]. 
Taken together, these data suggest that the post-transcriptional induction of vimentin 
expression observed upon desmin expression in T24 cells might be caused by desmin-
vimentin heterodimer and tetramer formation. As a result, vimentin subunits are protected 
against rapid turnover to which they would otherwise have been subjected due to their low 
cytoplasmic concentration, which may not allow efficient tetramer formation. 
Alternatively, the observed induction of vimentin expression in the presence of a type-Ill 
(i.e., desmin) IF network could result from changes at the translational instead of the post-
translalional level. It has been demonstrated that in addition to the post-translation 
assembly of vimentin from the soluble pool of tetramers, a significant portion of nascent 
vimenlin polypeptides directly (independent of ribosomes) associates with the IF cytoskele-
ton and incorporated into IF during translation [40, 54]. This process is known as 
cotranslational assembly. The presence of desmin IF in T24 cells which normally do not 
contain a type-III-IF network could conceivably enhance translation at this level. In 
addition, IF are involved in binding mRNA, polyribosomes, translation factors and other 
components of the translation complex [22, 54-56]. Stabilization of vimentin subunits (or 
increased vimentin translation) as observed here in vitro, i.e., in desmin-expressing T24 
cells, probably also occurs in vivo during certain stages of myogenesis. The ratio of 
65 
vimentin to desmin expressed and incorporated into the IF network of differentiating 
muscle cells changes gradually, resulting in a total replacement of vimentin by desmin 
[51]. 
Vimentin could be expressed at very high levels in T24 cells. By SDS/PAGE analysis 
of different dilutions of cytoskeletal extracts of stably transfected cells it was determined 
that vimentin levels could exceed desmin levels at least 10-fold (e.g. Fig.6) and therefore 
represented at least 3% of total cellular protein. Immunofluorescence assays on these cells 
showed that part of this vimentin was present in strongly fluorescent clumps. The same 
phenomenon was observed after staining the cytokeratin IF, which were clearly affected 
by the vimentin overexpression. Colocalization of type-Ill IF with intact cytokeratin IF 
was also observed in the cells expressing lower levels of type-III-IF protein. In a previous 
study we demonstrated that overexpression of amino-terminally deleted desmin disturbed 
the endogenous cytokeratin network of HeLa cells [21]. Our present results indicate that 
this disruption may, at least in part, have been caused by high levels of desmin expressi-
on. 
The extremely high levels of vimentin expression and the concomitant disturbance of the 
cytokeratin-IF system did not appear to affect cell growth of viability. This is in accordan-
ce with previous reports, describing the total disruption of cytokeratin-IF systems in 
cultured cells [57, 58] and suggests that IF do not fulfil and essential function in many 
cultured cell types. As demonstrated here and in previous studies, cell lines can be useful 
in studying the various regulatory mechanisms that control vimentin expression. However, 
to address the question of the function of these cytoskeletal structures studies must be 
undertaken at the level of the intact organism, i.e. in transgenic animals. 
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in the vimentin promoter 
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Identification of two silencers flanking an AP-1 enhancer in the 
vimentin promoter 
We have studied 5'-upstream sequences required for the transcriptional regulation of the hamster 
gene encoding the intermediate filament protein vimentin Although vimentin is regarded as the 
intermediate filament protein of mesothelial tissue, it is also produced in most cultured cells The 
human mammary carcinoma cell line MCF-7 belongs to the exceptions It contains no vimentin and 
the complete upstream promoter region is inactive in this particular cell line By using transient 
transfection of chimeric constructs into MCF-7 and HeLa cells and subsequent chloramphenicol 
acetyltransferase assays, we were able to show the presence of two negative control regions flanking 
a double AP-1 enhancer element Our data indicate that these elements exert their effect irrespective 
of orientation and position, suggesting that they are silencers In vitro footpnntmg assays, gel mobility 
assays and Southwestern (protem-DNA) blotting revealed the presence of trans-acting factors 
interacting with both silencer elements The silencing effect was particularly pronounced in MCF-7 
cells, although DNA-binding proteins are present in HeLa cells as well 
INTRODUCTION 
The family of genes encoding intermediate filament (IF) proteins, is developmenlally 
regulated in a tissue-specific way (Lazandes, 1982, Traub, 1985, Osborn and Weber, 1986, 
Steinen and Roop, 1988, Bloemendal and Pieper, 1989). Vimentin is the protein which 
occurs in the adult organism in cells of mesenchymal origin and in the eye lens. In vitro, it 
is also expressed in most cultured cells regardless of their origin In tissue culture, vimentin 
mRNA synthesis is inducible by growth factors in a variety of cell types (Ferrari et al , 1986; 
Alldndge et al., 1989). 
The vimentin gene, like c-fos and c-jun, belongs to the group of primary response genes 
Therefore, de novo protein synthesis is not required for serum induction (Ritthng, et al , 
1987). The function of the vimentin gene in this context is still unclear In addition to peptide 
growth factors, vimentin expression is also inducible by phorbol esters in certain cell types. 
A duplicated AP-1 sequence in the human vimentin promoter is responsible for growth factor, 
serum and TPA induction (Ritthng et al , 1989). 
The protein complex, which is able to bind to the 24-bp double AP-1 consensus, consists 
Abbreviations 
AP-1, activator protein 1, bp, base pair(s), cat, gene encoding CAT, CAT, chloramphenicol acetyltransferase, 
DTT, dithiothreitol, IF, intermediate filament, nt, nudeotide(s), oligo, oligodeoxynbonucleotide, SILI, silencer 
element 1, tk, thymidine kinase, TPA, 12 O-tetradecanoylphorboI-13 acetate 
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of several proteins including c-Jun, c-Fos and Fos-related antigens. These proteins have 
been shown to be inducible by serum (Cohen and Curran, 1988; Lamph et al., 1988; Quantin 
and Breathnach, 1988; Ryder et al., 1988; Ryseck et al., 1988). Growth factor and TPA 
induction of AP-1 activity presumably involves signal-transduction pathways leading to 
posttranslational modifications (Lee et al., 1987; Chedid et al., 1991). 
We have previously investigated the hamster vimentin promoter region involved in down-
regulation of vimentin expression upon muscle cell differentiation (Pieper et al., 1987). 
Additional information about the vimentin upstream region was gained from studies in 
transgenic mice, revealing that a 3.2 kb 5'-region is sufficient for tissue-specific expression. 
(Krimpenfort et al., 1988; Pieper et al., 1989). Here we further characterize the most 
important enhancer region and show the presence of a double AP-1 consensus sequence, 
which was found earlier in the human vimentin promoter (Rittling et al., 1989). We 
demonstrate that the AP-1 enhancer element, believed to be responsible for tissue-culture 
induction of vimentin, is conserved in location as well as in function in man and hamster. 
Evidence is presented for an arrangement, in which the AP-1 element is flanked by two 
silencer regions. Gel mobility shift assays and Southwestern (protein-DNA) blotting 
demonstrates the binding of proteins from HeLa and MCF-7 nuclear extracts to both silencer 
elements. Moreover, the boundaries of protein-binding sites have been defined by 
phenanthroline/copper footprinting. Although HeLa and MCF-7 cells are both of epithelial 
origin, the newly identified hamster silencer regions contribute to the repression of 
transcription only in the vimentin-free mamma carcinoma cell line MCF-7. In HeLa cells, the 
culture induction of the vimentin gene by the AP-1 enhancer element apparently dominates 
the negative effects of the two silencer regions. 
RESULTS AND DISCUSSION 
(a) Identification of two silencer regions flanking the AP-1 double consensus 
In the present study the most important enhancer region located between an EcoRl site at 
1039 bp and a Smal site at 602 bp upstream from the cap site has been characterized. The 
437-bp region comprises the AP-1 consensus sequence at approximately -700, previously 
identified in the human vimentin promoter (Rittling et al., 1989). Two epithelial cell lines, 
HeLa and MCF-7 were used for transient transfection assays with vimentin-CAT chimeric 
constructs. The latter cell line, as an exception, contains no vimentin and the complete 3.2-kb 
upstream promoter region is inactive in transient transfection assays (Heuijerjans et al., 1989; 
Pieper et al., 1992). As shown by Van der Burg et al. (1989), AP-1 induction is not impaired 
in proliferating MCF-7 cells. Since almost all cells in culture express vimentin, regardless 
of their embryonic origin, MCF-7 cells apparently can inhibit tissue culture induction of 
vimentin expression. Most probably, this negative regulation takes place at the transcriptional 
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Fig. 1. Transient CAT transfection assays using 
chimeric vimentin-CAT constructs in MCF-7 (M) 
and HeLa (H) cells. Three hamster vimentin 
promoter deletion fragments were fused to the CAT 
gene in pSUPERCAT. All deletion fragments 
terminate at a Psll site 101-bp downstream from the 
cap site. BamHl (B), EcoRl (E) and Snml (S) 
restriction sites were used as 5'-boundaries. MCF-7 
and HeLa cells were plated at a density of 2-3 χ 10s 
cells per 100-mm dish, 48 hours prior to 
transfection. HeLa cells were cultured in DM EM 
with 10% fetal bovine serum and MCF-7 cells were 
cultured in EMEM with insuline and 10% fetal 
bovine serum. Approximately 16 h before 
transfection, MCF-7 cells were shifted to DMEM. 
Cell cultures were transfected via calcium-phosphate 
precipitation (Wigler et al., 1977) with 10 /ig of 
CsCI-isolated chimeric plasmid DNA and 3 μg of 
pRSV-beta-galactoside (internal control plasmid). 
Cultures were harvested 48 h post-transfection. 
Determinations of ß-galactosidase and CAT 
activities were performed according to Edlund et al. 
(1985) and Gorman et al. (1982), respectively. 
Experiments were quantitated by excision of 
radioactive spots from the silica plates and 
determination of their "C content by liquid 
scintillation counting. All values shown are the 
average of three to four experiments. 
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Fig. 2. Transient transfection and CAT assays with 
chimeric constructs containing a heterologous 
promoter. For construction of pVES437 and 
pVAS153, respectively, a 437-bp EcoRUSmal 
restriction fragment and a 153-bp AlullSmal 
fragment were inserted downstream from the CAT 
gene in pBLCAT2, a CAT plasmid with a Herpes 
simplex thymidine kinase promoter (Luckow and 
Schutz, 1987). Subsequently pVAS153, pVBl and 
pVB2 were constructed from various BaI3\ 
digestions starting from 5' or З'-ends. Insertion of 
an oligonucleotide with a double AP-1 consensus in 
the downstream polylinker between EcoRl and Sinai 
resulted in pVAP-1. For construction of pSlL2(AP-
1) and pSlH(AP-l), 3' and 5'-flanking regions of 
the AP-1 consensus element, respectively, were 
inserted upstream from the tk promoter in clone 
pVAP-1. All procedures were performed as 
indicated in Fig. 1. Relative CAT activity levels 
were obtained by normalizing all values for the 
activity of a construct containing an SV40 promoter. 
For M and H see Fig. 1. 
level. Support for this assumption stems from a recent study describing the expression of 
vimentin in MCF-7 cells in which mutant vimentin gene constructs under the control of an 
epithelium-specific keratin intermediate filament promoter have been used (McCormick et al., 
1991). 
We transfected three different vimentin-cat (vim-cat) chimeric constructs into HeLa and 
MCF-7 cells (Fig. 1). The activity of the complete promoter region fused to the cat gene was 
very low in MCF-7 cells. Deletion of sequences between -1039 and -602, however, resulted 
in a sixfold activation of vimentin-CAT expression. In the case of HeLa cells, deletion of 
sequences between -1039 to -602 leads to a sharp decrease in vimentin-CAT expression as 
a result of elimination of the AP-1 enhancer element located between -707 and -686 (Rittling 
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Fig. 3. (A) Gel mobility shift assays of the hamster negative control regions SILI and SIL2 and the AP-1 
enhancer element. Nuclear extracts were prepared by a modification of the method of Dignam et al. (1983). 
Briefly, cells were lysed in 10 mM Hepes pH 7.9, 10 nuM KCl, 1.5 mM MgCI2, 0.1 mM EGTA, 0.5 mM DTT 
and 0.5 mM phenylmethylsulfonyl fluoride (PMSF). Nuclei were isolated by a centrifugation step in lysis buffer 
containing 6.8% sucrose and extracted in lysis solution with with 400 mM NaCI and 5% glycerol. Nuclear 
proteins were concentrated by (NH4)2SO, precipitation (33 % w/v). Dialysis took place in 20 mM Hepes, 100 
mM KCl, 0.2 mM EGTA, 0.2 mM EDTA with 20% glycerol in the dialysis solution and 5% glycerol in the 
dialysis sample. Restriction fragments containing SILI and SIL2 as well as an oligonucleotide with a double AP-
1 consensus 
5'-AATTCCGTGAATCATCACCACTGACTCAGC-3' 
AGGCACTTAGTAGTGGTGACTGAGTCG 
were cloned in pGem3 (PROMEGA) and 3:P-labeled by filling in with Klenow polymerase. A 1-2 ng portion 
of each fragment was incubated with 1-3 μΐ of nuclear extract with 4 μg poly [d(I-C)] in a final buffer 
concentration of 25 mM Tris (pH 7.9), 6.25 mM MgCl2% 0.5 mM EDTA, 50 mM KCl, 0.5 mM dithiothreitol 
and 4% Ficoll. The samples were incubated on ice for 10 min and loaded onto a 6% native Polyacrylamide gel 
prepared in 0.5 X Tris-boric acid-EDTA (TBE), pH 8.3. All lanes labeled with 1 represent the incubations 
without extract, 2 with nuclear extract and in 3 shifted complexes were competed by unlabeled competitor DNA 
in 50-fold molar excess. (B) Southwestern blot analysis with HeLa (H) and MCF-7 (M) nuclear extract, 
incubated with a MP-labeled S1L2 fragment. Southwestern blotting and screening were performed according to 
Silva et al. (1987). After electrophoresis and blotting of nuclear proteins, the nitrocellulose filter was screened 
with a labeled S1L2 probe. With the aid of the end-labeled DNA fragment a protein of approximately 200 kD 
could be detected. 
et al., 1989; Pieper et al., 1992). Apparently, the 437-bp region (-1039 to -602) displays 
opposite effects in the two cell lines. For a more detailed analysis this region has been cloned 
as an EcoRl/Smal fragment in the downstream multiple cloning site of pBLCAT2. This 
expression plasmid with the heterologous Herpes simplex tk promoter enables the 
performance of enhancer tests (Luckow and Schütz, 1987). Several similar constructs have 
been prepared, from which 5' or 3' segments of the 437-bp fragment have been deleted, (Fig. 
•2). The 437-bp fragment strongly enhances the tk promoter in HeLa cells (Fig. 2). 
Surprisingly, in MCF-7 cells the tk promoter is silenced by the 437-bp region. Deletion of 
5'-sequences between -1039 and -755 has no effect at all, but subsequent deletion of 3' AP-1 
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flanking sequences (pVBl) results in a 5-fold 
increase in CAT activity in MCF-7 cells. 
Deletion of 5'-flanking sequences (pVB2) 
displays even stronger effects, since CAT 
activity increases approximately 20-fold, 
suggesting the presence of negative regulatory 
sequences. A synthetic oligonucleotide with the 
double AP-1 consensus also inserted in the 
ЕсоШ and Smal sites, shows strong enhancer 
activities in HeLa as well as in MCF-7 cells 
(pVAP-1). The sequences deleted to yield 
pVBl and pVB2 respectively, were cloned as 
restriction fragments upstream of the tk 
promoter in pVAP-1 in the reversed 
orientation, resulting in pSILl(AP-l) and 
pSIL2(AP-l). The 3' AP-1 flanking sequence, 
designated SIL2, has an even stronger silencing 
activity in this position in contrast to the 5'-
flanking element, designated SILI, which 
displays almost equal silencing activity in both 
positions. Athough the negatively regulating 
regions and the AP-1 consensus sequences are 
normally closely connected in the vimentin 
enhancer region, both silencer elements 
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Fig. 4. Phenanthroline/Copper nuclease foolprinting 
of DNA-protein complexes. Foolprinting was 
performed according to Kuwabara and Sigman 
(1987). Preparative band shifts were carried out 
with SILI and SIL2 restriction fragments labeled at 
one end. After electrophoresis the whole gel was 
immersed in the foolprinting solution. After 
cleavage the gel was exposed to X-ray film for 3-4 
h at 4 °C. The labeled bands were cut out and the 
DNA was eluted in 0.5 M ammonium acetate (pH 
8.0). Free (F) and bound (B) DNA were analyzed 
after precipitation, on a 6% sequencing gel, 
together with a Maxam and Gilbert sequencing 
reaction (G + A). Protected regions are shown by 
bars and boundaries of protein-binding sites are as 
indicated. 
separately express strong repressor activities 
when cloned 5' of the CAT gene (Fig. 2). The two elements act as transcriptional silencers 
irrespective of orientation and positron and silencing activities are not confined to the own 
promoter, but involve also the heterologous tk promoter. 
(b) MCF-7 and HeLa nuclear extracts contain proteins binding to both silencer regions 
In order to confirm that both negatively acting regions bind nuclear proteins, gel 
mobility shift assays were performed. For this purpose the SILI and the SIL2 sequences were 
isolated as a 61-bp Hinfi fragment and a 74-bp Hinfl fragment, respectively and subcloned. 
Both silencer fragments and an oligonucleotide encompassing the double AP-1 consensus 
were end-labeled by Klenow (large fragment) polymerase. As shown in Fig. ЗА HeLa and 
MCF-7 nuclear extracts produce shifted complexes of equal intensities with the AP-1 
oligonucleotide. The SILI fragment also reveals retarded bands of similar intensities with the 
two different nuclear extracts. Interestingly, using the SIL2 fragment, we obtained a shifted 
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-811 
he ggttaaaaaaettgggacaatga gcttggagttctcagagtctggagteaatctcagctaa cggttttccctgaace g 
mo ggtttaaaa cttcggacaatgaatgagcttagcgctcttggagtctggagtcaatctcaactaa cggttttcc tgaacc g 
hu ggt agcactgagaactagcagcgcgcgcggagcecgctgagacttgaatcaatctggtctaa cggtttcccctaaacc g 
eh ggattt ctgtcctgcctttgaggctctttgggg ateae ttet aatgacctttttgteagagctctttcccgagacag 
-733 
ha ctagecgatctcaccct cagggctcontgaatceteacca:tgactcagcgaccccaccctcgtcgcttggactt 
im ctagacgatctcaccct cagggctccttgagtcîtatcca;tgactcsjcgaccccaccc cgtcccctgggctt 
hu ctaggagccctcaatcggcgggacagcagggcgcggtgagtcaregeeg¡tgactaagcgaccccacccctctccctcgggctt 
ch t gaccgtgtgcct acagaaactaaaa gcaaacag accctcggtta aeaccg ctcctgccgc tcccccgctga 
•658 
ha tactcaagaggcagtgg agcctggtcctctggggttggactgaatccgttagatcccgggataggaccac tcaaaa 
no tactccagaggcegtgg ctcctaatcctctetagttgaactgagtccgttagatcaggggatatgaccecgtcaaa 
hu tectet gccaccgccgtctcgcaactcccgccgtecgaagctggactgagcecgttaggtcgatggaeagaggcgcgggccgg 
ch ccaggagcgctgt geeegaag caaagcgatgcccctcctgcagcc gtgegagt gcgcagcgccgtcc g 
Fig. 5. Partial alignment of hamster (ha), mouse (mo), human (hu) and chicken (ch) vimentin upstream regions. 
AP-1 consensus sequences (boxed) are conserved in mouse, hamster and man. Protected regions in the footprint 
analysis are marked by asterisks. Numbering is according to the hamster start site of transcription. 
complex of much higher intensity with MCF-7 extract. In each case competition experiments 
are performed with a 50-fold molar excess of unlabeled fragment. Although the total protein 
concentrations of MCF-7 and HeLa extracts are approximately equal, the intensity of the 
retarded band produced by the SIL2 sequence is much weaker in the case of the HeLa 
extract. This may be due to a lower amount of trans-acting factor in HeLa nuclear 
extracts. The same conclusion may be drawn from the Southwestern analysis, where the band 
present in the HeLa lane is also of lower intensity (Fig. 3B). The SIL2 sequence binds a 
protein of approximately 200 kDa as judged by comparison to molecular mass standards. The 
molecular mass of the protein is comparable to that of the smallest spectrin molecule from 
an erythrocyte protein preparation used as an extra molecular-weight marker (results not 
shown). We have confirmed the specificity of the binding by addition of unlabeled competitor 
in a high molar excess. Under the conditions applied, Southwestern analysis of the SILI 
region has not been successful yet. 
(c) Tlie localization of protein-binding sites for two negatively acting regions in the hamster 
vimentin promoter 
In order to define the boundaries of protein binding sites more precisely, a strand- cleavage 
protection assay has been performed. Phenanthroline/copper footprinting has been applied to 
the fragments also used for the gel mobility shift assay. The end-labeled fragments have been 
subjected to a preparative band shift assay. After cleavage with the copper/phenanthroline 
complex, retarded and free bands have been cut out, DNA has been eluted and analyzed on 
a sequencing gel together with Maxam and Gilbert G+A sequencing reactions (Kuwabara and 
78 
hamster vimentin 3' silencer region 
glut, trans. Ρ ggageagga -811 agaaetagcagcgcge 
inn ι ti m i ι 
ha. vimentin -655 tcaagaggcegtggegcetgg -635 -655 tcaageggeagtggagcetgg 
II || || || III lllll II Ш И П 
eh. vimentin -608 caggagcgctgtgeccgaa -592 -420 tcaccaggcaatgaagcctgg 
hamster vimentin 5' silencer region 
ha. vimentin -741 ctgaaccgctagagatctca ccctcaggg -712 
III III IUI 
hu. vimentin -310 tcagtccc cagg 300 
Fig. 6. Sequence comparison of the hamster (ha) negative control regions with other known negative regulatory 
elements (A) The hamster 3' silencer region is compared to the glutalhion transferase Ρ (glut trans P) gene 
negative element and to the chicken vimentin negative element (B) A comparison of the 3' silencer region with 
a fragment from the mouse muscle creatine kinase (CKM) gene and with a potential negative regulatory element 
from the human vimentin promoter (hu) (C) A certain degree of similarity is also found for the 5' silencer 
element in another potential human negative regulatory region 
Sigman, 1987). We have observed protection against cleavage at position -741 extending 
through position -712 (SILI) and at position -655 extending through position 635 (SIL2) as 
shown in Fig. 4. The strongest protection for the SILI fragment, however, occurred between 
positions -741 and -728. In Fig. 5 regions protected in the footprint analysis have been 
marked by asterisks 
(d) Comparison of the hamster vimentin negatively acting sequences to other known 
negative control regions 
Several negative regulatory elements have been described previously for other mammalian 
genes (Cao, et al., 1989, Montgomery et al , 1990, Savagner et al., 1990, Paciucci and 
Pelhcier, 1991). True silencers are defined as elements which can exert their effect 
independently of their orientation and distance with respect to the promoter/enhancer. At 
present, the mechanism underlying silencer action is not well understood Several proposals 
have been put forward of which binding of a repressor protein to its DNA target to inhibit 
transcription, is the most direct one. In the cell, repressor protein levels might be modified 
per se. Alternatively, other proteins, may interact with the repressor and prevent binding 
to the silencer element. 
Another mechanism by which silencer sequences may cause decreased gene transcription 
involves interaction with the nuclear matrix In the immunoglobulin heavy-chain gene, regions 
bound to the nuclear scaffold and flanking an important enhancer coincide with two negative 
hu. vimentin 
ha. vimentin 
mouse CKH 
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regulatory elements (Kohwi-Shigematsu and Kohwi, 1990). Homologies with consensus 
scaffold-binding regions were also found in silencer elements present in the or T-cell-receptor 
gene (Winoto and Baltimore, 1989). 
The two silencer elements identified by us are flanking an AP-1 enhancer element. 
However, neither element displays any similarity with known scaffold-binding consensus 
sequences. Comparison of the vimentin 3' AP-1 flanking element (SIL2) to other known 
silencer elements revealed considerable similarity to the glutathion transferase Ρ silencer 
elements (Imagawa et al., 1991). The 9-bp core binding sequence is composed almost entirely 
of G and A residues. In the hamster SIL2 region this sequence is represented twice with only 
a slight variation (Fig. 6). Interestingly, a 19-out-of-23 basepair match was found in the 5'-
upstream region of the mouse muscle creatine-kinase gene (Sternberg et al., 1988). This 
region, however, has never been tested for negatively acting functions. For both the SILI 
and the SIL2 sequences, homology was found in the human vimentin upstream region. 
Potential negatively acting regions in the human promoter (Rittling et al., 1989), although 
found at different locations, do contain sequences with homology to the hamster silencer 
elements (Fig. 6). A silencer element in the chicken vimentin promoter region reported 
by Farrell et al. (1990) and our SIL2 region, map at corresponding positions according to 
the alignment in Fig. 6. The AP-1 enhancer element does not seem to be conserved in the 
chicken upstream region. A closer look at the sequences of the negative elements of hamster 
and chicken vimentin revealed no obvious homology in nucleotide composition. Our in vitro 
DNA-protein interaction studies seem to point at binding proteins with different 
characteristics. We could not detect any similarity in nucleotide composition of the two 
silencer regions. Therefore, we may exclude the possibility that the same protein binds to 
both silencer elements. This has also been sustained by performing crosswise competition gel 
mobility shift assays (results not shown). 
(f) Conclusions 
(1) In this report we characterize, by transient transfection and by in vitro DNA-protein 
interaction studies, two negatively regulating DNA segments serving as targets for nuclear 
proteins in MCF-7 and HeLa extracts. The newly identified silencer elements which can 
function independently of orientation and position both flank a double AP-1 consensus 
sequence that is functionally and positionally conserved in mouse, hamster and man (Fig. 
5). 
(2) Southwestern blot analysis and gel mobility shift assays showed an excess of protein, 
binding to SIL2 in MCF-7 nuclear extracts compared to HeLa nuclear extracts. If we assume 
that the binding proteins are directly involved in down-regulation of vimentin expression, this 
quantitative difference could explain a partial repression of vimentin transcription in MCF-7 
cells. The protein(s) binding to the SILI sequence, which is the strongest silencer element, 
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seems to be represented at similar levels in MCF-7 and HeLa nuclear extracts. The latter 
observation, described also by Frisch et al. (1990) for the human type IV collagenase gene, 
implies a mechanism more subtle than simple regulation of protein concentration. It is evident 
from our experiments that both silencer elements must cooperate in order to repress 
transcription in the vimentin-negative MCF-7 cell line. 
(3) To determine the nature of the binding proteins, mutagenesis studies will be performed 
in the near future. The role of silencer proteins in the regulation of vimentin expression in 
vivo is still unclear. However, in the absence of serum induction of the AP-1 sequence, 
silencer elements may play a role in the repression of vimentin transcription in tissues lacking 
vimentin expression in vivo. We are currently conducting experiments in transgenic mice to 
verify this hypothesis. 
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Chapter 4 
Negative regulation of a special, double AP-1 consensus 
element in the vimentin promoter: interference by the 
retinole acid receptor 
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Negative regulation of a special, double AP-1 consensus element 
in the vimentin promoter: interference by the retinoic acid 
receptor 
The growth-regulated vimentin gene contains a functional double AP-1 binding site formed by 
two nearly perfect inverted repeats. We present evidence for down-regulation of vimentin 
expression by the retinoic acid receptor (RAR) in two mesodermally derived cell types. By 
mutation analysis we prove that the double consensus element is responsible for this negative 
regulation. From in vitro protein-DNA interaction studies we conclude that AP-1 binding is 
inhibited at RAR amounts required for occupation of the cognate RAR binding site in nuclear 
extracts from 3T3 cells and differentiated embryonal carcinoma cells. Furthermore, we show that, 
unlike in other cases, /nj/w-activation of the vimentin AP-1 enhancer element can occur in 
undifferentiated embryonal carcinoma cells, despite the low amount of Jun and Fos proteins 
present in these cells. Here, however, down-regulation by retinoic acid cannot be detected. 
INTRODUCTION 
The cytoskeletal protein vimentin belongs to the group of intermediate filament proteins 
(IF). Each member of this group shows a more or less tissue-specific distribution pattern. 
Vimentin is characteristic for mesenchymal cells. Unlike other IF proteins, vimentin is 
also detectable during specific stages in embryonal development. Its expression is switched 
off in later stages and is replaced by a more specialized IF protein. For instance, during 
muscle cell differentiation vimentin is exchanged for the muscle-specific IF protein 
desmin, whereas in epithelial differentiation specific types of keratins are being switched 
on. Apart from its complex expression pattern during development, the vimentin gene is 
identified as a growth-regulated gene (Ferrari et al., 1986). This is believed to be due to 
the presence of an enhancer element to which a complex of proteins, named AP-1, can 
bind (Rittling et al., 1989; Pieper et al., 1992). AP-1 is mainly composed of the proto-
oncogene products Fos and Jun (Curran and Franza, 1988). 
Abbreviations: 
IF, intermediate filament(s); AP-1, activator protein 1; CAT, chloramphenicol acetyltransferase; tk, 
thymidine kinase; RSV, Rous Sarcoma Virus; RA, retinole acid; RAR retinole acid receptor; RXR, retinoid 
X receptor; RARE, retinole acid receptor binding element; SV40, Simian Virus 40; GST, glutathione-S-
transferase 
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The vitamin A metabolite, retinoic acid (RA), plays a major role in differentiation and 
patterning in a number of developmental systems. The effects of RA on gene transcription 
are believed to be mediated by the structurally related nuclear retinoic acid receptors 
(RAR), which fall into two different groups, the classic RARs (RAR a, ß and 7) and the 
more recently discovered retinoid X receptors (RXR a, ß and 7). All these receptors are 
encoded by distinct genes and belong to a larger family of DNA binding regulatory 
proteins, the steroid and thyroid hormone receptors (Petkovitch, 1992). The RARs and 
RXRs bind as homodiiners or heterodimers to their target sequences, the retinoid response 
elements (RARE), included in regulatory regions of retinoid responsive genes. The DNA 
sequences required for the action of all members of the family of hormone receptors 
display varying degrees of homology (reviewed by Petkovitch, 1992; Zhang and Pfahl, 
1993). Another important resemblance of these nuclear receptors is, that apart from their 
positive effects on transcription, they are also involved in gene repression. This negative 
regulatory mechanism can take place via different kinds of interactions (reviewed by 
Schule and Evans, 1991; Miner et al., 1991; Pfahl, 1993). For instance, for the osteocal-
cin and proliferin genes, repression is exerted through a combined response element, 
which serves simultaneously as a hormone receptor and an AP-1 recognition site (Schule 
et al., 1990a; Diamond et al., 1990). A second inhibitory pathway by hormone receptors 
has been put forward. A functional AP-1 site in the 5' regulatory region of certain genes 
seems to be directly responsible for the repressive effect. It has been proposed that Fos 
and Jun are able to interact with the hormone receptor in solution, which subsequently 
prevents the complex from DNA binding and gene activation (Schule et al., 1990b; 
Nicholson et al., 1990; Yang-Yen et al., 1990; Jonat et al., 1990). Whereas this phenome-
non has been well documented for the collagenase and stromelysin genes, the exact 
mechanism for this interaction is not clear yet. It has been reported that the leucine zipper 
regions of Fos, as well as Jun, play a major role (Shemshedini et al., 1991; Schule et al., 
1990b). Furthermore, mutation analysis of the hormone receptor protein indicates that 
regions involved in normal protein-protein or protein-DNA interactions are important for 
AP-1 inhibition (Kerppola et al., 1993; Schule et al., 1991; Hudson et al., 1990). 
Since the vimentin gene also contains an AP-1 enhancer element, down-regulation by 
for instance RA might be an important mechanism during development or differentiation 
of certain tissues. Previous reports indicated a negative as well as a positive effect exerted 
by RA on vimentin expression, depending on the cell type used (Rius and Aller, 1992; 
Leung et al., 1992; Järvinen, 1990; Wood et al., 1990). However, the elements involved 
in the vimentin promoter have not yet been investigated. In this report the role of the 
double AP-1 consensus element in the repression of gene transcription by RA has been 
analyzed by mutation analysis. For this purpose two different cell lines have been used, 
the NIH 3T3 cell line co-tranfected with all three RARs and the mouse P19 embryonal 
carcinoma cell line in undifferentiated and differentiated states. The P19 cell line serves as 
a model system for cells sensitive to differential regulation of gene expression by 
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administration of RA (McBurney et al., 1982). 
MATERIALS AND METHODS 
Recombinant plasmids 
The wild-type vimentin reporter construct -3100vimcat and the deletion construct -
602vimcat are derivatives of pSUPERCAT and have been described earlier (van de 
Klundert et al., 1992). The AP-1 mutant was constructed by subcloning a 2.3-kb Xhol 
fragment from the hamster vimentin gene (Quax et al., 1983) in pGem-7Zf(+) (Promega, 
Madison, WI). In this construct the double AP-1 consensus sequence was altered by іи 
vitro mutagenesis (Fig. 1) and subsequently, the mutagenized 0.8 kb Bglll/Xhol subfrag­
ment was exchanged with a corresponding fragment in the wild-type vimentin reporter 
construct, resulting in -3100[AP-l]vimcat. The mutagenized bases have been verified by 
sequence analysis. The tkcat[AP-l] construct is derived from pBLCAT2 and contains an 
oligonucleotide fragment, comprising the vimentin AP-1 element, shown in Fig. 1 inserted 
in the downstream multiple cloning site. In this construct the cat gene is under control of 
the heterologous herpes simplex tk promoter (Luckow and Schütz, 1987). The RARa, 
RARß and RARY expression plasmids have been kindly provided by Dr. P. Chambón. 
The RARa bacterial expression vector has been created by inserting a 1.8 kb hRARa, 
Kpnl/EcoRl fragment (Petkovich et al., 1987; Giguere et al., 1987) lacking the first 19 
amino acids in pGEX3X. This system promotes expression and isolation of a glutathione-
s-transferase (GST) fusion protein from bacterial lysates by affinity chromatography using 
glutathione agarose beads. The 3xRARE[tkcat] expression vector, which was used as a 
positive control for RA responsiveness and the RSV c-jun expression vector were kindly 
provided by Dr. P. van der Saag and Dr. A. van der Eb, respectively. 
Cell culture, DNA transfections and CAT assays 
3T3 cells have been cultured according to standard conditions in Dulbecco's modified 
Eagle's medium (DMEM) containing 10% fetal bovine serum. Undifferentiated P19 
embryonal carcinoma cells have been cultured in 1:1 DMEM/Ham's F12 medium contai-
ning 7.5% fetal bovine serum. Differentiated P19EC derivatives, designated P19EPI-7, 
P19END-2 and P19MES-1, were kindly provided by Dr. С Mummery and represent 
subclones with mainly epidermal, endodermal and mesodermal characteristics, respective­
ly (Mummery et al., 1985; 1986). Test transfections have been carried out in medium 
containing charcoal-stripped fetal bovine serum. Since serum only contains RA concentra­
tions up to ΙΟ"10 M and the results encountered were comparable with the CAT values 
obtained with standard serum, we continued our experiments under these standard 
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conditions. Cells were plated into 8-cm Petri dishes in DMEM containing 5% fetal bovine 
serum for the NIH 3T3 cells and 1:1 DMEM/Ham's F12 with 5% fetal bovine semm for 
the P19EC and P19MES cells 48 hours before transfection. All cell types have been 
transfected at densities of approximately 25% via a calcium phosphate-mediated method 
described earlier (van de Klundert et al., 1992). Cultures are transfected by a mixture of 
CsCl-isolated DNA containing cat plasmid, internal control plasmids, pRSV-ß-galactoside 
or pSV40-ß-galactoside, and either RARa, β and 7 (NIH 3T3) or c-jun (P19EC) expressi­
on vectors. After the glycerol shock, DMEM (or DMEM/F12) containing 5% fetal bovine 
serum and ΙΟ"7 M all-trans-RA has been applied. 48 hours post-transfection cells are 
harvested and transfection efficiencies are determined by monitoring ß-galactoside levels. 
After correction for protein contents, cell lysates have been assayed for CAT expression 
by a CAT ELISA assay (Boehringer Mannheim, Germany). 
Northern blot analysis 
RNA isolation, Northern blotting and hybridization have been performed as described 
previously (Pieper et al., 1992). Total RNA from P19EC, P19EPI, P19END and P19MES 
cells, cultured under high and low serum conditions, has been isolated. As a vimentin 
probe, a hamster vimenlin cDNA has been used. Relative RNA levels have been quantita-
ted by densitometric scanning (Biorad, imaging densitometer, GS-670, Richmond CA). 
Bacterial expression of RARet and preparation of nuclear extracts 
Nuclear extracts from NIH 3T3, P19MES and P19EC cells have been prepared by a 
modification of the method described by Dignam et al. (1983). Briefly cells are lysed in 
10 mM Hepes, pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 0.1 niM EGTA, 0.5 mM dithi-
othreitol and 0.5 mM phenylmethylsulfonyl fluoride. Nuclei are isolated by centrifugation 
in lysis buffer containing 6.8% sucrose and extracted in 400 mM NaCl, containing 5% 
glycerol. Nuclear proteins are concentrated by (NH4)2S04 precipitation (33% w/v). 
Dialysis takes place in 20 mM Hepes, pH 7.9, 100 mM KCl, 0.2 mM EDTA, 0.2 mM 
EGTA, with 20% glycerol in the dialysis solution and 5% glycerol in the dialysis sample. 
After dialysis, extracts are quickly frozen in liquid nitrogen and stored in small samples at 
-70 °C. A hRARa-GST has been expressed in bacteria according to procedures previously 
described (Smith and Johnson, 1988). Briefly, bacteria are sonicated and the debris is 
pelleted. The supernatant is mixed with 1 ml of preswollen glutathione-agarose beads in 
20 mM Hepes pH 7.6, 100 mM KCl, 0.2 mM EDTA, 1 mM dithiothreitol, 1 mM 
phenylmethylsulfonyl fluoride, 20 μg/ml aprotinin, containing 20% glycerol. With 
constant stirring for 2 hours at 4°C the beads are washed in the same buffer, subsequently 
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proteins are eluted by reduced glutathione. Proteins from different elution steps are 
quickly frozen in small samples and subjected to sodium dodecyl sulfate-polyacrylamide 
gel electrophoresis (PAGE) to confirm their molecular weight. The same procedure has 
been applied to a construct without insert, to obtain GST protein alone. 
DNA binding assays 
Electrophoretic mobility shift assays have been performed with two oligonucleotide 
fragments. The RARE oligonucleotide contains the RA response element of the RARß 
promoter (coding strand: 5'GGGTTCACCGAAAGTTCACTCATCTTA3'). The AP-
1/TRE oligonucleotide, which comprises the vimentin double consensus or TPA resposive 
elements (TRE), is shown in Fig. 1. The double- stranded oligonucleotide probes contain 
Hindlll and EcoRl overhangs, respectively, and have been end-labeled with 32P, using 
Klenow large fragment polymerase. As a control the binding of GST-RARa fusion protein 
to its recognition sequence has been tested under the following conditions: 20 mM Tris pH 
8.0, 4 mM MgCl2, 5 mM spermidine, 50 mM KCl, 0.03 mg/ml poly[d(I-C)], 2 mM DTT 
in 8% glycerol and 0.1% NP40. Labeled DNA (2 ng) and approximately 1 μg of purified 
RAR fusion protein have been incubated on ice for 10 minutes and loaded onto a 6% 
native Polyacrylamide gel prepared in 45 mM Tris-borate pH 8.3, 1 mM EDTA (TBE). 
Nuclear extract of 3T3 cells has been pre-incubated with or without different concen­
trations of GST-RAR or GST protein for 10 minutes at 37 °C, after which 3 ng of labeled 
AP-1 DNA has been supplied, following incubation for 15 minutes at 37 °C. Subsequent­
ly, incubations with P19MES or P19EC nuclear extracts have been performed. The buffer 
conditions for the incubations with nuclear extracts are as indicated for the GST fusion 
protein alone, with minor modifications (10 mM Tris instead of 20 mM and 6% Ficoll 
instead of glycerol). Also higher amounts of poly[d(I-C)] are required (0.1 mg/ml). 
Samples have been electrophoresed under the same conditions. 
RESULTS 
Virnentin expression is differentially regulated in P19 EC cells 
We and others previously characterized the positive as well as negative regulation of 
the vimentin gene (Rittling et al., 1989; van de Klundert et al., 1992; Pieper et al., 1992). 
Vimentin expression is differentially regulated during development. In certain stages a 
switch occurs between vimentin and a more tissue-specific IF protein. For instance during 
differentiation of myoblasts into mature muscle cells vimentin is exchanged for desmin. 
P19 EC cells can be induced to differentiate by different concentrations of RA or DMSO 
and thereby serve as a model system for the study of changes in gene expression during 
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Fig. 1. Nucleotide sequence of the positive strand of 
the vimentin region encompassing the double AP-1 
consensus element. The mutated bases are marked 
by asterisks. 
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development. Cells differentiate into 
mainly ectodermal cells, like neural and 
neuro-mesodermal cells, by addition of 5 
χ ΙΟ
7
 M RA. Administration of ί α 9 M 
RA (or 0.5% DMSO) leads to predomi­
nantly endodermal cells and RA concen­
trations of IO-8 M (1% DMSO) stimulates 
the production of mesodermal cells, like 
skeletal muscle cells. By applying these 
procedures stably growing cell lines ex­
pressing ectodermal, endodermal, or 
mesodermal markers can be obtained 
(McBurney et al., 1982).Total RNA has 
been isolated from cell lines, named 
P19EPI, P19END and P19MES respecti­
vely, representing all three alternate path­
ways and from the undifferentiated parent 
cell line P19EC. After blotting, filters 
have been hybridized with a hamster 
vimentin cDNA probe. Approximately 
equal amounts of RNA have been elec-
trophoresed, as confirmed by hybridiza­
tion with a ribosomal DNA probe (results 
not shown). P19EC cells and P19EPI 
cells contain only small amounts of vi­
mentin mRNA (Fig. 2). The latter cells 
represent the neural cell populations 
which are devoid of vimentin when ter­
minally differentiated. Endodermal cells, 
represented by the cell line P19END, express threefold higher levels of vimentin mRNA 
in comparison to ectodermal cells. Furthermore the P19MES cell line representing the 
progenitor cells for muscle differentiation has been cultured under high (7.5%) and low 
(2%) serum conditions (Doney et al., 1984). Terminal differentiation of muscle cells 
requires a conversion of culture conditions from high to low mitogen content. We have 
observed a 3.5-fold decrease in vimentin mRNA expression, under low serum conditions. 
Furthermore, expression levels are 10-fold higher in P19MES cells cultured under 7.5% 
serum conditions, in comparison to undifferentiated P19EC cells (Fig.2). Treatment of 
P19MES cells cultured under 2.5% serum with ΙΟ"7 M RA for 48 h results in a further 
50% decrease of vimentin mRNA (results not shown). Since RA has been shown to induce 
ША 
* # * 
1 2 3 
Fig. 2. Northern blot analysis of P19EC cells and 
differentiated derivatives. Hybridization has been 
performed with a hamster vimentin cDNA. 
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muscle cell differentiation (Halevy and 
Lerman, 1993) we have decided to per-
form transient transfections in P19MES 
cells by treating these cells with RA. For 
comparison undifferentiated P19EC cells 
have also been used in our transient trans-
fection experiments. The time between the 
addition of RA and harvest of the cells is 
not long enough for P19EC cells to diffe-
rentiate. Moreover, the undifferentiated 
P19EC cells serve as a control for cells 
expressing low amounts of vimentin. 
Analysis of S'-flanking regions of the 
hamsier vimentin gene 
For transient transfections using vimer 
used. The NIH 3T3 cell line has been chosen as a representative of cells from mesodermal 
origin, normally expressing vimentin, but containing low levels of RARs. P19EC cells 
differentiate upon RA addition and thus contain functional amounts of RARs. This is also 
true for the P19MES cells, which in contrast to the parent cell line, contain high amounts 
of vimentin. To study the effects of RA addition on vimentin-CAT expression, NIH 3T3 
cells have been cotransfected with a mixture of RAR expression vectors (RARa, RARß 
and RAR7, I μg each). Since we expected a low vimentin expression in P19EC cells, due 
to low AP-1 activity, an RSV c-jun expression vector has been cotransfected in increasing 
amounts (0, 2, and 4 /xg). In all transfections the CAT activity of a construct with the 
SV40 promoter and enhancer (Promega) has been used as a positive control and all CAT 
values are presented as a percentage of the CAT activity of the positive control. Test 
transfections have been performed in NIH 3T3 and P19EC cells with a construct contai­
ning 3 copies of the RARE and the thymidine kinase promoter driving the cat gene. Very 
high CAT activities are obtained, under the same condition applied to the vimentin-cat 
transfections. CAT activities after RA admission are 35-fold (P19EC) and 25-fold (3T3) 
higher than controls without RA (Fig. 3). The latter cells have been cotransfected with 
RAR expression vectors as mentioned earlier. 
Previous reports have provided evidence for the presence of an AP-1 enhancer in the 
vimentin promoter located approximately 700 bp upstream from the transcription initiation 
site (Rittling et al., 1989; van de Klundert et al., 1992; Pieper et al., 1992). The dement, 
which is very conserved between hamster and humans, is responsible for serum inducibili-
ty and TPA responsiveness. Since the element has been reported to be involved in steroid-
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Fig. 3. Control transfection assays with a con­
struct containing 3 RAR recognition sites. P19EC 
cells and NIH 3T3 cells are incubated without (-) 
or with ( + ) ΙΟ"7 M RA. CAT values are repre­
sented as relative amounts, compared to the acti­
vity of the SV40 promoter. 
ntin-cat constructs three cell types have been 
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mediated down-regulation of the collagenase and stromelysin genes (Schule et al., 1991), 
we investigate here, whether the AP-1 element might also be involved in vimentin down-
regulation. 
In Fig. 4a the results from the transfections with 4 different vimentin-cat constructs in 
P19MES cells and NIH 3T3 cells are shown. Mutagenesis of the double AP-1 consensus 
sequence in the full length vimentin 5'-flanking region leads to sixfold lower amounts of 
CAT in P19MES cells and fourfold lower amounts in 3T3 cells. These results are 
comparable with the effect of deletion of all regulatory sequences up to -602 bp, including 
the AP-1 element, as has been shown earlier for HeLa cells (van de Klundert et al., 
1992). Addition of ΙΟ7 M RA after transfection suppresses CAT activity of the wild-type 
vimentin promoter by more than fourfold in both cell types used. This effect is even more 
pronounced using the construct with the heterologous tk promoter and the vimentin AP-1 
containing oligonucleotide. The effect of RA admission is very low (non-significant) for 
both constructs lacking the AP-1 enhancer element. 
In P19EC cells the situation seems to be different. The relatively high CAT activity of 
the vimentin promoter constructs in P19EC cells (without cotransfection of c-jun) is a 
rather unexpected result (see Fig. 4B). Relative CAT activities (compared to the activity 
of the SV40-cat positive control) are approximately 40% in P19EC cells compared to 
almost 70% in P19MES cells. Comparison of the cat transfection results with the Nor­
thern blots reveals a more pronounced difference in vimentin mRNA abundance. This 
discrepancy probably arises from a difference in expression of the positive control in both 
cell types. Comparison of CAT values obtained by using the SV40 promoter construct in 
P19EC cells and P19MES cells reveals a four to fivefold lower activity in P19EC cells, 
corrected for transfection efficiency. Moreover, we would have expected a low activity of 
the vimentin promoter in P19EC cells considering the low amount of AP-1 activity in 
these cells (de Groot et al., 1990). It is striking that the construct containing the mutageni-
zed AP-1 consensus sequence exhibits fourfold lower CAT activities compared to the 
wild-type promoter construct. This implies the mwj-activation of the AP-1 enhancer 
element in these cells, despite the absence of Fos and Jun protein. CAT expression of the 
wild-type vimentin promoter and the AP-1 oligo-derived construct is up-regulated three to 
fourfold using the highest concentration (4 μg) of cotransfected jun expression plasmid. 
Here, we would have expected a much higher response too, in view of the results obtained 
with, for instance, the collagenase promoter (Angel et al., 1988; Chiù et al., 1988; 
Sassone-Corsi et al., 1988). Furthermore, administration of IO7 M RA only leads to a 
small decrease in CAT activity (Fig. 4B). As expected, the CAT activity of the construct 
with the mutated AP-1 element is not affected by the cotransfection of c-jun expression 
vector. In conclusion, vimentin expression is down-regulated by addition of RA in 
P19MES and NIH 3T3 cells but not in P19EC cells. Unexpectedly, the AP-1 enhancer 
element in the vimentin promoter can be transactivaled in P19EC cells, most probably due 
to the presence of binding proteins other than Fos or Jun. 
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In vitro DNA-protein interaction studies 
Binding of components of the AP-1 
complex to the vimentin double consensus 
sequence has been shown earlier (Ritlling 
et al., 1989; van de Klundert et al., 
1992). To investigate whether RARa is 
able to diminish the binding activity of the 
AP-1 complex, we have expressed the 
protein as a GST-fusion product in Esche­
richia coli. For this purpose a partial 
cDNA fragment lacking the coding se­
quences for the first 19 amino acids has 
been used. To confirm the binding of this 
bacterially expressed fusion protein to its 
cognate recognition sequence, we have 
end-labeled an oligonucleotide fragment 
containing a functional RARE and have 
incubated it with the affinity purified 
RARa fusion protein (Fig. 5A). A compe­
tition assay has been performed simultane­
ously with a fivefold and fortyfold molar 
excess unlabeled fragment. 
The inhibition of AP-1 complex bin­
ding by RARa, has been investigated by 
performing competition experiments with 
3T3 nuclear extracts and the bacterially 
expressed fusion protein. Using electrop-
horetic mobility assays the binding activi­
ties of nuclear extract, to an end-labeled 
probe containing the AP-1 recognition 
sites or TREs (coding strand: 5'GGG-
T T C A C C G A A A G T T C A C T -
CATCTTA3'), with or without preincuba­
tion with different amounts (0.5, 0.8 and 
1.5 t^g) of RARa fusion protein, have 
been tested (Fig. 5B). First, as a control 
the binding of bacterially expressed RARa 
fusion protein to the AP-1 consensus has 
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Fig. 4. Schematic representation of CAT activities 
using 4 different vimentin cat constructs and 2 
different cell types (A). The wild-type hamster 
vimentin 5'-flanking region is represented by -3100-
vimcat. In -3100[AP-lmut|vimcat the double AP-1 
consensus sequence is destroyed by site directed 
mutagenesis and -602vimcat is a deletion construct 
lacking the AP-1 element. The last construct, tk-
cat[AP-l]CAT, is a reporter construct which con-
tains the heterologous tk promoter and an oligonu-
cleotide comprising the vimentin AP-1 element. 
NIH 3T3 cells are co-transfected with RARa, 
RARJi and RAR-y (1 ¿ig each). Values are presented 
as relative amounts of the CAT activity of the po-
sitive control (SV40-cat) and are the result of 3 to 4 
independent experiments. RA was added immedia-
tely after transfection (concentration 107 M) and 
cells were cultured in the presence of RA for 2 
days. The bar diagram in В represents the results 
obtained with the PI9EC cells. Cells are co-trans­
fected with 0, 2 or 4 ¿ig RSV c-jun expression 
vector. 
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Fig. 5. Control gel mobility shift assay with an end-labeled RARE probe (A). The labeled DNA has been 
incubated in binding buffer either with 1 fig of a bacterially expressed RARa fusion protein (lane 2) or 
without any added protein (lane 1). Competition has been performed with a 5-fold and 40-fold molar excess 
of unlabeled DNA fragment (lanes 3 and 4). In (B) gel mobility shift assay with nuclear extracts and a 
bacterially expressed RARa GST fusion protein incubated with an AP-1 consensus (TRE) probe are shown. 
Lane 1 represents a control without nuclear extract. Lanes 3, 2: 3T3 extract (2.5 μ&) has been added to the 
probe and extract with 50-fold molar excess unlabeled competition DNA, respectively. Lane 4: marked with 
an asterisk, 1.5 μg GST protein (mock) has been added together with 2.5 fig of 3T3 nuclear extract. Lanes 
5-7: increasing amounts (0.5, 0.8, and 1.5 fig) of GST-RARor in combination with 2.5 fig of 3T3 nuclear 
extract have been used. Lane 8: GST-RARcr only has been incubated with the 3 2P labeled probe. Lanes 9-12: 
shifted complexes obtained with 2.4 μg P19MES and P19EC nuclear extract, respectively. Lanes 10, 12: 1.5 
Mg GST-RARa has been added. 
been tested and found to be negligible (lane 8). Also as a control, GST protein alone has 
been incubated with 3T3 nuclear extract (lane 4) using the same amount of protein as in 
the lane with the highest concentration of RARa-GST. As shown in Fig. 5B lanes 5, 6 
and 7, the binding of AP-1 complex to its cognate binding sequence can be inhibited by 
addition of RAR fusion protein. This inhibition is concentration-dependent, since higher 
amounts of RAR lead to a more faint band representing the retarded complex. 
The same amount of RAR fusion protein needed for occupancy of the RARE site leads 
to almost complete exclusion of AP-1 binding. This implies that the concentrations of 
RARa fusion protein used in these experiments lie within physiological range. Incubation 
of the AP-l/TRE probe from the vimentin promoter with a nuclear extract from P19MES 
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cells causes a retarded complex resembling the complex revealed by 3T3 extract. The 
amount of shifted complex can also be diminished by incubation with GST-RARa. On the 
other hand when P19EC nuclear extract is used, the shifted complex migrates with a 
higher mobility and competition with GST-RARa does not result in a disappearance of the 
retarded band. In this way can be asserted that the proteins binding to the double AP-1 
consensus sequence in the vimentin promoter in P19EC cells are different from the ones 
in P19MES and 3T3 cells. 
DISCUSSION 
We report here that vimentin expression is inhibited following treatment of fibroblastic 
NIH 3T3 cells and mesodermally differentiated P19 cells with RA. Our results support the 
data obtained with the collagenase and stromelysin genes, where AP-1 elements were the 
main target of down-regulation by hormonal receptors (Jonat et al., 1990; Lafyatis et al., 
1990; Nicholson et al., 1990; Schule et al., 1990b; 1991; Yang-Yen et al., 1990). We 
present additional evidence for the involvement of the AP-1 element, by mutation analysis 
of this sequence in the vimentin promoter, a special double consensus formed by two 
inverted repeats (Fig. 1). We conclude from our in vitro binding assays that the binding of 
AP-1 complex in nuclear extracts from P19MES and 3T3 cells can be blocked by addition 
of purified GST-RARa protein. The inhibition of binding of AP-1 by RAR is concentra-
tion-dependent and no RA seems to be necessary in vitro. Furthermore the amount of 
RAR protein required for inhibition lies within physiological range because the same 
amount of protein is needed for occupation of its own recognition sequence. Using P19EC 
cells, however, a shifted complex with a higher mobility is obtained. Addition of the 
highest concentration of RARa fusion protein does not lead to full inhibition of AP-1 
binding activity, in contrast to the effects of RAR on AP-1 binding in P19MES and 3T3 
extracts. 
The mechanism published so far to be responsible for this repression implies direct 
binding of Fos or Jun protein to the hormonal receptor in solution, thereby preventing the 
AP-1 complex from gene activation. There is, however, evidence from in vivo footprinting 
experiments, that the AP-1 site remains occupied during, for instance, dexamethasone 
repression by the glucocorticoid receptor of collagenase expression (König et al., 1992). 
An hypothesis to explain this phenomenon has been presented by Kerppola et al., (1993) 
who suggested that the glucocorticoid receptor causes a depletion by differential binding of 
Fos protein, resulting in a shift from Fos-Jun heterodimers to Jun-Jun homodimers. Since 
Jun-Jun homodimers are less potent transcriptional activators, this may lead to a lower 
promoter activity without reducing AP-1 site occupancy. Often both Jun and Fos, but (in 
some cases only Jun) are reported to be the preferential target of a specific receptor, like 
in the case of the thyroid hormone receptor (Lopez et al., 1993). 
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Repression of transcription by RA of the vimentin promoter has only been found in the 
two mesodermally derived cell types tested. This implies a cell type-specific effect. The 
results obtained with the undifferentiated P19 EC cells point to a different mechanism, 
because RA addition does not decrease promoter activity significantly. Furthermore, we 
expected a very low activity of the vimentin promoter in these cells and therefore we 
performed co-transfection experiments with a c-jun expression vector. In the case of the 
collagenase promoter this has led to high increases in promoter activity (Angel et al., 
1988; Chiù et al., 1988; Sassone-Corsi et al., 1988). Our results demonstrate that only a 
low amount of stimulation is obtained with this procedure. The main difference between 
the collagenase AP-1 and the vimentin AP-1 enhancer element is formed by its arrange-
ment. In the collagenase promoter only one AP-1 element is present (Angel et al., 1987), 
whereas in the vimentin regulatory region the double AP-1 consensus sequence can be 
regarded as two inverted repeats forming a nearly perfect palindrome. Exactly the same 
arrangement has been published earlier for the rat glutathione transferase Ρ gene (Okuda 
et al., 1990). Here, transfection of promoter constructs in F9 EC cells also revealed rather 
high CAT activities, which could hardly be stimulated by addition of c-Jun or c-Fos. The 
only member of the Jun family present in significant amounts in undifferentiated F9 and 
P19EC cells is Jun D (de Groot et al., 1990). Therefore, it is tempting to speculate about 
a role for this particular protein in binding to the specific conformation of the two 
consensus sequences caused by the palindromic arrangement. The data obtained by the 
transient transfection assays are in accordance with the gel mobility shift analysis using 
P19EC nuclear extracts. In this case a faster migrating complex has been revealed which 
does not disappear by the highest concentration of RARa fusion protein. This also points 
to a different protein or protein complex binding in P19EC cells. This hypothesis is 
currently under investigation. The binding of Jun D instead of for instance c-jun, might 
also be an explanation for the lack of RA repression. Proof for this assumption can be 
gained from a study, describing inhibition of estrogen receptor activity by overexpression 
of c-Jun and c-Fos, but not Jun D protein (Doucas et al., 1991). More recently it has been 
shown that Jun D is not able to inhibit glucocorticoid receptor activity in contrast to c-Jun 
(Berkoflint et al., 1994). Furthermore, the region which is defined to be important for 
binding to the hormone receptor is not conserved in Jun D (Berger and Shaul, 1991). A 
question which remains is why overexpression of c-jun does not lead to higher vimentin 
expression. This can only be explained by assuming that activation of the double AP-1 
consensus by Jun-Jun homodimers can hardly contribute to the amount of activation 
already caused by some other protein present in untransfected P19EC cells. Since RA 
addition is rather brief, Jun or Fos protein will not be induced (de Groot et al., 1990), so 
the fact that there is no inhibition detectable must imply that the RAR protein cannot 
prevent an AP-1-activating protein or protein complex from binding in undifferentiated 
P19EC cells. This strongly suggests that under the conditions described vimentin expressi­
on is not inhibited by the RAR. 
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A proximal promoter element in the hamster desmin 
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A proximal promoter element in the hamster desmin upstream 
regulatory region is responsible for activation by myogenic 
determination factors 
The muscle-specific intermediate filament protein desmin is up-regulated during skeletal muscle 
differentiation. When myoblasts leave the cell cycle and fusion into multinucleated myotubes starts, 
genes associated with myogenesis become activated. The activation is believed to be mediated by 
the muscle-specific determination factors. We present evidence that both MyoD and myogenin are 
able to activate the transcription of the hamster desmin gene. A proximal promoter fragment of 89 
base pairs is sufficient for this transactivation process. The single Ε-box in this region is essential 
for desmin promoter activity in mouse C2 skeletal muscle cells and upon co-transfection of a 
myogenin expression vector also in human primary fibroblasts. Mutation of this MyoD binding site 
abrogates desmin transcription and transactivation of the promoter no longer occurs. By using gel 
electrophoretic mobility shift assays we were able to demonstrate that nuclear proteins from C2 
muscle cells and myogenin/E12 glutathione S-transferase fusion proteins are able to bind to the 
functional Ε-box consensus sequence. A second Ε-box, situated in a more upstream regulatory 
region, which also binds to purified Helix-Loop-Helix proteins in vitro is only moderately affected 
by site-directed in vitro mutagenesis. 
INTRODUCTION 
Intermediate filament protein-encoding genes form a large family with a more or less 
tissue-specific distribution. The proteins can be divided into 6 different subtypes on the 
basis of their biochemical and immunological properties. One of these, the type III 
intermediate filament protein desmin is expressed in adult cardiac, skeletal and smooth 
muscle. The hamster desmin gene has been cloned and analyzed (Quax et al., 1984; Quax 
et al., 1985). The promoter regions of the hamster and the human gene have been 
characterized previously in our laboratory (Pieper et al., 1987; Pieper et al., 1988) and by 
others (Li and Paulin, 1991). The experiments revealed the presence of a proximal region 
in the hamster promoter directing muscle-specific expression and a more upstream 
enhancer region in the human promoter. 
Abbreviations: 
HLH, helix-loop-helix: CAT, chloramphenicol acetyltransferase; bp, base pair(s); DMEM, Dulbecco's 
modified Eagle's medium. 
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The transcriptional regulation of several muscle-specific genes has recently been 
elucidated. In a number of cases the trans-acúng factors involved belong to the group of 
the myogenic determination factors (Lassar et al., 1989; Piette et al., 1990; French et al., 
1991; Prody and Merly, 1992; Yutzey et al., 1992). Each member of the family including 
MyoD, myogenin, myf-5 and MRF4 (myf-6, herculin) is expressed in skeletal muscle 
exclusively and seems to play an important role in myogenesis in vitro (Davis et al., 
1987; Edmondson and Olson, 1989; Wright et al., 1989; Braun et al., 1989; Rhodes and 
Konieczny, 1989; Miner and Wold, 1990; Braun et al., 1990). These nuclear phosphopro-
teins are able to induce a skeletal muscle phenotype upon forced expression in fibroblasts 
and in a variety of nonmesenchymal cells (Choi et al., 1990; Weintraub et al., 1989; for 
review see Olson (1990), Weintraub et al. (1991a), and Wright (1992)). Myf-5 mRNA is 
the first of the family to be expressed in mouse development at day 8 of gestation, 
followed about 12 h later by myogenin, just before the appearance of myf-6. MyoD is 
detected approximately 2 days later, accompanied by the disappearance of myf-6 (Rudnic-
ki et al., 1992; Buckingham, 1992; Ott et al., 1991; Bober et al., 1991; Sassoon et al., 
1989). In tissue culture of skeletal muscle model systems like the mouse C2 cell line the 
situation is slightly different, since MyoD is expressed in myoblasts and myotubes, 
whereas myogenin is found primarily in differentiated myotubes (Edmondson & Olson, 
1989; Braun et al., 1989). Myf-6 (MRF4) is not expressed in most established muscle cell 
lines (Rhodes & Konieczny, 1989; Braun et al., 1990; Miner & Wold, 1990). It has not 
been possible to assign a specific role to the individual myogenic factors (Thayer et al., 
1989; Braun et al., 1989). Moreover, targeted inactivation of MyoD in transgenic mice 
has resulted in elevated levels of myf-5, indicating that the absence of expression of one 
protein may lead to an up-regulation of another one (Rudnicki et al., 1992). 
For transactivation the factors must bind to specific binding sequences defined as E-box 
sequences consisting of the general consensus CANNTG (Lassar et al., 1989). Detailed 
mutagenesis studies have revealed that the most essential part of each protein is formed by 
a so-called basic helix-loop-helix (HLH) structure (Tapscott et al., 1988; Benezra et al., 
1990). The basic region is involved in DNA binding, whereas the helix-loop-helix motif is 
required for a dimerization process (Davis et al., 1990). Most myogenic HLH proteins are 
able to bind to their target sequence as homodimers. Higher affinity, however, is reached 
after hetero-oligomerization with other more widely distributed HLH proteins, like the 
E12 or E47 proteins (Lassar et al., 1991; Finkel et al., 1993). Other E proteins, like ITF2 
and HEB have also been defined (Henthorn et al., 1990; Hu et al., 1992). 
There are indications for an involvement of members of the MyoD family in regulating 
the desmin gene (Weintraub et al., 1989; Choi et al., 1990). In an attempt to understand 
whether and how transcriptional control is exerted by these proteins we looked for E-box 
sequences in the hamster desmin upstream promoter region. At least 8 putative consensus 
sequences were found, several of which are in previously defined regulatory regions. Here 
we present the analysis of the sequences involved in muscle-specific regulation of the 
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hamster desmin promoter region and the transactivation of these sequences by MyoD and 
myogenin. 
MATERIALS AND METHODS 
Construction of eukaiyotic expression plasmids 
A 3.4-kilobase EcoRVHpall fragment containing the hamster promoter region and 
subfragments, which were inserted in a CAT vector, were described earlier (Pieper et al., 
1987). The different promoter lengths used for insertion were obtained by restriction 
endonuclease digestions and the length of each fragment was given according to the start 
site of transcription, 89 bp (6), 450 bp (5), 1600 bp (2) and 3400 bp (1) (see also Fig. 1). 
Three additional constructs were created by using exonuclease ВаІЗІ and restriction 
enzyme BanI digestions containing -53, -625 bp and -926 bp of promoter sequences. 
Mutant promoter constructs were prepared by oligonucleotide-di reeled mutagenesis of 
desmin promoter subfragments. For this purpose, one Ε-box located at -825 bp from the 
cap site was changed from CAGCTG into a StuI site (AGGCCT). The Ε-box at -80 
required a similar mutation, ultimately resulting in several combinations of mutated and 
non-mutated Ε-boxes which were incorporated in the full 3.4 kb desmin promoter region. 
All base substitutions were verified by DNA sequencing. Ml contains a mutated -825 box, 
M2 a mutated -80 box and M3 contains both mutated Ε-boxes. M4 is also a double 
mutant, in which a BanI restriction site was used to destroy a third putative Ε-box by 
making a 5' deletion. Supercoiled plasmid DNA was purified by CsCl gradient centrifuga-
tion (Sambrook et al., 1989) and quantitated by means of both ethidium bromide staining 
and spectrophotometric measurement. 
Cell culture, immunofluorescence and CAT transfections 
The C2 skeletal muscle myoblasts cells (Yaffe and Saxel, 1979) were grown in 
Dulbecco's modified Eagle's medium (DMEM) enriched with 20% fetal calf serum. To 
induce myotube formation, confluent cultures were switched to low mitogen fusion 
medium (DMEM supplemented with 2% horse serum). C2 cells start to fuse within 24 to 
36 h. Human dermal primary fibroblasts from foreskin were cultured for several passages 
in DMEM supplemented with 10% fetal bovine serum. Cell samples were stored in liquid 
nitrogen until further use. In order to investigate whether these cells can differentiate 
along the myogenic lineage, infections with a recombinant retrovirus containing the MyoD 
coding sequences under the control of a viral long terminal repeat promoter and the 
geneticin selection marker were performed. Cells were infected by exposure to virus-
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containing medium overnight in the presence of 4 μg/ml Polybrene (Weintraub et al., 
1989). Subsequently, cells expressing virus-encoded proteins were selected by supplemen­
tation of the culture medium with geneticin (Life Technologies Inc.) 24 h after infection. 
For detection of desmin protein by immunofluorescence staining, the medium was changed 
to DMEM supplemented with 2% horse serum 48 h before harvesting. Staining procedu­
res were performed on cultured cells as described by Krimpenfort el al. (1988). We used 
a polyclonal rabbit antibody (poly-des) to chicken gizzard muscle desmin (Ramaekers et 
al., 1983). 
Approximately 48 h before transfection with desmin-CAT promoter deletion and 
mutation constructs, C2 cells were plated in 10-cm Petri dishes. Calcium phosphate co-
precipitations were performed as described earlier (Van de Klundert et al. 1992). For each 
construct equimolar amounts of DNAs were used and a vector with the ß-galactosidase 
reporter gene linked to the Rous sarcoma virus long terminal repeat (ß-Gal) was co-
transfected as an internal control. After transfection cells were kept in DMEM containing 
2% horse serum for 48-36 h to obtain myotube formation. Primary human dermal 
fibroblasts were transfected by electroporation. Briefly, cells were washed twice with 
phosphate buffered saline (PBS) and 3-5 [times] 107 cells were mixed with 10 /ig Rous 
sarcoma virus ß-Gal and 5 pmol of des-CAT construct and 5 pmol of pEMSVscribe-
myogenin in 500 μ\ of phosphate-buffered saline. After 10 min incubation on ice, cells 
were electroporated in a 1-ml electroporation cuvette (Eurogentec, Belgium) by a 2000-V 
pulse from an ISCO type 494 power supply and immediately replated on 10-cm Petri 
dishes. Cells were refed after 12 h with DMEM containing 2% horse serum and harvested 
24 h later. All transfections were performed at least three times with two different DNA 
preparations. To correct for differences in transfection efficiencies the amount of lysate 
used for the CAT assay was corrected for protein content and ß-galactosidase activity 
according to the procedure described by Edlund et al. (1985). CAT activities were 
determined according to Gorman et al., (1982). 
Preparation of nuclear extracts 
Nuclear extracts were prepared by a modification of the method described by Dignam 
et al. (1983). Briefly, cells were lysed in 10 mM Hepes pH 7.9, 1.5 mM MgCl2, 10 mM 
KCl, 0.1 mM EGTA, 0.5 mM dithiothreitol, 0.5 mM phenylmethylsulfonyl fluoride. 
Nuclei were isolated by centrifugation in lysis buffer containing 6.8% sucrose and 
extracted with 400 mM NaCl, containing 5% glycerol. Nuclear proteins were concentrated 
by (NH„)jS04 precipitation (33% w/v). Dialysis took place in 20 mM Hepes pH 7.9, 100 
mM KCl, 0.2 mM EDTA, 0.2 mM EGTA, with 20% glycerol in the dialysis solution and 
5% glycerol in the dialysis sample. After dialysis, extracts were quickly frozen in liquid 
nitrogen and stored in small samples at -70 °C. 
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Bacterial expression vectors 
The glutathione-MyoD (GST-MyoD) expression plasmid was created as described by 
Lassar et al. (1989). In brief, an Alu\ fragment of the MyoD cDNA, extending from the 
third amino acid to 88 nucleotides downstream of the terminal amino acid, was isolated 
and ligated into a Smal cleaved glutathione J-transferase expression vehicle (Gex 3X; 
Smith and Johnson (1988)). The vector expressing the glulathione-myogenin (GST-
myogenin) fusion protein was a kind gift from Dr. Eric Olson. Amino acids 33 to 224 of 
myogenin are included in this construct. The purification of both the MyoD and myogenin 
fusion proteins from bacterial lysates was performed according to Lassar et al. (1989). An 
Xhol fragment containing a partial E12 cDNA was isolated and ends were filled in with 
T4 polymerase and ligated in frame downstream of a T7 promoter). The latter fragment 
contains all the necessary information for heterodimerization (Sun and Baltimore, 1991). 
Using 20 units of T7 polymerase, an mRNA was synthesized from the linearized El2 
plasmid in a 60 μΐ reaction volume for 1 h at 37 °C (reaction conditions: 40 mM Tris-
HC1 pH 7.9, 6 mM MgCl2, 2 mM spermidine-HCl, 10 mM NaCI, 5 mM NTP, 10 mM 
dithiothreitol, 80 μg bovine serum albumin, 50 μΜ GpppG, 60 of units RNasin). After 
purification the RNA was translated in wheat germ extract according to the procedures 
described by the manufacturer (Promega). The purified GST-MyoD, GST-myogenin and 
the in vitro translated truncated E12 proteins were analyzed on 10% SDS Polyacrylamide 
gels. For heterodimerization equal amounts of fusion proteins and in vitro translation 
products were mixed and incubated at 30 °C for 1 h in the presence of 20 mM EDTA 
(Murre et al., 1989). 
Mobility shift assays 
A double-stranded oligonucleotide fragment containing the -80 Ε-box sequences (sense 
strand 5'AGGGATCCTGCAGCTGTCAGGGGAGG 3', nonsense 5'AATTCCTCCCCTG-
ACAGCTGCAGGATCCCT 3') were subcloned in the EcoRl and Hindu sites of pGEM-
3Zf(+) (Promega) using a synthesized EcoRI site and a blunt site. To generate a probe 
containing the -825 Ε-box element a 95-bp Rsal/Hindll fragment was subcloned in the 
Hindll site of pGEM-3Zf(+). The resulting plasmids were digested with EcoRI and 32P-
end-labeled, after which a second restriction enzyme in the vector polylinker was used to 
release the fragment followed by gel purification. Binding reactions for the nuclear 
extracts were performed in a final volume of 25 μί containing 20 mM Hepes, pH 7.9, 100 
mM KCl, 1.5 mM MgCl2, 100 mM EDTA, 4 /¿g of poly[d(I-C)], and 8% glycerol for 15 
min on ice in the presence of 1-2 ng of labeled DNA fragment. The incubations with 
purified fusion proteins (0.1-0.2 μg) contained, 20 mM Hepes, pH 7.9, 50 mM NaCI, of 
1 μg poly[d(I-C)] and 4% glycerol. Unlabeled competitor DNA was added to the binding 
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reactions 10 min before addition of the protein mixtures. Samples were size-fractionated 
through a 6% acrylamide gel (1:19 methylenebisacrylamide/acrylamide) containing 6.7 
mM Tris, 3.3 mM NaAc, 1 mM EDTA, pH 7.9 at 10 V/cm. 
RESULTS 
Desmin transcription regulation 
Desmin expression is up-regulated severalfold upon differentiation of the mouse C2 
myoblasts to myotubes. Withdrawal of high serum leads to elongation and fusion of 
myoblasts and formation of multinucleated myotubes. This process is associated with an 
elevated expression of myogenic determination factors. Both MyoD and myogenin are 
expressed in this cell line. MyoD is already present in a relatively undifferentiated stage 
of the cells, while myogenin expression is detectable in myoblasts but highly up-regulated 
during differentiation. Using a subclone of the C2 cell line (C2C12) the hamster desmin 
upstream regulatory region was analyzed previously, showing that the most proximal 
promoter region harbors sequences responsible for muscle-specific expression (Pieper et 
al., 1987). The members of the MyoD family are obvious candidates for the regulation of 
muscle-specific expression of desmin. In the present report we have a closer look at the 
desmin upstream region by employing additional deletion constructs and a site-directed 
mutation analysis. A large part of the hamster upstream region was sequenced earlier 
(Pieper et al., 1988). We now also detected 8 Ε-boxes among several putative muscle-
specific di-acting sequences. Only 2 of these Ε-box elements comply to the general 
sequence rule described by Buskin and Hauschka (1989). These two Ε-box consensus 
sequences were chosen for mutation analysis, since they are comprised within hamster and 
man homology regions (Li and Paulin, 1991). Transfections were performed with mouse 
C2 cells and nonmyogenic human primary fibroblasts upon co-transfection of a myogenin 
expression vector. The CAT activities of the different deletion and mutation constructs are 
shown in Fig.l. The results indicate that the increased activation of the desmin promoter 
in C2 myotubes, compared to myoblasts, is also reflected in the higher CAT activity of 
the different deletion constructs in myotubes. Overall activities are approximately 4-8-fold 
higher in myotubes compared to myoblasts, with regard to the activity of a construct 
where the CAT gene is driven by the SV40 promoter/enhancer (results not shown). 
Comparison of the CAT values of the different deletion constructs in myoblasts and 
myotubes show a similar trend (Fig.l). Highest CAT activity is obtained in myoblasts and 
myotubes with construct 3 (-926 descat). At -929 an Ε-box is located which is destroyed 
by the insertion of this fragment in the CAT vector. In construct 4 (-1600 descaí) this E-
box is still intact. CAT activity decreases when sequences between -926 and -645 are 
deleted, indicating the presence of a positive regulatory region. A small decrease in CAT 
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Fig. 1. Transcriptional activation of desmin in primary fibroblasts and C2 myogenic cells. Primary 
fibroblasts were infected with a retrovirus encoding MyoD, leading to expression of endogenous desmin as 
detected by immunofluorescence. The same cells were used for transient transfections with different desmin 
CAT deletion constructs upon co-transfection with a myogenin expression vector. Desmin deletion and 
mutation constructs were also transfected into C2 myoblasts, which were allowed to differentiate into 
multinucleated myotubes. The 5' end point of each deletion, created by endonuclease or exonuclease 
digestion, is shown and mutation of the Ε-box sequences (E) is as indicated (m). All constructs share the 
same 3' end point at +25 bp relative to the transcription start site. Myoblasts, myotubes and fibroblasts 
were harvested 48 to 72 h after transfection and CAT values were determined by liquid scintillation counting 
(Β, Τ and Ft). All values are the average of three or four independent transfections and presented in tables 
and bars. CAT values are normalized to the activity of the longest promoter fragment, although overall CAT 
activities are 4-8 fold higher in C2 myotubes compared to myoblasts. This is not reflected in the diagrams 
because the absolute level of desmin expression varies between the different myotube transfections. 
activity can be observed in myotubes, when nucleotides are deleted between -450 bp and -
89 bp. Further deletion up to -53 bp, using ВаІЗІ exonuclease, leads to an almost 50% 
decrease in CAT activity. The mutation analysis demonstrates that the change of the 
CAGCTG sequence at -80 to AGGCCT, leaving the rest of the full-length promoter intact 
(M2), leads to almost complete abolishment of the promoter activity. A similar mutation, 
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involving the E-box at -825 (Ml), does not 
exhibit very drastic effects. CAT activity 
isonly 60-70% lower than the activity of the 
full-length non-mutant. The double mutant 
with both Ε-boxes mutated (M3) and the 
additional deletion of all nucleotides up to -
926 (M4) show, as expected, background 
CAT levels too. 
The activity of the desmin 5' upstream 
region is very low in human primary dermal 
fibroblasts. Therefore, only the results obtai­
ned with the co-transfection of the myogenin 
expression vector are shown. These results 
resemble those of the C2 cells very closely. 
Only the decrease in CAT activity between 
construct 3 and 4 (-926 descat and -625 
descat) is more pronounced. 
In conclusion, transfection of the above 
mentioned deletion and mutation constructs in 
C2 myoblasts and myotubes demonstrates the 
presence of a weak negatively regulatory 
region between -1600 bp and -926 bp, which 
is not further characterized. The destruction 
of an Ε-box located at -929 does not lead to a 
decrease in CAT activity, instead an almost 
2-fold increase can be observed when the 
whole region between -1600 and and -926 is 
deleted. This is also reflected by the results 
obtained with the primary fibroblasts upon 
co-transfection of the myogenin expression 
plasmid. Correspondingly, also the positive 
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Fig. 2. Gel mobility shift assays with nuclear ex­
tracts from C2 myoblasts and myotubes. DNA 
restriction fragments were end-labeled and incuba­
ted with myoblast and myotube nuclear extracts. 
The fragment extending from -90 bp to -65 bp 
comprises the proximal Ε-box at -80 bp and the 
second fragment (-938 to -795) comprises e.g. the 
-825 Ε-box and the putative MEF-2 consensus 
sequence. The first hue of each panel contains 
DNA without protein extract (-) and subsequently 
incubations with blasts and myotube nuclear 
extracts are shown. Each last lane represents a 
competition assay with a corresponding unlabeled 
DNA fragment (100-500 fold molar excess) in 
combination with a myotube nuclear extract. 
element located between -926 and -625 can 
be clearly recognized in myoblasts, myotubes and myogenin cotransfected fibroblasts. This 
element displays an even stronger effect in fibroblasts. We believe that this is due to a 
higher concentration of transactivating protein upon co-transfection, compared to endoge­
nous levels in C2 cells. A further positive element was found after evaluation of the 
results upon deletion up to -53 bp (including deletion of the Ε-box element at -80 bp). The 
mutation analysis, indicates that this Ε-box is very important, because substitution of 4 
nucleotides leads to complete abolishment of the promoter activity. 
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Fig. 3. Gel retardation assays with purified glutathione-S-transferase MyoD and myogenin fusion proteins. 
Purified fusion proteins were dimerized with in vitro translated partial E12 protein before incubation with the 
same labeled DNA fragments used in combination with the nuclear extracts (see Fig. 5). The first lane of 
each panel contains the probe without protein (-). Subsequent lanes represent incubations with either MyoD 
or myogenin (myog.) fusion proteins with or without the appropriate unlabeled competition DNA (500 fold 
excess). Additionally, in each last lane this competition DNA comprises a mutated E-box. 
In vitro interaction of purified HLH proteins and proteins in nuclear extracts with 
elements in the desiniti 5' upstream region 
The Ε-box elements at -80 bp and -825 bp have been chosen for in vitro DNA- protein 
interaction studies. Nuclear extracts have been prepared from myoblasts and differentiated 
myotubes and DNA fragments have been end-labeled by Klenow large fragment polymera­
se. Using an oligonucleotide fragment containing the -80 Ε-box as a probe, a pattern of 
retarded bands characterized by only 1 band in myoblasts and 2 bands in myotube nuclear 
extracts is displayed (Fig.2). Competition with a 100-fold molar excess of an unlabeled 
fragment shows that the affinity of the binding proteins is specific. Moreover, the same 
fragment has also been used for incubation with a HeLa nuclear extract which yields a 
totally different pattern, suggesting that both protein DNA complexes are muscle-specific 
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(results not shown). The results obtained with the -825 Ε-box fragment are much more 
complex. At least 3 major retarded complexes are visible (Fig. 2). The specificity of 
all complexes has been confirmed by competition analysis with an unlabeled fragment 
added in 100-fold molar excess. The latter fragment is an Rsal/ Hindi restriction 
fragment extending from -891 to -796, which not only contains the -825 bp Ε-box but also 
comprises an MEF2 site located at -855. 
To investigate whether MyoD and myogenin proteins are able to bind to both E-box 
sequences we used the pGex bacterial expression system to purify these proteins by 
affinity chromatography. MyoD and myogenin are able to bind as homodiiners in vitro, 
whereas both proteins bind as heterodimers with a third non-muscle-specific protein in 
vivo. In vitro heterodimers are known to bind with higher affinity compared to homodi-
mers. Therefore, often a heterodimerization step involving the E12 protein is carried out. 
The E12 protein we used has been synthesized as a truncated protein by coupled in vitro 
transcription and translation. Despite the fact that it is not a full-length protein, it contains 
all the necessary information for heterodimerization with MyoD and myogenin and, as 
expected, we found higher binding affinities in experiments using heterodimers (results not 
shown). Fig.3 shows that prominent retarded complexes are obtained with MyoD and 
myogenin fusion proteins using the -825 Ε-box fragment. As a control we have performed 
competition experiments with unlabeled DNA fragments containing the wild-type or the 
mutated Ε-box consensus sequence. The retarded complexes resulting from incubation of 
the -80 Ε-box with heterodimerized myogenin are comparable with the experiment 
described above. MyoD, however, hardly showed affinity for the labeled oligonucleotide 
fragment. 
The results of the in vitro binding studies suggest that the retarded bands obtained with 
the nuclear extracts from myoblasts and myotubes, in combination with the labeled -80 E-
box fragment, may be due to the binding of myogenin and MyoD. In the lane with the 
myotube extract an additional band is visible, this may be caused by myogenin, which is 
expressed primarily in myotubes. Also supported by the observation that bacterially 
expressed myogenin is capable of binding to this Ε-box. For the -825 Ε-box fragment this 
is still elusive, since the latter is a much larger DNA fragment and more, yet unidentified, 
proteins may bind to it. However, it is clear that both myogenin and MyoD are able to 
bind to the -825 Ε-box containing DNA fragment and that the -80 Ε-box hardly binds to 
bacterially produced MyoD, heterodimerized with the E12 protein. 
DISCUSSION 
We have investigated the sequences responsible for the regulation of the hamster desmin 
muscle-specific expression. A consensus element for the binding of HLH proteins located 
at -80 bp upstream from the cap site appears to be essential for desmin expression. 
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Substitution of these sequences for a StuI restriction site leads to elimination of promoter 
activity. Furthermore, an upstream positively acting region has been characterized which 
functions both in myoblasts and myotubes. The latter region is more prominently 
displayed when human fibroblasts and co-transfection of a myogenin expression plasmid 
are used. This is probably due to the excess amount of myogenin created by this procedu­
re. On the other hand mutation of the HLH binding element, which is situated in this 
region at -825 bp, has only a moderate effect in both cell lines. Another Ε-box consensus 
element located in the same region, which is destroyed by digestion with the BanI 
restriction enzyme, is probably not important at all, because no negative effects on CAT 
activity are visible. We also tested the enhancer activity of the upstream positively acting 
region but only small effects were detected (results not shown). More detailed experiments 
in combination with a further mutation analysis of the putative consensus elements situated 
in the latter region will be performed in the near future. 
From our in vitro binding assays we may conclude that several nuclear proteins are 
able to bind to the region surrounding the Ε-box at -825. Some may well be specific for 
myotubes because bands of higher intensity appear in the lane with the myotube nuclear 
extract. Since no other Ε-boxes are present in this DNA fragment it is also conceivable 
that the Ε-box at -825 bp, which does not contribute to the enhancer activity of the region, 
can bind to purified glutathione transferase (GST) fusion proteins. In vitro synthesized 
myogenin seems to have a preference for the -80 Ε-box, which is essential for desmin 
expression. GST-MyoD binding to this element is only visible after longer exposures. The 
observation that for instance MyoD can bind strongly to the -825 bp Ε-box, but does not 
seem to transactivate the same element, has also been reported in other cases (Fushisawa-
Sehara et al., 1992). This discrepancy may be caused by a difference between the in vivo 
and in vitro situation. Moreover, other factors interacting in the vicinity of the E-box 
sequence may interfere with binding of MyoD family members in vivo. 
The analysis of the human desmin promoter region revealed that the upstream positive 
element is important for high-level expression (Li and Paulin, 1991). While our work was 
in progress, the cloning and characterization of the mouse upstream regulatory region has 
been published (Li and Capetanaki, 1993). Our results are comparable with the situation 
in the human and the mouse desmin promoter regions. Additionally we present a mutation 
analysis, showing that particularly the Ε-box at -80 bp is important for the muscle-specific 
expression of the desmin gene. Another candidate factor, which might be involved in the 
regulation of expression (also put forward for the human and mouse desmin regulatory 
regions), is a putative consensus element for the myocyte-specific enhancer factor, MEF-
2. This protein complex binds to A+T-rich elements in several other muscle-specific 
genes (Gossett et al., 1989). Moreover, this complex of binding proteins was shown to be 
inducible by members of the MyoD family like myogenin and MyoD (Cserjesi and Olson, 
1991; Lassar et al., 1991). 
A minimum of two MyoD binding sites is often required for enhancer function (Lassar 
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et al., 1989; Piette et al., 1990; Wentworth et al., 1991; Gilmour et al., 1991). In 
numerous other muscle-specific genes Ε-boxes per se are not sufficient for high level 
transcription. Binding sites for other cell type-restricted and ubiquitous factors like MEF-
2, CArG and Spi binding proteins cooperate with the Ε-box to confer transcriptional 
activity (Sartorelli et al., 1990; French et al., 1991; Pari et al., 1991). Incidentally even a 
single Ε-box or a single MEF-2 site has been reported to be a target of transactivation 
(Prody and Merly, 1992; Nakatsuji et al., 1992). The latter situation may be consistent 
with the situation in the hamster desmin promoter. We cannot rule out, however, the 
involvement of other factors like the MEF-2 recognition site situated in the upstream 
enhancer region in contributing to the level of desmin expression. To date none of the 
MyoD family members has been detected in heart tissue but for some other genes 
expressed in both skeletal muscle and heart, the MEF-1 factor has been reported to play 
an important role in the latter organ (Nakatsuji et al., 1992; Navankasattusas et al., 1992). 
Further studies using cardiac muscle cells or transgenic animals can address these 
questions. 
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Chapter 6 
SV40 large Τ antigen-induced inhibition of terminal diffe­
rentiation of primary skeletal muscle cells is associated 
with a block in the expression of MyoD and myogenin 
F. A. J. M. van de Klundert & H. Bloemendal 
Mol. Biol. Rep. in press 

SV40 large Τ antigen-induced inhibition of terminal differentia­
tion of primary skeletal muscle cells is associated with a block in 
the expression of MyoD and myogenin 
Transformation of hamster primary myoblasts with the SV40 large Τ antigen leads to inhibition 
of terminal differentiation. This process is associated with a block in the transcription of the 
muscle-specific determinator genes MyoD and myogenin. The effect of SV40 large Τ antigen on 
the terminal differentiation is dominant and cannot be bypassed by re-expression of retrovirally 
encoded MyoD. The intermediate filament protein desmin is normally up-regulated when 
myoblasts differentiate into myotubes. Surprisingly, desmin is expressed at relatively high levels in 
transformed hamster muscle cells grown under proliferative conditions. So desmin expression can 
be independent of the onset of differentiation. This is in accordance with the expression of the 
protein in fibroblasts, infected with a MyoD-encoding retrovirus and grown under proliferative 
conditions, when no other muscle-specific proteins are present. 
INTRODUCTION 
The intermediate filament (IF) protein desmin, which is expressed mainly in skeletal 
muscle, smooth muscle and heart, is a very early marker of muscle differentiation. At day 
8.5 in the development of the mouse, the protein is expressed in the heart rudiment and at 
day 9.0 post coitum it appears in the myotome [1]. During differentiation of cultured 
skeletal muscle cells desmin expression is up-regulated to high levels. A certain amount of 
desmin, however, is already present in replicating myoblasts [2,3]. It has now been well 
established that desmin expression is regulated by myogenic determination factors like 
MyoD, myogenin, myf-5 and MRF-4 [4,5,6]. These experiments have all been performed 
in tissue culture. Despite all the available data on expression regulation, the function of 
desmin in differentiated muscle cells in vivo remains totally elusive. 
It has been suggested recently that desmin expression is a prerequisite for myoblasts to 
fuse into multinucleated myotubes [7]. On the other hand several reports indicate that cells 
expressing a high amount of desmin but no MyoD and myogenin are incapable of fusion 
[8,9]. Lack of fusion and absence of functional MyoD and myogenin has often been 
observed after transfection with oncogenes [10,11,12] or the addition of exogenous growth 
Abbreviations: 
DMEM, Dulbecco's modified Eagle's medium; LTR, long terminal repeat; PBS, phophate buffered saline; 
SDS, sodium dodecyl sulphate. 
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factors [13,14]. Also cellular transformation by SV40, polyoma and adenoviruses has been 
reported to inhibit terminal differentiation [15,16,17,18, 
19]. 
In the case of SV40 large Τ antigen conflicting results have been reported concerning 
the inhibitory effect on terminal differentiation [9,20]. Therefore, we have transfected 
primary hamster muscle cells with a plasmid encoding the large Τ transcription unit. 
Several resulting clones have been tested for differentiative abilities in correlation with 
desmin expression. We have found high amounts of desmin protein but no myotube 
formation. Next, the expression of the muscle-specific proteins MyoD and myogenin has 
been investigated in some of the cell clones and we were not able to detect their mRNAs. 
By infecting a representative cell line with a MyoD encoding virus we tried to overcome 
the negative effects of the large Τ antigen expression on the terminal differentiation. These 
experiments contribute to a better understanding of the regulation of desmin expression in 
relation to myogenesis. 
MATERIALS AND METHODS 
Cell culture and DNA (ransfection 
C2 skeletal muscle myoblast cells [21] and transformed hamster skeletal muscle cells 
were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 20% 
fetal calf serum. For induction of myogenic differentiation, confluent cultures were 
switched to low serum medium (DMEM with 2% horse serum or 0.4 % ultroser G). C2 
cells are known to fuse within 24 to 36 hours. 
Transformed hamster skeletal muscle cell lines were established from thigh muscle 
tissue from a Syrian gold hamster [22]. Tissue was dissociated and the obtained satellite 
cells were plated into 35-mm tissue culture dishes (10s cells per dish) in 2 ml growth 
medium containing 20% fetal bovine serum and 2% chicken embryo extract [23]. After 24 
h cell debris and nonadherent cells were removed by washing with Dulbecco's modified 
phosphate-buffered saline (DPBS). At this point several cell samples were plated into 100-
mm dishes (at a density of 0.5 106 cells per dish) for transfection with an expression 
plasmid encoding the SV40 large Τ antigen and a defective SV40 origin of replication [24] 
in order to obtain transformation. Other cell samples were plated in DMEM containing 
10% serum and switched to 2% horse serum later on for determination of differentiating 
capacities. Transfection was performed according to a modified calcium phosphate 
precipitation method [25]. After two weeks in DMEM with 20% fetal bovine serum and 
no further supplementations, cell clones containing actively growing cells were isolated 
and expanded. 
Human primary fibroblasts were cultured in DMEM supplemented with 10% fetal 
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bovine serum. Fibroblasts and tranformed hamster cells were infected with a recombinant 
retrovirus containing the MyoD coding sequences under the control of a viral long 
terminal repeat promoter [26]. Cells were selected by supplementation of geneticin, which 
is a virus-encoded selection marker. After selection, clones were pooled and cells were 
maintained either in standard growth medium or in differentiation medium for 48 h. 
RNA isolation and Northern blotting 
RNA from proliferating C2 myoblasts and 3 day post-fusion C2 myotubes was isolated 
by the Li-urea method [27]. The same procedure has been applied to three cell clones 
obtained after transfection with the SV40 plasmid. Total RNA samples (10 μ£) were 
glyoxylated, fractionated on 1% agarose gels and transferred to Hybond N (Amersham). 
Hybridization was performed with 4 different probes [28]. The complete cDNA probe 
encoding hamster desmin [29] a 1.5-kb EcoRl myogenin cDNA fragment and a complete 
MyoD cDNA were labeled according to standard procedures. Total RNA amounts were 
determined by hybridization with a ribosomal DNA probe. 
Immunoßuorescent staining and Western blotting 
Indirect immunofluorescent staining procedures were performed on cultured cells as 
described previously [30]. We used a polyclonal rabbit antibody (poly-des) to chicken 
gizzard muscle desmin [31] and a monoclonal anti-skeletal myosin (fast twitch) antibody 
(Sigma). The preparation of cytoskeletal extracts of cultured cells and one-dimensional 
SDS-gel electrophoresis were described previously [32]. Two Western blots containing 12 
different transformed cell lines were incubated with a polyclonal antibody to desmin and a 
monoclonal antibody to large Τ antigen (kindly provided by Dr. van der Eb), both 
followed by an incubation with a peroxidase conjugated second antibody (Nordic). Bands 
were visualized by incubation in phosphate buffered saline (PBS) with 0.6 mg/ml 4-
chloro-1-naphtol (solubilized in ethanol) and 0.6 μΙ/ml of a 30% H 20 2 solution. The same 
immunodetection procedure has also been used for a Western blot containing C2 cells and 
transformed hamster muscle cells grown under proliferative and differentiation promoting 
conditions. 
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Fig. 1. Western blot analysis of 12 transformed hamster muscle cell lines, using a monoclonal antibody 
directed against SV40 large Τ antigen and a destrun polyclonal antibody. 
RESULTS 
After transformation with the origin-defective SV40 plasmid we have analyzed 12 
rapidly growing cell clones for the expression of large Τ antigen with a monoclonal 
antibody. The different cell clones express various amounts of large Τ antigen (Fig. 1). 
The same cell panel has also been tested for desmin expression using a polyclonal antibo­
dy. High amounts of desmin protein have been detected in all cell lines. To induce 
differentiation, cells originating from each of the 12 different clones and a small cell 
sample of untransfected primary hamster muscle cells, have been switched to low mitogen 
medium, immediately after clonal isolation. The untransfected hamster cells showed 
extensive differentiation into myotubes. Occasionally a few elongated cells with a 
myotube-Iike appearance were seen in some of the transformed cell clones. However, no 
multinucleated myotube formation could be detected. In Fig. 2, cells originating from one 
of the transformed hamster clones are compared with fully differentiated C2 myotubes by 
immunofluorescence staining with a polyclonal desmin antibody. Differentiation tests have 
been performed at a very early stage. This means that cell clones have been isolated two 
weeks after transfection and immediately split into two cell samples, one for expansion 
and one for the differentiation test. 
Because of the limited lifespan of the primary hamster muscle cells we have included 
the mouse cell line C2 as a control cell line in our experiments. Moreover, the established 
mouse muscle cell line C2 is a generally accepted model system for muscle cell differenti­
ation and this cell line has also been used in comparison with fusion-defective muscle cell 
lines in several other cases [33, 9]. Fusion of C2 myoblasts into multinucleated myotubes 
is associated with an elevation of desmin expression. Furthermore, C2 cells are known to 
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contain myogenic diffentiation markers like 
MyoD and myogenin. Myogenin is poorly 
expressed in undifferentiated myoblast cells 
and becomes highly elevated in multinuclea­
ted myotubes. MyoD is expressed in myo­
blasts and myotubes. Since all cell clones 
tested gave similar results we only show 
the Northern blot analysis of one of the 
transformed clones in comparison with the 
analysis of C2 myoblasts and myotubes (Fig. 
ЗА). C2 cells and transformed hamster cells 
have been analyzed for MyoD, myogenin Fig. 2. Phenotype of C2 cells and 4Ha5 cells stai-
and desmin mRNA. Desmin is highly ex- n e d w i ' h a ^ т і п P 0 ^ 1 0 ™ ' 3 » ' ^ after culru-
ring under ditterentiative conditions, 
pressed under normal conditions (10% fetal 
bovine serum) and in low serum medium. Here, howerever, a two-fold decrease can be 
observed in comparison with the mRNA amounts in cells grown under normal conditions. 
As shown in Fig. ЗА under high and low serum conditions no MyoD and myogenin 
could be detected in the transformed hamster cell line. Because we wanted to determine if 
desmin mRNA levels correlate with protein expression, we have also performed Western 
blot analysis with a polyclonal desmin antibody (Fig. 3B). We can conclude from these 
experiments that desmin protein levels are very similar in hamster muscle cells cultured in 
medium supplemented with 10% fetal bovine serum or 2% horse serum, although mRNA 
levels are approximately 2-fold lower under low serum conditions. 
To compare the primary conditions for desmin expression in different cell types, we 
have infected human fibroblasts with a retrovirus where MyoD coding sequences are 
governed by a viral LTR (long terminal repeat) promoter. Infected cells can be selected 
because the retroviral DNA also encodes the G418 resistance gene. In this way up to 30% 
of the cells express MyoD, like has been shown for several non-muscle cell types, where 
retrovirally encoded MyoD leads to differentiation along the myogenic lineage [26,34]. It 
is reported earlier that for this differentiation step forced expression of MyoD must be 
followed by withdrawal from the cell cycle. We have observed desmin expression in cells 
cultured under proliferative and differentiative conditions (Fig. 4). Therefore, MyoD 
expression alone is sufficient for induction of the desmin gene in cells which are normally 
desmin-negative. 
The retroviral infection procedure has also been applied to investigate whether 
differentiation can proceed in fusion-incompetent hamster cells by forced expression of 
MyoD. After selection, the cells have been switched to differentiation medium and 
immunofluorescence tests have been performed for the detection of the terminal differenti­
ation marker fast-twitch skeletal myosin. We have never observed myotube-like cells after 
infection with the MyoD-encoding virus followed by selection by geneticin and either no 
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myosin protein could be detected in selected 
hamster muscle cells. On the other hand in 
differentiated C2 myotubes myosin expres­
sion was clearly visible (results not shown). 
This indicates that desmin can be expressed 
independent of the expression of MyoD and 
myogenin. The large Τ antigen block can, in 
this case, not be bypassed by re-expression of 
MyoD. 
DISCUSSION 
We have shown that primary muscle 
satellite cells transfected with the transcrip­
tion unit of SV40 large Τ antigen do not 
conform to terminal differentiation anymore. 
Previous reports largely describe the transfec-
tion of established muscle cell lines with 
transforming genes such as ras, jun, myc and 
EIA [10,12,11,35]. ЛИ our isolated cell 
clones were growing exponentially and conti­
nued to express desmin. We have performed 
Northern blot analysis with a few clones for 
detection of MyoD and myogenin mRNA 
expression. Although desmin expression 
levels were comparable in C2 muscle cells 
and transformed hamster cells, no MyoD and 
myogenin mRNA could be detected. 
Activated Ras and excess Fos have been 
shown to prevent terminal differentiation 
[10], by interfering with MyoD expression. 
Another possible mechanism is provided by 
the direct interaction of MyoD with the leuci­
ne zipper of c-Jun. In the case of excess c-
Jun, cell growth is favored instead of cellular 
differentiation. Recently new information in 
this respect has been provided by experi­
ments concerning the retinoblastoma gene 
product. This protein in its unphosphorylated 
4Ha5 C2 
10% 2% 10% 2% 
I 
desmin 
MyoD 
myogenin 
control 
В 
52 kDa— 
Fig. 3. Northern blot analysis of 4Ha5 and C2 
cells grown under proliferating (10% fetal bovine 
serum) and differentiation promoting (2% horse 
serum) conditions (A). Northern blots were hybri­
dized with the indicated probes and RNA amounts 
are approximately equal as detected by hybridiza­
tion with a ribosomal DNA probe (control). Cells 
grown under the same conditions were used for 
Western blot analysis with a monoclonal desmin 
antibody (B). 
Fig. 4. Human fibroblasts infected with a retrovi­
rus encoding MyoD were grown exponentially 
(10% fetal bovine serum) and under differentiati­
on promoting conditions (2% horse serum) and 
incubated with a polyclonal desmin antibody. 
Desmin-positive cells are detected under both 
culturing conditions. 
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form is proven to be important for withdrawal from the cell cycle during myogenesis [36]. 
Cell cycle withdrawal can be prevented by binding of the SV40 large Τ antigen to the 
retinoblastoma protein. Although MyoD also has the ability to cause growth arrest upon 
expression in cell lines transformed by oncogenes [37], the SV40 large Τ antigen 
demonstrates a dominant effect over MyoD by reversing the cell cycle block. 
The absence of MyoD and myogenin may contribute to the lack of differentiation in 
our transformed hamster muscle cells. There are indications that MyoD may be more 
important in this respect because BC3H1 cells, which do express myogenin but no MyoD, 
are fusion incompetent. In this case the block can be overcome by exogenous expression 
of MyoD [33]. Retrovirally encoded MyoD cannot induce terminal differentiation in our 
transformed muscle cells. This means that inhibition of terminal differentiation by 
activated Ras and by overexpressed Fos operates via a different mechanism. This 
conclusion can be drawn because MyoD expression did result in re-expression of markers 
associated with terminal differentiation in the case of Ras and Fos [10]. 
The above evidence indicates that desmin expression is not totally dependent on the 
expression of MyoD and myogenin. Cells in a highly proliferative state, represented by 
the transformation with large Τ antigen, are still able to express the early differentiation 
marker desmin. This is in agreement with the results obtained with the MyoD-infected 
fibroblasts where desmin expression can be detected in cells cultured in high mitogen 
medium. 
129 
REFERENCES 
1. Schaart G, Viebahn С, Langmann H & Ramaekers F (1989) Development 107: 585-596 
2. Pieper FR, Slobbe RL, Ramaekers FCS, Cuypers HT & Bloemendal H (1987) EMBO J. 6: 3611-3618 
3. Li ZL, Paulin D (1991)7. Biol. Chem. 266: 6562-6570 
4. Li H & Capetanaki Y (1993) Nucleic Acids Res. 21: 335-343 
5. Li Ζ & Paulin D (1993) J. Biol. Chem. 268: 10403-10415 
6. Klundert van de FAJM, Jansen HJ & Bloemendal H (1994) J. Biol. Chem. 269: 220-225 
7. Li H, Choudhary SK, Milner DJ, Munir MI, Kuisk IR & Capetanaki Y (1994) J. Cell Biol. 124: 827-
841 
8. Grossi M, Calconi A & Tato F (1991) Oncogene 6: 1767-1773 
9. Haider SR, Wang W & Kaufman SJ (1994) Exp. Cell Res. 210: 278-286 
10. Lassar AB, Thayer MJ, Overell RW & Weintraub H (1989) Cell 58: 659-667 
11. Miner JH & Wold BJ (1991) Mol. Cell. Biol. 11: 2842-2851 
12. Su H, Bos TJ, Monleclaro FS & Vogt PK (1991) Oncogene 6: 1759-1766 
13. Salminen A, Braun Τ, Buchberger A, Jürs A, Winter В & Amold H-H (1991) J. Cell Biol. 115: 905-
917 
14. Li L, Chambard J-C, Karin M & Olson EN (1992) Genes Dev. 6: 676-689 
15. Fogel M & Defendi V (1967) Proc. Natl. Acad. Sci. USA 58: 967-973 
16. Yaffe D, and Gershon D (1967) Nature 215: 725-727 
17. Graessmann A, Graessmann H & Fogel M (1973) Dev. Biol. 35: 180-186 
18. Holtzer H, Yeoh BG, Meganathan R & Kaji A (1975) Proc. Natl. Acad. Sci. USA 87: 4051-4055 
19. Maione R, Fimia GM & Amati Ρ (1992) Oncogene 7: 85-93 
20. Iujvidin S, Fuchs О, Nudel U & Yaffe D (1990) Differentiation 43: 192-203 
21. Yaffe D & Saxel О (1977) Differentiation 7: 159-166 
22. Yasin R, Beers G, Nurse KCE, ΑΙ-Ani S, Landon DN & Thompson EI (1977) J. Neurol. Sci. 32: 347-
360 
23. Benders AAGM, Kuppevell van THMSM, Oosterhof A, & Veerkamp JH (1991) Exp. Cell Res. 195: 
284-294 
24. Gluzman Y, Sambrook JF & Frisque RJ (1980) Proc. Natl. Acad. USA 77: 3898-3902 
25. Klundert van de FAJM, van Eldik GJ, Pieper FR, Jansen HJ and Bloemendal H (1992) Gene 122: 337-
343 
26. Weintraub H, Tapscott SJ, Davis RL, Thayer MJ, Adam MA, Lassar AB & Miller AD (1989) Proc. 
Natl. Acad. Sci. USA 86: 5434-5438 
27. Auffray С & Rougeon F (1980) Eur. J. Biochein. 107: 303-314 
28. Church, GM and Gilbert W (1984) Proc. Natl. Acad. Sci. USA 81: 1991-1995 
29. Raats JMH, Henderik JBJ, Verdijk M, van Oort FLG, Gerards WLH, Ramaekers FCS & Bloemendal 
H (1991) Eur. J. Cell Biol. 56: 84-103 
30. Krimpenfort PJ, Schaart G, Pieper FR, Ramaekers FC, Cuypers HT, van de Heuvel RM, Vree Egberts 
WT, van Eys GJ, Berns A & Bloemendal H (1988) EMBO J. 7: 941-947 
31. Ramaekers FCS, Verheyen RHM, Moesker O, Kant A, Vooys GP & Herman CJ (1983) Am. J. Surg. 
Pathol. 7: 381-385 
32. Broers JLV, Camey DN, Klein Rot M, Schaart G, Lane EB, Vooys GP & Ramaekers FCS (1986) J. 
Celi. Sci. 83: 37-60 
33. Choi J, Costa ML, Mermelstein CS, Chagas С, Holtzer S & Holtzer H (1990) Proc. Natl. Acad. Sci. 
USA 87: 7788-7992 
130 
34. Webster KA, Muscat GEO, Kedes L (1988) Nature 332: 553-557 
35. Gu W, Schneider JW, Condorelli G, Kaushal S, Mandavi V & Nadal-Ginard В (1993) Cell 72: 309-
324 
36. Crescenzi M, Fleming TP, Lassar AB, Weintraub & Aaronson SA (1990) Proc. Nail. Acad. Sci. USA 
87: 8442-8446 
37. Brennen TJ, Edmondson DG & Olson EN (1990) J. Cell Biol. 110: 929-937 
131 

Summary/Samenvatting 

SUMMARY 
The cytoskeletal proteins desmin and vimentin belong to the family of the intermedia-
te filament (IF) proteins. This family consists of 6 different classes of proteins, which 
show a more or less tissue-specific pattern of expression. Desmin is the IF protein of 
muscle tissue and its expression is mainly confined to skeletal muscle, smooth muscle and 
the heart. Vimentin exhibits a more complex pattern of expression. During development, 
this protein is expressed in various organs but later on it is gradually replaced by a more 
specialized IF protein. However, vimentin remains expressed in mesothelial tissue and in 
the eye lens. Moreover, almost all cells in culture start to express vimentin, irrespective 
of their origin. 
The functions of the various IF proteins have long remained elusive. In the past few 
years, however, some light has been shed on the function of a few more specialized IF 
proteins. In chapter 1 the expression regulation of all IF proteins is described. Furthermo-
re, their most important tentative functions are delineated. 
In chapter 2 and 3, more particularly, the expression regulation of vimentin is 
described. The experiments have been aimed at identifying the elements governing 
vimentin expression in cells which contain vimentin in vivo and in the tissue-culture 
induction mechanism. In the vimentin promoter region an element has been defined which 
binds a protein complex, named AP-1. This complex consists of proteins, which are all 
inducible by growth factors. Binding of the AP-1 complex results in strong activation of 
the transcription. The fact that the components of the AP-1 complex are all inducible by 
growth factors and serum, forms one of the possible explanations for the tissue culture 
induction. During the course of these studies it became clear that a special kind of 
regulation is used for suppression of transcription in cells without vimentin. In the 
vimentin-negative breast cancer cell line MCF-7 the action of the AP-1 enhancer is extin-
guished by adjacent sequences. 
In chapter 4, evidence is provided for another kind of a down-regulatory mechanism, 
which may be especially important during development. The AP-1 enhancer mentioned in 
chapters 2 and 3 can also be silenced because of interference by another trans-acting 
factor. This factor, which belongs to the family of the hormonal receptors, prevents the 
AP-1 protein complex from transactivation. 
In chapter 5, the expression regulation of the muscle-specific IF protein desmin is 
described. It was known already that the most important sequences for transcription 
regulation resided in a region just upstream from the transcription initiation site. In this 
region, and in another region further upstream, specific sequences are present which serve 
as targets for the muscle determination factors belonging to the recently identified MyoD 
family. Each of these transcription factors is able to induce differentiation along the 
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myogenic lineage in a number of non-muscle cells. Recognition sites for these factors 
have been found in regulatory regions of several muscle-specific genes. The MyoD 
binding sequence in the desmin 5' upstream region, situated most closely to the transcrip­
tion start site, is essential for promoter function. The more upstream binding site forms an 
enhancer region together with another newly identified element, named MEF-2. For full 
enhancer function both the MyoD binding element and the MEF-2 sequence must be 
present. 
The fact that desmin expression can also be independent of at least two of the 
members of the MyoD family is described in chapter 6. After transformation of primary 
skeletal muscle cells with SV40 Large Τ sequences terminal differentiation into myotubes 
is inhibited and mRNAs for MyoD and myogenin could not be detected. 
The data provided in chapters 5 and 6 contribute to a better understanding of the 
regulation of desmin expression in skeletal muscle. In smooth muscle and heart, however, 
to date no evidence has been found for the involvement of members of the MyoD family 
in transcription regulation. This implies a totally different, as yet unknown, mechanism 
for desmin expression regulation. 
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SAMENVATTING 
De cytoskeletaire eiwitten desmine en vimentine maken deel uit van de familie van de 
intermediaire filament-eiwitten. Deze familie omvat 6 verschillende subgroepen die allen 
min of meer weefsel specifiek tot expressie komen. Desmine is kenmerkend voor spier-
weefsel en wordt dan ook voornamelijk gevonden in skeletspierweefsel, glad spierweefsel 
en het hart. Vimentine vertoont een veel complexer expressiepatroon. Vroeg in de 
ontwikkeling van een organisme wordt vimentine aangetroffen in verschillende weefsels, 
waarna weer uitschakeling van het gen plaats vindt in latere stadia. Het eiwit blijft 
aanwezig in mesotheliale weefsels en in de ooglens. Bovendien blijken vrijwel alle cellen 
die in weefselkweek worden gebracht het vimentine-gen aan te schakelen ongeacht hun 
herkomst. 
De functie van de verschillende IF eiwitten is lange tijd onduidelijk geweest. Pas 
enkele jaren geleden is een tipje van de sluier opgelicht voor wat betreft de meer 
gespecialiseerde typen. In hoofdstuk 1 is de expressie-regulatie beschreven van de 
verschillende IF eiwitten. Daarnaast komen in dit hoofdstuk ook enkele voorlopige 
conclusies met betrekking tot hun functies aan de orde. 
In hoofdstuk 2 en 3 wordt meer in het bijzonder, de expressie-regulatie van vimentine 
nader toegelicht. De in deze hoofdstukken beschreven experimenten waren erop gericht 
om de promotergebieden te karakteriseren die betrokken zijn bij het sturen van vimentine-
expressie in cellen waarin het eiwit reeds in vivo voorkomt en in het achterhalen van het 
mechanisme dat verantwoordelijk is voor de weefselkweek-inductie. Hierbij is gevonden 
dat zich in het vimentine-proinotergebied een zogenaamde "enhancer-sequentie" bevindt 
die noodzakelijk is voor een hoge expressie van het eiwit. Aan deze sequentie kan een 
complex van eiwitten binden, het AP-1 complex, waarbij een sterke stimulatie van 
transcriptie optreedt. De eiwitten die deel uitmaken van het AP-1 complex zijn allen 
induceerbaar door groeifactoren en door serum. Dit is één van de mogelijke verklaringen 
voor de weefselkweek-inductie. Ook werd ontdekt dat er een speciaal regelmechanisme 
bestaat voor verlaging van de promoter-activiteit van vimentine in cellen die dit eiwit niet 
bezitten. In de vimentine-negatieve borsttumor-cellijn MCF-7 zijn regulerende eiwitten 
actief die aan weerszijden van de "enhancer" kunnen binden en die daarbij de werking van 
de promoter onderdrukken. 
In hoofstuk 4 wordt nog een ander model besproken dat remming van vimentine-
expressie tot gevolg heeft. De hier voorgestelde situatie zou vooral belangrijk kunnen zijn 
tijdens de ontwikkeling. De werking van het AP-1 complex, zoals beschreven in hoofdstuk 
2 en 3 kan ook verstoord worden doordat interferentie optreedt met een andere trans-
criptiefactor, afkomstig uit de familie van de hormonale receptoren. Het resultaat is dat 
het AP-1 complex verhinderd wordt om stimulatie van de transcriptie te bewerkstelligen. 
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In hoofdstuk 5 wordt de regulatie van de transcriptie van het spierspecifieke IF eiwit 
desmine beschreven. Het was al bekend dat bepaalde sequenties, die verantwoordelijk zijn 
voor deze regulatie, zich bevinden in een gebied dat zeer dicht bij de startplaats voor de 
transcriptie is gelegen. In deze regio en in een gebied dat verder stroomopwaarts ligt zijn 
elementen gevonden die kunnen dienen als bindingsplaatsen voor transcriptiefactoren. 
Deze eiwitten behoren tot een recentelijk ontdekte familie van spierdeterminantfactoren. 
De familie bestaat uit 4 leden waarvan MyoD de bekendste is. Elk van deze eiwitten kan 
een groot aantal celtypen aanzetten tot spierceldifferenliatie. Sindsdien zijn er in regulatoi-
re regio's van verschillende spierspecifieke genen bindingssequenties voor deze factoren 
gevonden. De zogenaamde MyoD bindingsplaats in de desinine promoter die het meest in 
de nabijheid van de transcriptiestartplaats is gelegen is essentieel voor de werking van 
deze promoter. De verder stroomopwaarts gelegen sequentie vormt samen met een ander 
element, dat MEF-2 genoemd wordt, een eenheid. Beide elementen zijn nodig om de 
basale activiteit van de promoter te verhogen. 
Dat de regulatie van desmine-expressie niet alleen afhankelijk is van bovengenoemde 
elementen wordt geïllustreerd in hoofdstuk 6. Na transformatie van primaire skeletspier-
cellen middels bepaalde virus-gecodeerde eiwitten zoals SV40 "large Τ antigen" wordt de 
differentiatie geremd maar desmine blijft aanwezig. Dit, in tegenstelling tot de twee 
belangrijkste vertegenwoordigers van de MyoD familie, MyoD en myogenine, die beiden 
verdwijnen. In hart en glad spierweefsel zijn nog nooit leden van de MyoD familie aange­
toond. Dit betekent dat de regulatie van desmine-expressie in deze weefsels op een andere 
manier moet plaatsvinden. 
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